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Abstract 
The primary cilium has recently been recognised as an essential 
regulator of the Sonic hedgehog (Shh) signalling pathway. Mutations that 
disrupt cilia function in humans can cause conditions known as ciliopathies. A 
wide range of phenotypes is observed in chick and mouse ciliopathy models, 
including polydactyly, craniofacial defects and polycystic kidneys. The Shh 
pathway and therefore primary cilia are vital for many developmental processes, 
including embryonic muscle development, with recent evidence suggesting they 
may also play a role in adult muscle regeneration. Our studies focus on the 
Talpid3 gene, which encodes a centrosomal protein required for primary cilia 
formation and Shh signalling. The Talpid3 loss-of-function mutant has perturbed 
ciliogenesis and displays many of the phenotypes that are typically associated 
with developmental Shh mutants and with ciliopathies. Talpid3 mutants have 
defects in Shh signalling, and processing of Gli transcription factors is affected 
in structures such as the developing limb buds and the neural tube. However, 
the role of Talpid3 in muscle development and regeneration remains unknown.  
The role of Talpid3 in adult muscle regeneration was investigated using a 
tamoxifen inducible, satellite cell specific knock-out of Talpid3 in mice. This 
mouse model was generated by crossing Talpid3 floxed mice to a mouse 
carrying an inducible Pax7-CreERT2 allele. To determine whether loss of 
Talpid3 affects muscle regeneration a cardiotoxin injury model was used. This 
showed that loss of Talpid3 in satellite cells results in a regeneration defect as 
fibres were smaller after 5, 10, 15 and 25 days of regeneration compared to 
control mice. This defect may be due to a reduced ability of Talpid3 mutant 
satellite cells to differentiate. We also show that Talpid3 plays a role in satellite 
cell self-renewal as we observe a complete loss of regeneration in some areas 
of the muscle following repeat injuries.  
We provide the first evidence that Talpid3 is critical for the regeneration 
of skeletal muscle following injury. 
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Chapter 1 Introduction  
1.1 Skeletal Muscle 
Skeletal muscle is by weight the largest organ in the human body, making 
up approximately 40% of total body weight and containing 50-75% of the body’s 
proteins (Frontera and Ochala, 2015). Skeletal muscle is vitally important to 
health and wellbeing, contributing to many bodily functions, both mechanical 
and metabolic. Mechanically it can convert chemical energy to mechanical 
energy to produce force for movement and posture. Chemically it contributes to 
basal energy metabolism to produce heat and serves as a store of 
carbohydrates and amino acids that can be used by the body in times of 
starvation, stress and chronic illness. It is therefore of great importance that 
proper muscle structure and function is maintained.  
 
1.1.1 Structure of skeletal muscle 
The structure of skeletal muscle is characterised by its very ordered 
arrangement of muscle cells and their associated extracellular matrix (Fig. 1.1). 
An individual muscle is surrounded by a connective tissue layer called the 
epimysium, within which are bundles of muscle cells surround by their own 
connective tissue layer called the perimysium. Individual muscle cells (from 
here on referred to as myofibres) are multinucleated, post-mitotic cylindrical 
cells with a cell membrane known as the sarcolemma. Myofibres are large, 10-
50µm in diameter (Lodish et al., 2000) and can range from 1-500mm in length 
depending on the muscle and species (Paul and Rosenthal, 2002). Myofibres 
can run the full length of the muscle from tendon to tendon (as in most muscles 
in humans and rodents) or will terminate intrafascicularly (rabbits, cats, cattle 
and chick) (Paul and Rosenthal, 2002). 
As mentioned myofibres are multinucleated, with the nuclei, for the most 
part, being evenly spaced throughout the cell and located at the periphery. 
Exceptions are seen in the end plate and at some myotendinous junctions in 
which nuclei are observed at a higher density (Bruusgaard et al., 2003). Each 
nucleus has its own domain, known as the myonuclear domain, and is 
responsible for the synthesis of proteins required within that domain. After 
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synthesis organelles and structural proteins will remain in the vicinity of their 
creating nucleus (Pavlath et al., 1989).  
The cytoplasm of myofibres, referred to a sarcoplasm, is filled mainly 
with myofibrils. Myofibrils are made up of myofilaments, the two most abundant 
being actin and myosin, arranged in a very ordered manner into structures 
known as sarcomeres that make up the basic contractile elements of skeletal 
muscle. It is the sliding of the actin and myosin filaments over each other that 
allows for force generation and contraction of skeletal muscle (Frontera and 
Ochala, 2015).  
 Other non-cellular components of skeletal muscle that are vital for 
function include a complex of proteins that are associated with the sarcolemma 
and connect to the internal myofilaments. Perhaps the most well studied of 
these is the dystrophin glycoprotein complex, which links the actin filaments 
with the sarcolemma and the extracellular matrix which stabilises the myofibres. 
Mutations in the dystrophin gene that lead to total or partial loss of dystrophin 
leave the sarcolemma destabilised making myofibres susceptible to injury 
during contraction. These mutations are responsible for the Duchenne and 
Becker muscular dystrophy disorders (Thomas, 2013). 
 Finally, residing between the sarcolemma of myofibres and the basement 
membrane, a specialised extracellular matrix, are the resident stem cells of 
skeletal muscle named satellite cells (SCs). SCs contribute to growth and 
homeostasis of skeletal muscle and are also the primary cell population 
responsible for repair and regeneration of myofibres following trauma or injury. 
More detail on SC structure and function is given in section 1.1.6.  
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Figure 1.1 Skeletal muscle structure. 
Skeletal muscle is composed of multinucleated myofibres, each of which is surrounded by a 
connective tissue layer known as the endomysium, bundled together into muscle fascicles and 
surrounded by the perimysium. Multiple muscle fascicles are surrounded by the epimysium and 
form the individual muscle. Image from (OpenStax, 2016) 
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1.1.2 Embryonic development of skeletal muscle 
All skeletal muscle found in vertebrates, except some muscles of the 
head and neck, develops from mesodermal structures that form either side of 
the neural tube and notochord known as somites. These transient structures 
start off as epithelial spheres; the ventral portion undergoes an epithelial to 
mesenchymal transition to form the sclerotome, a cartilage precursor cell layer, 
whilst the dorsal portion of the somite remains epithelial, forming the 
dermomyotome, a layer of skeletal muscle and dermis precursors. The 
dermomyotome can be further segregated into the medial and lateral portions; 
cells in the medial dermomyotome are precursors for the epaxial muscles of the 
back and intercostal muscles; cells in the lateral dermomyotome are precursors 
for the hypaxial muscle of the limbs and the remaining skeletal muscle (Ordahl 
and Le Douarin, 1992).   
Following the initial segmentation of the somite, muscle precursor cells 
begin to migrate from the dermomyotome, either into other locations within the 
embryo such as the limbs or towards the anterior, or migrate below the 
dermomyotome to create a structure within the somite known as the myotome. 
From these locations precursor cells begin to differentiate into myoblasts 
(committed muscle progenitors), multiple myoblast will then fuse together to 
form multinucleated myotubes. The final maturation of skeletal muscle is the 
formation of myofibres from multiple myotubes. The molecular signals involved 
in this process have been well characterised over many years of research and 
are detailed in the following sections.  
 
1.1.2.1 Inductive signals controlling somitogenesis 
The development and specification of the somites is controlled by signals 
from surrounding structures; the neural tube, the notochord and the overlying 
ectoderm (Munsterberg and Lassar, 1995). Somite explant experiments and in 
vitro manipulation of chick embryos have been used to reveal the combinatorial 
signals required to induce myogenesis within the somite. These types of 
experiments allow for co-culture of somites with other tissues or the addition of 
growth factors to investigate the inductive signals and have revealed that it is a 
combination of Shh, Wnt and BMP signals that determine the differentiation of 
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the different layers of the somite (Munsterberg et al., 1995; Zammit et al., 2006) 




The early differentiation of somites and the specification towards the 
myogenic lineage occurs in a multistep process that requires specific spatial 
and temporal expression of Sonic Hedgehog (Shh) and members of the 
Wingless (Wnt) and Bone Morphogenic Protein (BMP) families. It was somite 
culture experiments with bacterially produced N-Shh and cells that expressed 
Wnt-1, Wnt-3 or Wnt-4 that showed a transient Shh signal with prolonged Wnt 
signals can stably induce myogenesis in the ex vivo tissue (Munsterberg et al., 
1995).  
 
Figure 1.2 The inductive signals required for the differentiation of somites. 
A combination of Shh, Wnt and BMP are required to pattern the somite. In the dorsal 
dermomyotome WNT and SHH signals induce myogenesis through upregulation of Myf5. A 
combination of Shh and Wnt signals are required for the development of the dermomyotome, 
whilst Shh alone causes the differentiation of sclerotome.  Repressive activity of BMP in the 
dorsal dermomyotome is inhibited by Noggin to allow cells migrating to the myotome to 
continue with a myogenic programme (black arrow), whilst other cells are exposed to high 
BMP and adopt a dermatome fate (grey arrow). NT= Neural tube, FP= Floor plate, NC= 
Notochord, SC= Scleretome, DM= Dermomyotome, MY= Myotome. Adapted from 
(Gustafsson et al., 2002) 
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1.1.2.2 Paired box (PAX) transcription factor family  
The initial inductive signals of Shh, Wnt and the inhibitory signals of BMP 
(Reshef et al., 1998) together control the expression of a family of paired box 
(PAX) transcription factors. Pax1 is expressed in the cells of the sclerotome and 
is maintained by continuous Shh signals, which alters the way in which these 
cells respond to BMP signalling, priming them for condrogenesis (Munsterberg 
et al., 1995; Murtaugh et al., 1999) whilst Pax3 is expressed initially in the pre-
somitic mesoderm and throughout the whole early somite. Pax3 expression is 
repressed by high levels of Shh and therefore becomes confined to the 
dermomyotome containing cells fated for the myogenic lineage (Cairns et al., 
2008).  
Following the initial acquisition of cell fate within the somite some cells 
fated for the myogenic lineage must delaminate and migrate away from the 
somite to produce distal muscles, such as in the limb. Pax3 is required for this 
migration to occur. The spontaneous Pax3 mouse mutant, splotch, shows a 
severe myogenic phenotype; this mutant has been used extensively to study 
the role of Pax3 in skeletal muscle development. In situ hybridisation of wild 
type embryos at E9.5 showed Pax3 expression in cells in the limb bud, this 
expression is not present in the homozygous splotch mutant (Bober et al., 
1994), DiI labelling of somitic cells in wild type and homozygous splotch 
mutants revealed that it is not a failure of the splotch mutant cells within the limb 
bud to express Pax3 but instead a failure of these cells to migrate from the 
somite. In wild type embryos DiI labelled cells were seen up to 300µm from the 
injection site however labelled cells failed to migrate further than 30µm in 
splotch mutants (Daston et al., 1996). The requirement for Pax3 for myoblast 
migration is due to its ability to modulate the expression of c-MET. The 
upregulation of c-MET promotes the migration of myoblasts towards the c-MET 
ligand, hepatocyte growth factor/ scatter factor which is expressed in the limb 
bud (Epstein et al., 1996). 
Pax3 also plays a role in the migration of myoblasts into other regions of 
the embryo such as into the neck where myoblasts would contribute to the 
musculature of the throat and the tongue, this role was established following the 
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loss of Myf5 positive cells in these areas in Pax3 mutant mice (Tajbakhsh et al., 
1997).  
Once commitment to the myogenic lineage has been established there 
must be some regulation that allows the maintenance of the precursor pool 
whilst also allowing the differentiation and maturation into skeletal muscle. This 
is controlled in part by Pax3 and members of the Fibroblast Growth Factor 
(FGF) family. FGF is a potent stimulator of proliferation in myoblast cells and 
must be downregulated in order for myoblasts to differentiate (Clegg et al., 
1987). Interference of the FGF pathway by upregulating a mediator of the 
pathway, Sprouty1, prevents Pax3/Pax7 positive myogenic cells from 
progressing through the muscle differentiation programme (Lagha et al., 2008). 
Fgf4 is a direct target of PAX3, established through the presence of a PAX3 
binding site located in the 3’ flanking region of the gene. Together with the 
evidence that PAX3 also directly targets the Myf5 gene, this shows the 
importance of PAX3 in maintaining a balance between stem cell maintenance 
and tissue differentiation. 
Another member of the PAX family, Pax7, is also expressed during 
muscle development. Pax3 and Pax7 appear to have both similar and divergent 
roles during muscle development. Replacement of Pax3 with Pax7 allowed for 
normal somite development and formation of the dermomyotome however 
development of limb muscles was completely abolished. This further supports 
the role Pax3 plays in the migration of myogenic cells to distant muscle 
locations (Relaix et al., 2004). 
 
1.1.2.3 Myogenic regulatory factors (MRFs) 
 Whilst some myogenic precursors will migrate to other areas of the 
embryo, the first differentiated muscle appears within the somite, forming a 
structure called the myotome, located just below the dermomyotome. 
Subsequently myogenic cells from the dermomyotome will delaminate and 
migrate into the myotome, at this point Pax3 is downregulated and these cells 
rapidly differentiate activating a collection of myogenic determination genes. 
These genes are a group of basic helix-loop-helix transcription factors known as 
myogenic regulatory factors (MRFs) which are exclusively expressed in skeletal 
muscle progenitors and are very potent in inducing the formation of skeletal 
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muscle. Artificial expression of the MRFs in other cells types can force the 
expression of myogenic specific proteins and induce the formation of muscle 
fibres demonstrating their potency as myogenic determining factors. The ability 
of the four main family members, MyoD (Davis et al., 1987), Myogenin (Wright 
et al., 1989), Myf5 (Braun et al., 1989) and MRF4 (Rhodes and Konieczny, 
1989), to convert fibroblast cell lines to a myogenic fate aided in their discovery 
as master regulators of myogenesis.  
The temporal and spatial expression of the MRFs has been well 
characterised using in situ hybridisation and is summarised in Table 1.1. The 
function of each MRF has also been well characterised by examining the 
muscular phenotypes of mouse mutants with different combinations of MRF 
genes inactivated.  
 
 
The first of the MRFs to be expressed in the developing somite is Myf5 
and its expression is regulated by Pax3. The loss of Pax3 results in a loss of 
Myf5 expression in the hypaxial domain, conversely over expression of Pax3 in 
vitro can induce the expression of Myf5 in mesodermal tissue in the absence of 
other inductive signals such as Shh and Wnt (Maroto et al., 1997). Pax3 has 
been shown to act directly upstream of Myf5 in the hypaxial dermomyotome and 
its derivatives by binding to a regulatory region that is located 5’ to the Myf5 
locus (Bajard et al., 2006).  
Following the formation of the dermomyotome and the myotome, there 
begins to be a distinction between the medial and lateral portions, distinguishing 
the epaxial and hypaxial muscle. This is particularly evident with the expression 
of Myf5 which is first activated in medial, epaxial muscle precursors at E8.0 and 
Table 1.1 Summary of MRF temporal expression during embryonic 
development. 
 9 
at E9.75 in hypaxial muscle precursors in mouse embryos. Myf5 expression 
disappears from somites by E14 (Ott et al., 1991).  
The expression of the 3 remaining MRFs; MyoD, Myogenin and Mrf4 
differ in their timing of expression in different regions within the embryo. In mice 
MyoD expression is almost simultaneous to that of Myf5 in the head and limb 
muscle precursors (Buckingham, 1992) but is the last MRF to be expressed in 
the epaxial and hypaxial somites at around E10.5. In the somite Myogenin is 
expressed at E8.5 and Mrf4 at E9.5 (Sassoon et al., 1989). Although Myf5 
appears to activate the expression of MyoD in the hypaxial domain of the 
somites, the function of these two MRFs seems to be somewhat compensatory. 
Mutant mice with a homozygous inactivation of Myf5 do not show any defects in 
skeletal muscle formation at birth, however they do show a delay in the 
expression of muscle proteins such as actin and myosin heavy chain (MHC), 
which are absent in the somites of E9.5 Myf5 mutants but present in wild types 
(Braun et al., 1992). Similar results were also obtained when mutating MyoD in 
mice; formation, morphology and protein expression were indistinguishable from 
wild types, however mutant mice did show a significant increase in Myf5 
expression in neonatal skeletal muscle, which in wild types is almost absent 
(Rudnicki et al., 1992). These findings suggest that Myf5 and MyoD may be 
able to compensate for each other. To further investigate the roles of Myf5 and 
MyoD, mouse mutants were generated that lacked expression of both factors. 
These mice were completely void of skeletal muscle, showing that presence of 
either Myf5 or MyoD is essential for muscle formation, but they are in part 
functionally redundant. The double mutants do not form myoblasts, suggesting 
that Myf5 and MyoD play a role in the determination and differentiation of initial 
myoblasts (Rudnicki et al., 1993). 
Analysis of Myogenin (Mgn) and MRF4 (also known as Myf6) mutants 
details sequential roles for these MRFs as myogenesis progresses. Mice with 
mutations in Mgn fail to form functional skeletal muscle while still generating a 
few isolated differentiated fibres surrounded by unfused cells in muscle 
developing regions. The levels of MyoD expression in E15.5 embryos suggests 
that these cells are committed myoblasts, but the lack of multi nucleated 
myofibres indicates Mgn plays a role in differentiation and fusion of myoblasts 
into myofibres. (Hasty et al., 1993).  
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The role of MRF4 has been somewhat harder to distinguish due to its 
biphasic expression throughout development. The initial phase is a short, 
transient phase of expression from E10-E11.5, which is followed by a second 
phase after E16. Expression in the second phase is prolonged, with MRF4 
being the most abundantly expressed MRF postnatally (Bober et al., 1991). This 
biphasic expression suggests a potential early role for MRF4 in initial myoblast 
determination, supported by experiments in various Myf5/MyoD double mutants 
in which Mrf4 expression is downregulated in some allelic variants but not 
others. In Myf5/MyoD double mutants in which Mrf4 expression is maintained 
myogenesis is still able to occur (Kassar-Duchossoy et al., 2004). In Mrf4 
mutants there is a reduction in Myf5, MyoD and Mgn expression at E10. 
Suggesting a role for MRF4 in myoblast specification. The period of expression 
seen later in development during the foetal and postnatal stages suggests that 
MRF4 also plays a role in later myofibre formation, supported by the fact that 
Mrf4 homozygous mutants show a reduction in some intercostal muscles 
between the ribs (Patapoutian et al., 1995; Vivian et al., 2000). 
Using the spatiotemporal expression of MRFs along with the phenotypes 
of the mutants it is possible to construct a model of muscle development that 
details the factors involved in regulating and driving each stage of myogenesis, 
summarised in Fig. 1.3.  
Figure 1.3 Regulation of myogenesis by specific temporal expression of MRFs.  
Myf5 and MyoD are involved in the initial differentiation of somitic cells to primary myoblasts, 
however their functions are somewhat overlapping and can compensate for each other. 
There is also evidence that MRF4 may play a role at this stage, as a determining factor for 
the myogenic lineage. Myogenin is involved in the maturation and further differentiation of 
myoblasts to myotubes with MRF4 expression reappearing to induce maturation into 
myofibres. Adapted from (Rudnicki et al., 1993) 
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1.1.3 Satellite cell structure and origin 
Satellite cells (SCs) are mononucleated, undifferentiated cells that were 
first observed independently by Alexander Mauro and Bernard Katz in 1961. 
They are resident stem cells in vertebrate skeletal muscle. Mauro described 
their location on the periphery of adult skeletal muscle fibres, between the 
plasma membrane (PM) and the basement membrane (BM) (Fig. 1.4). The SC 
has a distinct morphological appearance with the majority of the cell being 
taken up by the nucleus, leaving room for few organelles (Katz, 1961; Mauro, 
1961). The nucleus is also significantly smaller than the myonuclei found within 
the myofibre (Watkins and Cullen, 1988). 
Early labelling experiments with [3H]thymidine showed SCs in adult 
skeletal muscle are mitotically quiescent but can quickly enter the cell cycle and 
become mitotically active following muscle injury ((Snow, 1977) cited by (Yin et 
al., 2013)). These studies also demonstrated the ability of SCs to proliferate and 
give rise to myoblasts, contributing to myofibre nuclei during muscle growth and 
regeneration (Moss and Leblond, 1970; Reznik, 1969).  
SCs were originally identified by their morphology and location within 
skeletal muscle. Nowadays many genetic and molecular markers are used to 
confirm the identity of a SC. The transcription factor Pax7 is expressed in all 
SCs and has become the canonical marker due to its specific expression in 
quiescent and early proliferating SCs across many species. Other transcription 
factors (Pax3, Myf5 and MyoD) and many membrane proteins such as, CD34, 
cMet, M-cadherin, integrin ⍺7 have also been used to identify SCs, however 
these are not unique to SCs in the adult organism and are not expressed in all 
SCs at a given time point, therefore Pax7 remains the most important marker 




The embryonic origin of SCs in adult skeletal muscle was first discovered 
using quail-chick chimera experiments in which quail somites were transplanted 
into developing chicken embryos. Using staining techniques to distinguish quail 
DNA from that of the chick, it could be seen that both myonuclei and SC nuclei 
contained quail DNA and were therefore of somitic origin ((Armand et al., 1983) 
cited in (Seale and Rudnicki, 2000)). The specific origin within the somite of 
SCs was not identified until many years later. GFP-labelling techniques and 
various Pax3 reporter mouse lines have provided evidence that SCs, like 
myoblasts, originate from specific regions within the dermomyotome. Muscle 
Figure 1.4 The structure and location of SCs on myofibres. 
(A) A longitudinal view of satellite cells shows its presence on the periphery of the myofibre of 
the tibialis anticus of the frog. (B) A transverse section through the satellite cell on a rat 
sartorius myofibre reveals the close contact between the muscle cells plasma membrane (mp) 
and that of the satellite cell (sp) with the basement membrane overlaying the two (bm).  
Adapted from (Mauro, 1961) 
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cells and SCs of the limbs develop from Pax3+ cells within the hypaxial 
dermomyotome (Schienda et al., 2006) whilst SCs located on muscles of the 
trunk originate from Pax3+ cells in the epaxial domain (Gros et al., 2005).  
Having determined the somitic origin of the majority of SCs it is also 
important to note the timing of expression of Pax7 is different depending on the 
location of the developing SCs. Those cells originating in the central region of 
the dermomyotome and expressing both Pax3 and Pax7 migrate into the 
forming myotome. A proportion of these cells will then continue to proliferate 
and in late foetal stages become incorporated under the basal lamina of the 
developing muscle fibres within the trunk, these cells become the SCs of the 
postnatal trunk skeletal muscles (Relaix et al., 2005). In contrast, cells that 
migrate from the dermomyotome into the limb bud will express Pax3 but not 
Pax7 whilst migrating. Whilst only expressing Pax3 these progenitors remain 
multipotent and have the potential to give rise also to limb vasculature and 
muscle cells (Kardon et al., 2002). In the mouse, it is not until E11.5 that a 
population of these cells will begin to express Pax7 restricting them to the 
myogenic lineage (Hutcheson et al., 2009). Again, a proportion of these cells 
will withdraw from the cell cycle to become the SCs of the postnatal limb 
muscles. 
As established, the majority of SCs have a somitic origin, however there 
is also an argument for a small portion of the SC pool to be of non-somitic 
origin. An unexpected finding from embryonic dorsal aorta explants showed 
they are able to give rise to myogenic precursor cells that have satellite cell like 
properties (morphology and expression of myosin). These cells expressed 
endothelial markers that true SCs also express and could contribute to foetal 
muscle growth and adult muscle regeneration (De Angelis et al., 1999) 
suggesting some SCs may be of a non-somitic origin. However, it has now been 
demonstrated that some cells of the somite are able to form both endothelial 
and myogenic lineages (Kardon et al., 2002), with later confirmation that some 
cells of the dorsal aorta are derived from the same Pax3+ population as 
myogenic cells, it is therefore possible that this relationship is due to having a 
common embryonic origin within the somite (Esner et al., 2006). 
In foetal development for the determination of a cell to become a 
quiescent satellite cell (QSC) there must be the expression of Pax7, as shown 
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by the almost non-existence of satellite cell-like populations in surviving adult 
Pax7 null mice (Seale et al., 2000). However, research by Lepper et al. (2009) 
suggested that the requirement of Pax7 is restricted to the perinatal period. 
Pax7Cre/fl mice in which Pax7 expression is removed in adulthood by the 
administration of tamoxifen, appear to still undergo muscle regeneration. The 
distinction between the requirement of Pax7+ satellite cells and Pax7 
expression in already determined SCs was achieved by the use of 
Pax7+/CE;R26ReGFP-DTA/lacz mouse to selectively ablate SCs upon induction with 
tamoxifen. In these mice muscle regeneration does not occur. This lead to the 
conclusion that muscle regeneration is dependent on the presence of Pax7+ 
satellite cells but not necessarily on the active expression of Pax7 (Lepper et 
al., 2011). However, it was later shown by von Maltzahn et al. (2013) and 
Gunther et al. (2013) that the level of recombination using the inducible Pax7-
Cre lox system was highly dependent on the tamoxifen scheme used. Due to 
SCs amazing ability to proliferate and contribute to muscle repair any ‘escaper’ 
SCs that have not undergone recombination would be able to regenerate 
injured muscle, therefore producing results that appear to show Pax7 null SCs 
repairing muscle. Using a tamoxifen scheme that minimised the possibility of 
‘escaper’ cells later revealed a drastic loss of muscle regeneration following the 
removal of Pax7, concluding that Pax7 is absolutely required for the normal 
function of SCs. 
The satellite cells in uninjured muscle reside quiescently in their niche as 
indicated by their low metabolic rate, cytoplasmic volume and number of 
mitochondria (Montarras et al., 2013). Quiescence in stem cells is actively 
maintained through the production of intracellular inhibitors of signalling 
pathways such as Sprouty1 (Spry1). QSCs express tryrosine kinase receptors 
that transduce IGF, FGF, HGF and PDGF signals, all of which can activate 
SCs. However, through the expression of Spry1, SCs can mitigate these signals 
and remain quiescent (Shea et al., 2010). Notch, BMP and Wnt signalling have 
also all been implicated in maintaining SC quiescence (reviewed in (Montarras 
et al., 2013)).  
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1.1.4 Skeletal muscle regeneration 
As suggested in section 1.1.6 the primary function of SCs in the adult 
organism is to repair and regenerate skeletal muscle following injury. It has 
been shown by labelling Pax7+ satellite cells that all regenerated muscle fibres 
after injury develop from satellite cells (Murphy et al., 2011). Muscle 
regeneration occurs in a multistep process, starting with a period of muscle 
degeneration and an inflammatory response which leads to the activation, 
proliferation and differentiation of SCs, finally there is a period of myofibre 
maturation to restore muscle to its functional capacity. 
 
1.1.4.1 Muscle degeneration and inflammatory response 
Following an injury that causes damage to the muscle sarcolemma, there 
is a period of muscle degeneration. This involves cellular necrosis, promoting 
the breakdown of the plasma membrane, an influx of calcium and the activation 
of calcium dependent proteases which degrade myofibrils and other cellular 
proteins ((Armstrong, 1990) cited by (Yin et al., 2013)). This necrosis activates 
the inflammatory response prompting an influx of immune cells to the site of 
injury. The first immune cells to appear are neutrophils that can be detected 
within the first hour and can remain elevated for up to 5 days post injury 
(Tidball, 2005). The secondary influx of inflammatory cells is by macrophages 
which happens in two waves, the first being inflammatory macrophages (M1) 
that secrete pro-inflammatory cytokines and phagocytose necrotic debris, these 
reach their peak concentration within about 24hrs of injury. Following are the 
anti-inflammatory macrophages (M2) that secrete anti-inflammatory cytokines, 
reaching their peak 2-4 days after injury (reviewed in (Ciciliot and Schiaffino, 
2010)). It is these M2 macrophages that are thought to be responsible in part 
for the activation and proliferation of myogenic precursors and SCs. 
Administration of macrophage enhanced medium has been shown to markedly 
increase the regenerative capacity of damaged muscle (Cantini et al., 2002). 
Conversely, suppression of M2 macrophages impairs muscle regeneration. 
More specifically, when M2 macrophages are impaired there is significantly less 
proliferation of SCs (Segawa et al., 2008).  
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1.1.4.2 Satellite cell activation and differentiation 
The second stage of muscle regeneration is characterised by the 
activation, proliferation and differentiation of SCs. As mentioned earlier, SCs 
become activated in response to the influx of inflammatory cells, namely M2 
macrophages, following injury. This prompts the SCs to re-enter the cell cycle 
and begin to proliferate. Multiple other signals have also been shown to trigger 
activation of SCs. Hepatocyte growth factor (HGF) was the first potent activator 
of SC proliferation to be discovered (Tatsumi et al., 1998). It can activate SCs 
both in vivo and in vitro however, its levels during muscle regeneration must be 
tightly regulated as it also inhibits differentiation. Injecting HGF into damaged 
limb muscles for three days after injury results in increased myoblast number 
but a reduction in muscle regeneration (Miller et al., 2000). Nitrous Oxide (NO) 
has been shown to play a regulatory role in this process. NO released following 
muscle injury stimulates the release of active HGF which then activates SCs by 
binding to c-Met on the SC surface promoting entry to the cell cycle (Tatsumi et 
al., 2006). 
Sphingomyelin is a component of plasma membranes in many cell types 
across many species and acts as a reservoir of lipid metabolites. Sphingomyelin 
is expressed on quiescent but not activated SCs (Nagata et al., 2006a), one of 
its metabolites, sphingosine-1-phosphate (S1P) is a mitogenic factor and has 
been shown to play a role in SCs entering the cell cycle. As would be expected, 
if S1P is blocked SC proliferation is reduced and muscle regeneration is 
perturbed (Nagata et al., 2006b) demonstrating a requirement in SCs for 
sphingolipid signalling to enter the cell cycle.  
The activation of SCs is not restricted to the immediate site of injury. It 
was established fairly early in SC research that SCs are able to migrate from a 
distant point on the myofibre to the site of injury ((Schultz et al., 1985) cited by 
(Yin et al., 2013)) and can even move from one myofibre to another crossing 
the basement membrane (Hughes and Blau, 1990). GFP-labelled muscle grafts 
have even shown the ability of muscle precursor cells to migrate between whole 
muscles (Jockusch and Voigt, 2003). 
More recent research has also revealed the partial activation of SCs in 
muscles distant from the site of injury. In 2014, a new cell cycle state of QSCs 
was discovered and termed GAlert. This state occurs in SCs via systemic signals 
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following an injury and is proposed as an adaptive state. SCs in GAlert are able 
to enter the cell cycle more rapidly than those in G0 leading to enhanced 
proliferation and differentiation (Rodgers et al., 2014).  
After activation and a period of proliferation some SCs must begin to 
differentiate. The switch between proliferation and differentiation is controlled by 
a balance of Wnt and Notch signalling. Notch-1 is present on QSCs with 
activated Notch-1 levels increasing upon SC activation, this coincides with the 
expression of its ligand Delta. Expression of constitutively active Notch-1 in SCs 
in ex vivo culture increased myoblast proliferation and reduced differentiation 
and formation of myotubes, whilst over expression of a Notch inhibitor, Numb, 
results in a reduction in proliferation but an increase in myotube formation even 
in growth media (Conboy and Rando, 2002). These results suggest Notch is a 
potent mitogen that helps maintain SCs in a proliferative state following 
activation.  
Using a TOPGAL reporter mouse, which expresses β-galactosidase in 
the presence of active β-catenin and therefore is a reporter of the canonical Wnt 
pathway, it has been shown that Wnt signalling is upregulated in SCs within 2-5 
days of injury in vitro and increases progressively with time in cultured SCs 
isolated from myofibres. Artificial upregulation of the Wnt pathway by over-
expression of Wnt-3A led to an accelerated myogenic lineage progression of 
activate progenitors in ex vivo culture. This was also mimicked in vivo with 
injections of Wnt-3A during the proliferative phase following injury, muscles 
were larger with a greater number of myotubes compared to controls 
suggesting a premature entry into a differentiation programme (Brack et al., 
2008). This demonstrates the precise timing required for correct muscle 
regeneration as although there is an increase in myotubes, early differentiation 
can result in there not being enough myoblast to fully heal an injury. Having 
identified Notch signalling as an important regulator of SC proliferation and Wnt 
as a regulator of specification and differentiation (Polesskaya et al., 2003) it was 
shown that there is cross talk between the pathways via GSK3β which allows 
for the switch from proliferation to differentiation by the reduction in Notch and 
increase in Wnt signalling (Brack et al., 2008). 
As in embryonic muscle development, proper commitment, differentiation 
and maturation of skeletal muscle relies on sequential expression of the MRFs. 
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QSCs, in general, do not express MyoD, Mgn or MRF4. Approximately 90% of 
QSCs do express Myf5 as determined by the examination of SCs in Myf5-LacZ 
mice, suggesting the majority of SCs are already committed to the myogenic 
lineage (Beauchamp et al., 2000). These Myf5 positive SCs are also positive for 
CD34 and M-cadherin.  
One of the first studies trying to characterise the temporal expression of 
the MRFs during SC activation used multiplex single cell RT-PCR and showed 
that at time 0 following myofibre and SC isolation all cells were Mgn and MRF4 
negative with only very few expressing Myf5 or MyoD (it is likely that the 
technique was not sensitive enough to detect levels of Myf5). By 24hrs the 
majority of cells had begun to express Myf5 or MyoD alone (32%) or Myf5 and 
MyoD together (35%). Mgn positive cells started to appear after 48hrs and 
always coincided with expression of Myf5 and MyoD. MRF4 was also first 
detectable at 48hrs but was only ever seen in cells that were positive for all 4 
MRFs (Cornelison and Wold, 1997). Mgn and MRF4 expression usually only 
occurs following one or more rounds of proliferation. However, it has been 
reported that MyoD, Desmin and Mgn can be detected in SCs 12hrs after injury 
without signs of proliferation, it has been suggested that these cells may be 
poised to differentiate without proliferation ((Rantanen et al., 1995) cited by (Yin 
et al., 2013)). 
With the production of anti-MRF antibodies it was possible to begin to 
understand the expression pattern in SCs on a protein level which mimicked 
closely the findings from RT-PCR. During quiescence, very few SCs were 
MyoD+, by 24hrs MyoD protein expression could be detected in almost all SCs 
(Zammit et al., 2002). It should be noted that the SC population is 
heterogeneous and a very small number of SCs that are Myf5/CD34/M-cadherin 
negative do not express MyoD within the first 24hrs. The number of 
Myf5/CD34/M-cadherin negative cells does not change within the first 24hrs, 
suggesting this distinct population of SCs do not immediately activate upon 
isolation (Zammit et al., 2002).  
The importance of MyoD in muscle regeneration has been demonstrated 
using MyoD-/- mice that show a greatly decreased ability to undergo muscle 
regeneration but increase in the number of SCs following injury. This suggest 
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that in MyoD-/- mice SCs are proliferating and undergoing self-renewal, but are 
not able to differentiate into myoblasts (Megeney et al., 1996). 
The differing expression of Myf5 and MyoD in populations of SCs 
suggests that these transcription factors have different functions during adult 
muscle regeneration.  While SCs from MyoD-/- mice fail to differentiate but are 
able to proliferate (Megeney et al., 1996), SCs from Myf5-/- mice show a defect 
in proliferation (Gayraud-Morel et al., 2007). It is suggested that Myf5+/MyoD- 
SCs function to have increased proliferation with delayed differentiation, whilst 
Myf5-/MyoD+ SCs function to differentiate early. SCs that are Myf5+/MyoD+ are 
therefore somewhere intermediate in their proliferation and differentiation 
propensities (Yin et al., 2013).  
The majority of SCs will enter the myogenic differentiation programme 
after a few rounds of proliferation with the expression of Mgn and MRF4 
marking the initiation of terminal differentiation (Cornelison and Wold, 1997; 
Smith et al., 1994; Yablonka-Reuveni and Rivera, 1994) and exit from the cell 
cycle. This process is regulated by MyoD expression (reviewed in (Yin et al., 
2013)). At this stage myoblasts begin to fuse to damaged fibres or to each other 
to begin repairing the damaged muscle.  
 
1.1.4.3 Satellite cell self-renewal 
The ability of SCs to self-renew is one of the hallmarks of them being stem 
cells. One of the key markers of SC self-renewal is the expression of Pax7. 
During regeneration, as SCs begin to differentiate Pax7 is downregulated. 
However, there is a small population of SCs that either maintain their Pax7 
expression or re-express it after approximately 72hrs (Zammit et al., 2006). 
Stem cells can self-renew via two types of divisions; asymmetric division gives 
rise to one daughter cell that is destined for differentiation and one that retains 
its stem-ness to maintain the stem cell pool, whilst symmetric division gives rise 
to two daughter stem cells. Some stem cells will have a propensity to divide 
either symmetrically or asymmetrically, SC however have been shown to do 
both (Kuang et al., 2007; Le Grand et al., 2009).  
Research has shown that Pax7+/Myf5- or Pax7+/MyoD- SCs often divide 
asymmetrically in an apical basal orientation on host myofibres producing one 
daughter cells that goes on to differentiate (Pax7+/Myf5+ or Pax7+/MyoD+) and 
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one daughter cell that exits the cell cycle to replenish the stem cell pool 
(Pax7+/Myf5- or Pax7+/MyoD-) (Kuang et al., 2007; Zammit et al., 2006). 
 
1.1.4.4 Contribution of other cell types to muscle regeneration 
SCs have been shown to be the primary cell type required for skeletal 
muscle regeneration, however there is mounting evidence that other cell types 
also contribute. Through transplant experiments and lineage tracing it has been 
shown that bone marrow stem cells and pericytes can also contribute to 
regeneration of myofibres (reviewed in (Yin et al., 2013)). 
Fibro/adipogenic progenitors (FAPs) play a unique role in the muscle 
regeneration process, they do not contribute to regenerating myofibres but 
instead proliferate in response to damage and become a pool of transient cells 
that provide pro-differentiation signals that enhance the rate of differentiation of 
myogenic progenitors (Joe et al., 2010). 
Another cell type of particular interest is a population of multipotential 
progenitors known as side population (SP) cells. SP cells have been identified 
in several tissue types including muscle and are characterized by exclusion of 
Hoechst dye. Muscle derived SP cells initially express no myogenic markers but 
can differentiate into SCs and fuse to myofibres in injured or dystrophic muscle 
whilst also reconstituting the hematopoietic system in lethally irradiated mice 
(Asakura et al., 2002; Gussoni et al., 1999). These SP cells have been shown 
to still be present in Pax7-/- mice and are therefore considered to have a distinct 
origin from SCs (Seale et al., 2000). 
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1.2 Primary Cilia  
1.2.1 Structure and Function 
Primary cilia are microtubular organelles that appear early in eukaryotic 
evolution. Whilst in non-vertebrates, such as C. elegans and D. melanogaster, 
cilia are only present on certain cell types, almost all vertebrate cell types are 
ciliated (Gerdes et al., 2009). Unlike motile cilia, the primary cilium is present as 
a solitary immotile organelle that projects from the apical membrane (Berbari et 
al., 2009). Cilia have 3 distinct domains; the basal body, the transition zone and 
the axoneme (Fig. 1.5). The basal body is docked into the cell membrane and 
consists of 9 microtubular triplets organised in a ring structure, these 
microtubules extend toward the cell surface until they reach the transition zone 
at which they extend as a continuum of doublets into the axoneme (Beisson 
and Wright, 2003; Gerdes et al., 2009).  Unlike motile cilia, the primary cilium 
does not have a central pair of microtubules and it’s structure is referred to as 
9+0 (Fig. 1.5) (Berbari et al., 2009). The basal body is derived from the mother 
centriole following exit from the cell cycle and organises the microtubular 
structure of the basal body and axoneme (Nigg and Raff, 2009). The 
microtubule structure is surrounded by a ciliary membrane which is continuous 
with the plasma membrane of the cell but is molecularly distinct.  
The length of the primary cilium varies between cell types, ranging from 
1-9µm, with a width of approximately 0.2µm (Scherft and Daems, 1967). It has 
been proposed that variations in cilium length will lead to variations in ciliary 
response pathways. Increased length will require less force for the cilium to 
bend, decreasing the threshold of Ca2+ influx. It will also increase cilium volume 
changing the concentration of ions, molecules and proteins within the axoneme. 
Finally, increased length will also increase the time required for cargo to be 
transported by intraflagellar transport (IFT) (Dummer et al., 2016). Although 
cilium length varies between cell types changes in length can occur due to 
injury or inflammation, in these instances cilium length could have effects on 
cellular function (Miyoshi et al., 2011).  
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In general, primary cilia function appears to be conserved. Primary cilia 
function as a signalling centre for the cell, able to detect both mechanical and 
chemical changes in the extracellular environment. Using IFT of molecules and 
receptors along the microtubules of the axoneme, primary cilia can transduce 
signalling pathways including, the Hedgehog (Hh), Wnt and PDGF signalling 
pathways (reviewed in (Berbari et al., 2009)). Primary cilia also function as  
mechanoreceptors: bending of primary cilia in MDCK cells (a line of canine 
kidney epithelial cells) leads to an increase in calcium signalling ((Praetorius 
and Spring, 2001) cited by (Berbari et al., 2009)). This function is especially 
important in kidney epithelial cells, mutations that affect primary cilia often lead 





Figure 1.5 The basic structure of the primary cilium. 
The primary cilium is composed of the basal body at the base of the structure, extending 
from this is the ciliary axoneme which is surrounded by the ciliary membrane. The region 
at the base of the axoneme that distinguishes the ciliary compartment from the rest of the 
cytoplasm is known as the Transition zone. Adapted from (Ainsworth, 2007) 
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1.2.2  Ciliogenesis  
Unlike motile cilia which undergo de novo centriologenesis, the primary 
cilium forms from an existing centrosome which becomes the basal body 
(Dirksen, 1991). The existing centrosome is composed of a mother and a 
daughter centriole. It is the mother centriole that contributes to the structure of 
the primary cilium. Because the centrosome acts as an anchor for both ciliary 
microtubules and mitotic spindles there are no reports of cells simultaneously 
having a primary cilium and mitotic spindles. Primary cilia are therefore 
regarded as post mitotic organelles and their assembly and disassembly occur 
in line with the cell cycle (Gerdes et al., 2009). 
The complex mechanistic and molecular control of ciliogenesis remains 
to be fully understood. However, it has been established that ciliogenesis 
occurs synchronously with the cell cycle (reviewed in (Izawa et al., 2015)) (Fig. 
1.6) and is initiated through de-repression of specific factors (Gerdes et al., 
2009). 
In brief, the assembly of the primary cilium is controlled by the loss of 
centriolar satellites, non-membranous electron-dense particles, which facilitates 
the accumulation of ciliary vesicles at the distal appendages of the mother 
centriole. Accumulation of more secondary vesicles leads to the production of a 
continuous vesicle that encapsulates the basal body and nascent axoneme 
(Kobayashi et al., 2014). The fusion of this vesicle to the plasma membrane 
creates the ciliary membrane compartment. Following the docking of the basal 
body the axonemal microtubules begin to extend beneath the membrane, this 
happens exclusively at the distal end of the cilium relying on IFT of proteins 
produced in the cytoplasm (Ishikawa and Marshall, 2011). 
Centriolar satellites are associated with a complex of many proteins, 
some of which act to supress ciliogenesis. CP110, a substrate of cyclin-
dependant kinases (CDKs), strongly expressed through G1 to S phase of the 
cell cycle, is one such protein that represses ciliogenesis. CP110 controls the 
duplication of centrosomes and its mutation or deletion leads to polyploidy 
(Chen et al., 2002). It has been identified that CP110 forms a complex with 
Cep97; the deletion of the CP110-Cep97 complex leads to the production of 
primary cilia in cycling cells, providing evidence for the repressive effective of 
this complex on ciliogenesis (Spektor et al., 2007). Other proteins that have 
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been identified to interact with this complex are  Cep290, Kif24 and Rab8a 
(Kobayashi et al., 2014), the importance of which to ciliogenesis will be 
discussed in more detail in section 1.4.  
As mentioned the outgrowth and elongation of the primary cilium is 
driven by IFT. After the cilium has reached full length it remains highly dynamic 
and continues to traffic proteins up and down the axoneme. New tubulin is 
continuingly accumulating at the distal tip of the axoneme, ciliary length is 
controlled however by the continued turnover of tubulin. This has been shown 
to be an active process that is regulated by IFT and the Kinase-13 molecular 
motor (Izawa et al., 2015).  
The re-entry of cells into the cell cycle requires the disassembly of the 
primary cilium, this occurs through a shift in the balance of the dynamic 
assembly and disassembly of the axoneme. This process has been extensively 
studied in cell culture due to the ease in controlling culture conditions. Serum 
starved cells will arrest the cell cycle and become quiescent in G0 allowing for 
the production of a primary cilium. Reintroduction of serum or particular growth 
factors to the medium prompts cells to re-enter the cell cycle which is 
accompanied by the re-absorption of the primary cilium. This process has been 
shown to be controlled by several proteins including human enhancer of 
filamentation (HEF1), Aurora A kinase, Pitchfork (Pifo) and Tctex-1. HEF1 and 
Aurora A kinase activate histone deacetylase 6 (HDAC6) which deacetylates 
microtubules allowing for cilium resorption (Kim and Tsiokas, 2011). The final 
stage of cilium disassembly involves the release of the basal body from the cell 
membrane, this is regulated in part by the Pifo protein. The release of the basal 
body frees up the centrole to act as microtubule organising centre (MTOC) 













Figure 1.6 Ciliogenesis and the cell cycle. 
Assembly of the primary cilia occurs during G1/G0 phases of the cell cycle. Upon cell cycle 
exit the centrosome migrates to the cell surface to form the basal body. Ciliary vesicles 
accumulate and encapsulate the mother centriole (A). Fusion of the ciliary vesicle with the 
plasma membrane creates the ciliary compartment and allows the assembly and elongation 
of the axoneme by IFT (B). Cells that have exited the cell cycle display a mature primary cilia 
(C). Cell cycle re-entry initiates the disassembly of the primary cilia (D, E). Finally, the basal 
body is released from the plasma membrane allowing the centrosome to act as a microtubule 
organising centre (F). Adapted from (Izawa et al., 2015) 
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1.2.3 Ciliopathies  
The importance of primary cilia to normal development and homeostasis is 
demonstrated by the myriad of phenotypic abnormalities that arise from 
mutations in proteins associated with primary cilia. Syndromes that arise due to 
the malfunction of the cilium are collectively termed ciliopathies.  
The presence of primary cilia is widespread within an organism therefore 
mutations in cilia genes often affect multiple tissues and organs. Common 
symptoms of ciliopathies include polycystic kidneys, retinal defects, changes in 
skeletal structure (polydactyly), infertility, liver fibrosis, situs inversus and mental 
retardation (Hildebrandt et al., 2011). Many of these symptoms are associated 
with developmental defects due to the requirement of primary cilia for normal 
signalling of the Shh and Wnt pathways which are essential for many 
developmental processes.   
Due to the vast number of proteins associated with the correct structure 
and function of the primary cilium the genetic mutations that lead to symptoms 
of human syndromes often overlap (Powles-Glover, 2014). This can lead to a 
difficult diagnosis of the underlying genetic problem. However, syndromes have 
been identified that result from mutations in a single gene (summarised in Table 
1.2) the severity of which is dependent on the type of mutation the patient has. 
For this reason, the severity and number of symptoms can vary greatly within 
the same syndrome.  
Due to the high evolutionary conservation of primary cilia it is possible to 
utilise animal models to study their structure and function, whilst modelling 
mutations that lead to ciliopathies. C. elegans, green algae, zebrafish, Xenopus 
and mice are all extremely useful models in the understanding of primary cilia 










Table 1.2 Examples of single gene ciliopathies.  
Examples of ciliopathies that arise from mutations in a single gene. (Summarised from 
(Hildebrandt et al., 2011; Stephen et al., 2015)). 
Ciliopathy Associated Genes Symptoms 










• Mental Retardation 
• Ataxia 
• Retinal Coloboma 
• Irregular Breathing  
• Malformation of 
midbrain-hindbrain 
junction 







Perinatal death due to 
malformation of multiple 
organs including; 
• Lung hypoplasia 
• Polycystic Kidneys 
• Postaxial polydactyly 
• Situs inversus 
 





• Retinal degeneration 
• Cystic kidney disease 
• Cognitive impairment 






Polycystic Kidney Disease 
PKD1 
PKD2 
• End stage renal 
disease 
Autosomal Recessive 
Polycystic Kidney Disease 
PKHD1 • End stage renal 
disease 
• Polycystic kidneys 
• Chronic liver fibrosis 
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1.2.4 Primary cilia and hedgehog signalling  
As mentioned the primary cilium is a key organelle for signal transduction 
within the cell. One of the pathways cilia are involved in is the sonic hedgehog 
(Shh) signalling pathway, which is of particular importance to this research. The 
discovery of its role in Shh signalling was due to phenotypic observations of 
mice with mutations in IFT proteins that presented very similarly to phenotypes 
that arise from a loss of function of Shh. Mutations in wimple (wim) and flexo 
(fxo), the mouse homologues of the intra-flagella transport genes Ift127 and 
Ift88 respectively, have been shown to be embryonic lethal with defects in 
neural tube closure, abnormal brain morphology and preaxial polydactyly; 
phenotypes very similar to those seen in Shh mutant embryos. Further analysis 
of these mutants showed the IFT proteins play a role in the Shh pathway at the 
level of GLI proteins (discussed in more detail in section 1.3) (Huangfu et al., 
2003). The requirement for primary cilia to transduce hedgehog signalling is 
however unique to vertebrates, invertebrates with mutations in IFT proteins only 
exhibit phenotypes that suggest a dysfunction in cilia formation within neuronal 
cells (Huangfu et al., 2003). 
Since the initial connection between Shh and the primary cilium was 
established many cilia associated proteins have been implicated in correct 
function of Hh signalling. These include many members of the IFT protein family 
(Cortellino et al., 2009; Qin et al., 2011), motor proteins such as KIF3a 
(Huangfu et al., 2003) and structural stability proteins such as ARL13b (Caspary 
et al., 2007). Analysis of these and many other mutants have confirmed the 
requirement of a structurally and functionally sound primary cilium for normal 
Shh signalling.  
 
1.2.5 Primary cilia function in skeletal muscle 
Primary cilia were reported to be present on CO25 myoblast cells in the 
1990’s ((Zeytinoglu et al., 1996) cited by (Fu et al., 2014)) however it wasn’t 
until recently that primary cilia were functionally linked to skeletal muscle 
myoblast activity. Fu et al. (2014) demonstrated the dynamic presence of 
primary cilia on C2C12 myoblast cells during cell differentiation. They showed 
that primary cilia are present during the early stages of differentiation but are 
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gradually lost as the process occurs. By disrupting the formation of primary cilia 
by miRNA silencing of cilia genes they showed the requirement for a primary 
cilium in muscle differentiation. In cilia deficient C2C12 cells the formation of 
myosin heavy chain (MHC) positive fibres was significantly reduced whilst 
proliferation was increased. This suggests a role for the primary cilium in cell 
cycle exit and the initiation of differentiation.  
The presence of a primary cilium on SCs has also been confirmed, 
however it is restricted to QSCs. Primary cilia are disassembled on entry of SCs 
into the cell cycle, with re-assembly of a primary cilium being restricted to those 
undergoing self-renewal. It appears that the presence of a primary cilium on 
self-renewing satellite cells is not a passive process but plays an active role in 
the ability of SCs to re-establish quiescence. Disruption of primary cilia leads to 
a reduction in the number of SCs expressing Pax7 after 72hrs in ex vivo 
myofibre culture, suggesting a reduction in the number of SCs re-entering 
quiescence (Jaafar Marican et al., 2016).  
 
 30 
1.3 Sonic Hedgehog signalling  
The Hedgehog (Hh) gene mutation was first discovered and characterised 
in 1980 in the fruit fly, Drosophila melanogaster, during a large scale screen to 
identify genes that change or impair normal larval body plan patterning 
(Nusslein-Volhard and Wieschaus, 1980).  Hh DNA from Drosophila was first 
cloned in 1992 (Mohler and Vani, 1992) and since then Hh homologues have 
been found and cloned from many vertebrate and invertebrate species 
including; Hirudo medicinalis (leech), Diadema antillarum (sea urchin) Mus mus- 
culus (mouse), Danio rerio (zebrafish), Gallus gallus (chicken) Rattus rattus (rat) 
and human (Varjosalo and Taipale, 2008).  
Due to evolutionary duplication events, higher vertebrates including 
mammals have multiple copies of the Drosophila Hh gene that have been 
named Desert hedgehog (Dhh), Indian hedgehog (Ihh) and the most well 
studied Sonic hedgehog (Shh) (Pathi et al., 2001). The areas of expression of 
these 3 proteins within the mouse embryo are largely distinct from one another 
(Bitgood and McMahon, 1995) and the mammalian Hh homologues have been 
shown to play roles in different developmental processes; Shh is important for 
the establishment of the left-right and anterior-posterior axes and the patterning 
of many tissues such as the limb, neural tube and somite, Ihh modulates 
chondrocyte differentiation and Dhh plays a role in germ-line proliferation and 
later stages of spermatogenesis (Pathi et al., 2001). SHH, DHH and IHH all 
signal through the same receptors and use the same transduction pathway, 
however, their potency and activity vary in different cell types, suggesting 
distinct roles for each protein during development (Pathi et al., 2001). From 
here on, this thesis will focus on Shh signaling due to its role in myogenesis. 
 
1.3.1 Overview of the pathway 
The Shh signalling pathway has been extensively studied; receptors, 
transduction molecules and response genes have all been classified with many 
fine details of their interactions being well characterised. The basic transmission 
of the Shh pathway is summarised in Fig. 1.7. 
 Activity of the SHH protein requires post-translational modification. This 
involves a cleavage event to produce the N-terminal “active” protein (SHH-N), 
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during this cleavage the C-terminus of SHH-N covalently binds a cholesterol 
moiety that allows the protein to be tethered to the plasma membrane. 
Tethering of SHH to the plasma membrane allows for controlled short range 
signalling, if unprocessed N-terminal SHH is expressed there is an expansion in 
cells that respond to the SHH signal suggesting it is having longer range effects 
(Porter et al., 1996). SHH has both short and long range activity in developing 
vertebrates. Dispatched (Disp) has been shown to control the short or long 
range activity of SHH by modifying the cholesterol anchor and releasing the 
active N-terminal SHH protein (Burke et al., 1999). This control allows for a 
gradient of SHH ligand to be produced, which is vital for the correct patterning 
of many embryonic structures. 
Patched (PTC) is a twelve-transmembrane receptor protein that localises 
to the primary cilium and is the receptor for the Shh ligand. PTC has a 
constitutively repressive function on the Shh pathway, as demonstrated by the 
ectopic expression of Shh response genes when PTC is mutated (Ingham et al., 
1991). In the absence of SHH ligand PTC has this inhibiting effect by repressing 
the function of another transmembrane receptor, smoothened (SMO) (Taipale 
et al., 2002). However, binding of SHH to PTC releases the inhibition on SMO. 
This relationship was established through observations that loss of Shh or Smo 
produce similar phenotypes, whereas loss of Ptc activity mimics an increase in 
Shh activity (Varjosalo and Taipale, 2008). The Ptc gene is also a target of the 
Shh pathway and its expression is upregulated with active Shh signalling, 
establishing a feedback loop that can fine tune and limit the activity of the 
pathway (Goodrich et al., 1996). 
Following binding of SHH to PTC, the receptor is internalised 
sequestering SHH ligand and inactivating PTC. In the absence of active PTC, 
SMO is hyperphosphorylated causing a conformational change promoting the 
accumulation and localisation to the ciliary membrane where its activity can 
regulate downstream transcription factors, namely the Ci/GLI protein family 







1.3.2 GLI proteins  
The Shh signalling pathway culminates in the regulation of a family of 
zinc finger proteins, the GLI proteins, that have dual roles as transcriptional 
activators/repressors of Shh response genes. Drosophila have one Gli gene, 
Cubitus interruptus (Ci) whereas, the Gli gene family in vertebrates consists of 3 
members, Gli1, Gli2 and Gli3. The activator/repressor function of these genes is 
regulated by post-translational modifications that are responsible for producing 
either full length activator protein (GLIA) or cleaved repressor protein (GLIR) (Hui 
and Angers, 2011).  
The basic structure of GLI/Ci proteins consists of a N-terminal 
transcriptional repressor domain, zinc finger DNA binding sites and a C-terminal 
transcriptional activator domain (Fig. 1.8). However, it has been shown that 
Figure 1.7 The Sonic Hedgehog pathway. 
In the absence of a Hh ligand the transmembrane receptor PTC has an inhibitory effect on 
SMO preventing it from translocating to the cell membrane. This allows for the GLI proteins 
present internally in the cell to be phosphorylated, marking then for cleavage in 
proteasomes. When the GLI proteins are cleaved, they translocate to the nucleus and can 
act as repressors of gene expression. However, binding of SHH ligand to PTC causes 
internalisation of the complex removing the inhibition on SMO. SMO can then move to the 
cell membrane and inhibit the phosphorylation of the GLI proteins. Without the 
phosphorylation mark, the GLI proteins remain in their full-length form, translocate to the 
nucleus where they act as transcriptional activators. Adapted from (Varjosalo and Taipale, 
2008). 
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GLI1 contains only the C-terminal transcriptional activator domain, whilst GLI2 
and GLI3 have both activator and repressor domains (Dai et al., 1999; Sasaki et 
al., 1999).  
Due to its protein structure GLI1 has robust transcriptional activator 
activity, however, it has been shown to be dispensable for development and 
Shh signalling. Gli1 null mice are viable and have no apparent phenotypes (Bai 
et al., 2002). GLI2 primarily acts as a transcriptional activator, with only a small 
portion of the GLI2A being cleaved to the repressor form. GLI2A is readily 
degraded in the absence of SHH, however active Shh signalling inhibits the 
processing and degradation of GLI2 allowing it to carry out transcriptional 
activation (Pan et al., 2006). GLI3, on the other hand, is readily processed into 
GLI3R and therefore functions primarily as a transcriptional repressor (Wang et 
al., 2000). Both Gli2 and Gli3 have been shown to be essential for development 
and the transduction of the Shh pathway, mice with mutations in these genes 
are unable to respond to Shh and possess many developmental defects. Many 
mutations in the human GLI2/3 genes have been linked to congenital 
malformations (reviewed in (Hui and Angers, 2011). 
Processing of GLIA to GLIR is mediated by phosphorylation events that 
mark the proteins for degradation by proteasomes. Ci, GLI2 and GLI3 all 
contain a processing determining domain (PDD) which appears to be critical for 
the partial processing to their respective repressor forms, removal of the PDD 
for Ci prevents the production of CiR (Methot and Basler, 1999). Consistent with 
its potent activator function GLI1 does not contain a PDD domain.  
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The phosphorylation of GLI is carried out sequentially by Protein Kinase 
A (PKA), Glycogen Synthase Kinase 3 (GSK3) and Casein Kinases 1 (CK1). 
GLI2 and GLI3 contain six phosphorylation sites in their C-terminal end. It is the 
phosphorylation of the first 4 sites that leads to the processing into their 
repressor forms, whilst phosphorylation of the fifth and sixth sites inhibits their 
transcriptional activity, providing a mechanism of control of GLIA function 
(Niewiadomski et al., 2014) Although phosphorylation of GLI2 and GLI3 are 
carried out by the same kinases, these events lead to partial degradation of 
GLI3 and the production of GLI3R whereas GLI2 usually gets completely 
degraded and very little GLI2R is produced (Pan et al., 2006). The 
phosphorylation of GLI proteins is mediated in the Shh pathway by SMO, 
however the precise mechanism is unknown. Treatment of Shh responsive 
C3H10T1/2 cells with SAG, a synthetic SMO agonist, leads to the reduction of 
phosphorylated GLI2/3, providing evidence that it is the action of SMO within 
the Shh pathway that is mediating GLIA/GLIR levels (Li et al., 2017). 
Figure 1.8 Structure of the Ci/GLI proteins. 
Ci and Gli proteins are zinc finger transcription factors all containing zinc finger DNA binding 
domains (Zn). Ci, Gli2 and Gli3 all contain C-terminal repressor domains (Rep) and N-
terminal transcription activator domains (TAD), however Gli1 only contain the TAD domain. 
Ci, Gli1 and Gli2 also contain a processing determining domain (PDD), crucial for processing 
into repressor forms. Adapted from (Hui and Angers, 2011). 
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1.3.3 Shh role in muscle development  
As previously mentioned the Shh pathway plays a vital role in the initial 
determination of myogenic precursors, sending inductive signals to the somite 
and promoting the specification of myogenic cells in the developing 
dermomyotome (Munsterberg et al., 1995; Munsterberg and Lassar, 1995). In 
situ hybridisation for Myf5 and MyoD in Shh-/- embryos provides evidence that 
the expression of these MRFs in the epaxial domain (dorso-medial 
dermomyotome) is dependent on Shh, however, expression in the hypaxial 
(ventro-lateral dermomyotome) domain is independent of Shh (Borycki et al., 
1999).  Using BrdU and TUNEL assays it was established that the loss in Myf5 
and MyoD is not due to a reduction in proliferative ability or an increase in 
apoptosis of cells in the expaxial domain, but due to the inductive role Shh 
usually plays in Myf5 expression. The fact that MyoD expression is defective in 
cell explants from Myf5-/- embryos even in the presence of ectopic Shh 
expression provides evidence that Myf5 is the direct target of Shh induction, 
which in turn activates MyoD expression (Borycki et al., 1999).  
As established, GLI proteins play an integral role in the transduction of 
the Shh pathway and in the activation or repression of Shh response genes. 
The expression of the Gli genes in somites has been characterised through in 
situ hybridisation. Gli2 and Gli3 are expressed in the anterior pre-somitic 
mesoderm but Gli1 is not. Gli1 is expressed in the ventral medial portion of 
newly formed somites and as the somite matures overlaps with Pax1 
expression specific to the sclerotome, Gli1 is excluded from the 
dermomyotome. For a transient period at the onset of expression Gli2 and Gli3 
are expressed throughout the somite but are soon restricted to areas of the 
myotome and dermomyotome (McDermott et al., 2005). This expression pattern 
suggests a role for Gli2 and Gli3 in myogenesis due to the overlap with Myf5 
(McDermott et al., 2005; Ott et al., 1991). 
 To confirm the role of the GLI proteins in Myf5 expression in situ 
hybridisation for Myf5 was carried out in various Gli2 and Gli3 mutants. The 
activation of Myf5 in Gli2-/- and Gli3-/- single mutants is normal which suggests 
Gli2 and Gli3 are functionally redundant and can compensate for each other. In 
compound mutants of Gli2/Gli3 however, Myf5 expression is delayed in the 
epaxial domain of the dermomyotome, whilst in Gli2-/-/Gli3+/- or Gli2+/-/Gli3-/- 
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mutants Myf5 expression is still present although is weaker than in wild types. 
These observations suggest that Gli2 or Gli3 is required for Myf5 expression 
and one functional allele is sufficient to induce Myf5 expression albeit to a lower 
level than wild types (McDermott et al., 2005).   
Myf5 has been established as a direct target of long range Shh 
signalling. GLI proteins bind directly to its enhancer in cells of the epaxial 
somite, as demonstrated by its complete inactivity in Shh null embryo and 
partial activity in Shh heterozygous embryos (Gustafsson et al., 2002). Taken 
together this provides evidence for Shh signalling being vitally important for 
skeletal muscle development.  
 
1.3.4 Shh role in muscle regeneration 
The function of the Shh signalling pathway has been recognised as vital 
in normal embryonic development but was thought to have a very minimal role 
within the adult organism. However, over the past decade the importance of 
Shh in maintenance and proliferation of adult stem cells and its role in the 
development of some cancers has started to become apparent. This thesis will 
focus on investigating the role of Shh in adult skeletal muscle stem cells.  
 Shh has been shown to play a role in the normal development of 
skeletal muscle, both through promoting proliferation of muscle precursor cells 
and by directly targeting muscle specific transcription factors. It is therefore 
reasonable to assume that Shh may play a similar role in muscle regeneration 
as the two processes follow very similar molecular and morphological pathways.  
In vitro studies using isolated SCs from mouse and chick provided the 
first link that Shh signalling could be involved in muscle regeneration. SCs and 
primary myoblasts cultured with SHH showed an increase in Ptc1 and Gli1 
transcripts, this increase was not seen if the cells were also cultured with 
cyclopamine, a SMO inhibitor, showing these cells are able to specifically 
respond to SHH signals (Koleva et al., 2005). These culture experiments have 
also shown Shh signalling can increase proliferation and promote 
differentiation. Incubation with SHH results in increased incorporation of BrdU 
and the expression of Mgn and MHC (Elia et al., 2007; Koleva et al., 2005), 
again these effects can be blocked with cyclopamine. This provides evidence 
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that Shh signalling is playing a role in the proliferation and differentiation of SCs 
and myoblasts in vitro. 
Some of the first in vivo evidence of the involvement of the Shh pathway 
in skeletal muscle regeneration came in the late 2000’s. Following injury 
through mechanical crush or cardiotoxin injection, Straface et al. (2009) showed 
there is a significant upregulation of Shh and Ptc1 in skeletal muscle suggesting 
the pathway is active after injury. The normal regeneration pathway includes 
upregulation of Myf5 and MyoD to induce differentiation of satellite cells into 
myoblasts. However, if the Shh pathway is blocked in regenerating muscle by 
administration of cyclopamine, this up-regulation is diminished, suggesting that 
Shh may play a role in the activation of Myf5 and MyoD to allow for muscle 
regeneration (Straface et al., 2009). 
Further evidence of the activity of the Shh pathway in skeletal muscle 
regeneration has been gathered using the mdx mouse, a disease model of 
human Duchenne Muscular Dystrophy (DMD). In DMD skeletal muscle is 
unstable due to the lack of dystrophin, leading to repeated rounds of muscle 
necrosis, degeneration and regeneration. As the disease progresses the ability 
of the muscle to regenerate declines and eventually leads to fibrosis of the 
muscle (Manning and O'Malley, 2015). Interestingly, the pattern of Shh 
signalling activity changes with the progression of the disease. Ptc1 and Gli1 
expression is increased in 1 month old mdx mice compared to wild types, by 6 
months expression is the same and by 12 months expression is significantly 
lower in mdx mice. This correlates with the amount of regeneration occurring at 
these stages of the disease, with the most occurring at a young age and very 
little as the mouse ages (Piccioni et al., 2014b).  Treatment with plasmid DNA 
encoding for Shh has been shown to improve the ability of mdx mice and mice 
with age associated impairment of SCs to regenerate after injury (Piccioni et al., 
2014a; Piccioni et al., 2014b), providing evidence that the Shh pathways plays 
a vital role in muscle regeneration.   
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1.4 Talpid 3 (Ta3) 
1.4.1 Discovery of the Talpid3 mutant  
The Talpid mutants are a group of 3 chicken mutants that are 
characterised by a distinct set of phenotypes including polydactyly, craniofacial 
abnormalities and shortened spinal column (Cole, 1942; Ede and Kelly, 1964a, 
b). The 3 mutants were independently discovered and are autosomal recessive 
mutations. The Talpid lethal was first described by Cole (1942), in which he 
observed fowl embryos to have shortened limbs, with a duplication in digits on 
both the forelimb and hindlimb which appeared to resemble the forelimb of a 
mole, which in latin is Talpa, leading to the group referring to these mutants as 
“Talpid lethals”.  This discovery was followed closely by the talpid2 and talpid3 
mutants (Abbott et al., 1959; Ede and Kelly, 1964a) Cole’s Talpid mutant has 
since become extinct, but experimental talpid2 and talpid3 flocks have been 
maintained which has allowed the identification of the genes responsible for 
these mutations as C2CD3 (Chang et al., 2014) and KIAA0586 (Davey et al., 
2006) respectively.   
 
1.4.2 The Talpid3 gene (KIAA0586)  
Using the chick talpid3 (Ta3) mutant in comparison with wild type chick 
DNA, the Talpid3 mutation was mapped to the KIAA0586 gene on chromosome 
5 of the chicken genome. KIAA0586 is ubiquitously expressed in wild type 
embryos, explaining the widespread phenotypic disruptions seen in ta3 mutant 
embryos. Further analysis of KIAA0586 orthologues across a number of 
vertebrate species including; Human, Dog, Mouse and Xenopus, revealed 
homology of all 30 exons however homologues were not found in the 
Drosophila, C. elegans or Ciona intestinalis invertebrate species (Davey et al., 
2006). This analysis also revealed the ta3 chick mutant arose due to a frame 
shift mutation following the insertion of a single thymine residue resulting in a 
premature in-frame stop codon. This premature stop produces a truncated 
protein of 366 amino acids rather than the 1524 amino acid protein produced in 
wild type embryos (Davey et al., 2006). 
 KIAA0586 was experimentally confirmed as the talpid3 gene through 
complimentary rescue experiments in the chicken neural tube. Ectopic 
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expression of SHH in wild type neural tube induces ectopic expression of 
Nkx2.2 and Islet1, dorsalises Pax6 expression, induces Ptc1 throughout the 
neural tube and reduces the ventral expression of Pax7. However, these 
changes do not occur in the ta3 mutant, with only weak expression of Ptc1. 
When ta3 neural tube was exposed to ectopic SHH and was also 
electroporated with a construct expressing KIAA0586 some misexpression was 
observed in line with ectopic SHH expression in wild types (Davey et al., 2006).  
 
1.4.3 The Talpid3 protein 
KIAA0586 encodes a 1524 amino acid protein that when mapped to 
other vertebrate species revealed a highly conserved region between amino 
acids 498-585, downstream of the mutation that results in a truncated 366 
amino acid protein and encoded by exons 11 and 12. This region is predicted to 
contain a single coiled-coil domain. Rescue experiments using the chick neural 
tube and various expression constructs revealed the need for the coiled-coil 
domain for the function of the protein. The highly conserved region (498-585 
amino acids) that contains the coiled-coil domain is not sufficient to rescue ta3 
neural tube mis-patterning, however, it is absolutely required for the rescue to 
occur (Yin et al., 2009).  
 
1.4.4 Talpid3 functions elucidated by studying Talpid3 mutants 
Talpid3 mutants of all species examined show a pleiotropic embryonic 
phenotype, mutants have widespread developmental defects in seemingly 
unrelated systems of the embryo (Ede and Kelly, 1964b). These phenotypes 
include unpatterned polydactyly, craniofacical defects including hypoteleorism, 
loss of endochondral bone formation, vascular defects and abnormal 
dorsoventral patterning of the neural tube, all leading to embryonic lethality 
(Buxton et al., 2004; Davey et al., 2007; Davey et al., 2006; Ede and Kelly, 
1964a, b).  
The phenotypes of all species with Talpid3 mutations studied so far show 
very similar phenotypes. The only difference being the ta3 chick does not show 
any abnormalities in left-right asymmetry, whereas Ta3 mice and zebrafish do. 
The reason for this is still not fully understood, however a recent discovery that 
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very early stage ta3 chick embryos have functional cilia is surprising, but a 
possible explanation. It has been hypothesised that there is potentially maternal 
TA3 protein present in the egg that allows the initial formation of primary cilia in 
the early embryo, resulting in normal functional cilia that then play a role in 
breaking the symmetry of the embryo. This idea is also supported by evidence 
from the Ta3 zebrafish mutant (MZTalpid3), which has maternal TA3 present 
and does not show a disruption in organ asymmetry, however when the 
maternal TA3 is not present the embryo shows a similar left-right phenotype as 
mice (Stephen et al., 2014). 
From looking at the range of phenotypes that ta3 mutant embryos 
present the conclusion was drawn that all the developmental defects were 
similar to phenotypes of embryos with defective Shh signalling.  
By examining the phenotypes presented in the ta3 mutant embryos and 
using in-depth molecular analysis, the role of Ta3 in developmental processes 
is being unravelled. As previously mentioned the presentation of phenotypes 
such as polydactyly and hypoteleorism, point towards a role for Ta3 in the Shh 
pathway. This being later confirmed by Lewis et al. (1999) who showed that 
components of the Shh signalling pathway were abnormally expressed in the 
limb of ta3 mutants. They also further explained the pleiotropic phenotype by 
showing that some genes regulated by the Shh pathway are unresponsive to 
Shh signals such as Gli1; whilst other genes, namely Ptc, are significantly 
upregulated in ta3 mutant limb bud tissue. This paper confirmed that the 
expression of SHH protein is normal in ta3 mutants and began to explore the 
idea that ta3 mutants have abnormal processing of Shh signals and 
downstream effectors (Lewis et al., 1999).  
Another observation of phenotypic similarities of ta3 mutants was with 
mouse embryos with mutations in intraflagellar transport (IFT) proteins, these 
mutants lack primary cilia. It has since been shown that ta3 mutants also lack 
primary cilia which explains the disruption of Shh signalling. Using rescue 
experiments in ta3 mutant chicken embryos, by electroporation of a construct 
encoding the full length chicken Ta3, it was confirmed that the loss of Ta3 is 
what causes the lack of primary cilia. Furthermore, using an antibody against 
chicken TA3 is was identified that the gene encodes a centrosomal protein that 
is required for normal primary cilia assembly (Yin et al., 2009). More specifically 
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TA3 appears to play a role in vesicle fusion to the basal body, which allows for 
growth of the axoneme (as described in section 1.2.2). In ta3 mutants migration 
of the centrioles to the apical region and maturation to basal bodies is not 
affected, however the basal body fails to dock into the apical membrane, 
resulting in failure of axoneme extension (Yin et al., 2009)  (Fig. 1.9).  
It is not only primary cilia, but all cilia that fail to form in ta3 mutants. 
Formation of motile cilia is different to primary cilia in that the cell must undergo 
de novo centriologenesis to form the basal bodies in these multi-ciliated cells. In 
ta3 mutants multiple basal bodies form but again they fail to dock into the 
plasma membrane, it has been reported that centrosomes of normally multi-
ciliated cells, in ta3 mutants, are rarely seen near the apical surface (Stephen et 
al., 2013). 
 
The specific role of Ta3 and the reason why the basal body fails to dock 
remains speculative. A couple of hypotheses were proposed by Yin et al. (2009) 
including a role for Ta3 during the fusion of vesicles to the basal body. There is 
a complex of centrosomal proteins known as the BBSome that functions to 
activate Rab8, a GTP-ase that traffics ciliary membrane proteins to the base of 
the primary cilium (Nachury et al., 2007). It has been speculated that TA3 may 
be part of the BBSome. Rab8a is mislocalised when there is a depletion of Ta3 
in RPE1 cells (human retinal pigment epithelial cells) suggesting a potential 
involvement of TA3 in this complex (Kobayashi et al., 2014). However, there 
may be some problems in using this cell model to determine the function of Ta3, 
other aspects of cilium formation studied in this paper show different results 
Figure 1.9 Ciliogenosis fails in Ta3 mutants. 
TEM sections show basal body and mature ciliary axoneme of mature primary cilium in wild 
type embryos (A-B) whilst in Taplid3 mutants basal bodies are still present but they have 
failed to dock into the membrane and there is an absence of the ciliary axoneme (C-D). 
Adapted from Yin et al. (2009) 
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from the ta3 chick model. For example, in Ta3 depleted cells there is an 
accumulation of centriolar satellites around the centrosomes, which is thought 
to play a role in preventing ciliogenesis. This is not seen in ta3 chicken embryos 
(Kobayashi et al., 2014). The precise role of Talpid3 therefore, remains to be 
established.  
 
1.4.5 Creation of the Talpid3 mutant mouse 
Since Ta3 null embryos show lethality relatively early in development, the 
generation of a ta3 mouse model that enables conditional knock-out of the Ta3 
gene is very useful to study the effects on later embryonic development. This 
has been achieved following the discovery that exons 11 and 12 of the Ta3 
gene are essential for TA3 protein function (Yin et al., 2009). Based on this a 
mouse line was created that contained loxP sites flanking exon 11 and 12 
allowing for conditional deletion of Ta3 function by Cre-recombinase (Bangs et 
al., 2011).  
A classical approach using homologous recombination was used to 
create the targeting vector (Fig. 1.10), which was transfected into C57BL/6 ES 
cells. Successfully transfected cells were transferred to pseudopregnant NMRI 
mice. Chimeric mice were bred to C57BL/6 females and mice with successful 
germline transmission were identified by black coat colour. Confirmation of the 
presence of floxed Ta3 (Ta3f/f) alleles was carried out by PCR.  
Ta3f/f mice were crossed with a mouse line that ubiquitously expressed 
Cre-recombinase (Cre) to generate ta3-/- mice. Analysis of ta3 null mice 
confirmed the requirement of exons 11 and 12 for normal TA3 function, 
reminiscent of what had been seen in the chick mutant. Ta3-/- mice show 
embryonic lethality at E10.5, have abnormal Shh signalling and lack primary 
cilia (Bangs et al., 2011).  
With the generation of the Ta3f/f mouse it became possible to explore the 
role of Ta3, and subsequently primary cilia and Shh signalling, in later 
developmental and adult processes in a tissue specific manner. The first 
conditional knock out (CKO) of Ta3 to be generated was limb specific using a 
Prrx1-Cre mouse strain, Prrx1 is expressed in limb mesenchyme from E9.5 in 
the forelimb and E10.5 in the hindlimb. Examination of Ta3 CKO limb 
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mesenchyme at E10.5 showed loss of primary cilia, however, endothetial cells 
retained their cilia, demonstrating specific loss of TA3 function in the 
mesenchyme. Fore- and hindlimbs of the CKO mutants showed polydactyl and 
soft tissue syndactyly. Skeletal formation also appeared to be affected as bones 
of the limbs were shorter with less ossification. Demonstrating the importance of 
TA3 to later stages of limb development (Bangs et al., 2011). 
 
 
1.4.6 Sonic hedgehog signalling in Talpid3 mutants 
Due to the failure of ciliogenesis in ta3 mutants there are severe 
disruptions in the signalling cascade of the Shh pathway. As the release of the 
Shh ligand is not dependent on the presence of primary cilia it is not surprising 
that Shh expression in ta3 mutants is relatively normal. There are slight 
variations between wildtypes and ta3 mutants however, for example in the limb 
bud of ta3 chick mutants there is an expansion of Shh expression into the 
middle portion of the bud, whereas Shh is restricted to the posterior portion in 
Figure 1.10 Cloning strategy for the generation of a Ta3f/f allele. 
Homologous recombination was used to insert LoxP sites (green) flanking exons 11 
and 12 of the mouse Ta3 gene. Flp recognition target (FRT) sites (red) allowed for Flp 
deletion of the neomycin selection cassette (orange). Forward (Ta3 Fwd) and Reverse 
(Ta3 Rev) primer binding sites are shown, used to identify WT, Ta3f and Ta3- alleles by 
PCR. Adapted from (Bangs et al., 2011)   
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wildtypes. This expansion coincides with an expansion in Hoxd13 expression, a 
gene regulated by the Shh pathway. However, using cyclopamine to block Shh 
transduction, the expansion of Hoxd13 is still present, showing this expansion is 
ligand independent (Davey et al., 2006). This observation combined with the 
fact that expression of Ptc, a component of the Shh receptor and a direct target 
of Shh, is significantly reduced in ta3 mutants (Lewis et al., 1999), points to the 
possibility that disruption of Shh signalling is due to a disruption somewhere 
downstream in the pathway, potentially with the GLI proteins. A disruption in the 
GLI proteins would also explain the mix of gain of function and loss of function 
like phenotypes observed in the ta3 mutants, possibly due to an increased level 
of GLIA or GLIR proteins. 
 In wildtype embryos the presence of both GLI3A and GLI3R is detected 
in the limb buds, with GLI3R being expressed in a gradient, with maximum 
levels at the anterior (Wang et al., 2000). However, in the ta3 chick mutant there 
is a significant increase in the expression of GLI3A protein and a loss of the 
graded expression of GLI3R, explaining the expansion of Hoxd13 expression, 
and also explaining how there is still Hoxd13 expression even after Shh is 
removed using cyclopamine (Davey et al., 2006). 
The processing of GLI3 is affected in the majority of cilia gene mutations 
(Goetz and Anderson, 2010) however, there is very little evidence that the 
processing of GLI2 is also affected. Li et al. (2017) have begun to address this 
issue with the generation of a Ta3 mutant mouse containing a Gli2FLAG allele, 
revealing that GLI2R protein levels were significantly reduced in Ta3 mutant 
embryos. Confirming earlier findings by Davey et al. (2006), they also showed a 
reduction in the levels of GLI3R in Ta3 embryos. The reduction of GLI2R and 
GLI3R was due to a reduction in the phosphorylation of these proteins.  
As previously mentioned, the phosphorylation of GLI is carried out in part 
by PKA. Co-immunoprecipitation of TA3 and two of the four subunits of PKA, 
PKARI⍺ and PKARIIβ, showed that these proteins interact in vitro, more 
specifically using various Ta3 mutant constructs it was shown that the C-
terminal region of the TA3 protein is required for PKA interaction but not the 
middle or N-terminal regions. PKARIIβ and TA3 co-localize to the centrosome in 
wild type fibroblast cells lines however in about 25% of ta3 mutant cells 
PKARIIβ was not localised to the centrosome which could account for some of 
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the reduction in GLI phosphorylation. Different regions of the TA3 protein 
appear to have different functional roles during TA3 ciliogenesis. Using Ta3 
mutant constructs it was shown that the N-terminal region allows centriolar 
localisation whilst the C-terminal region is required for ciliogenesis (Li et al., 
2017).  
 
1.5 Project Aims and Hypotheses 
Multiple lines of research have shown the involvement of primary cilia and 
Shh signalling in the development and regeneration of skeletal muscle. Ta3 
mutants have been shown to display multiple phenotypes linked to the loss of 
primary cilia and a disruption in Shh signalling. However, to date there is very 
little data that shows the role Ta3 plays in skeletal muscle development or 
regeneration. Therefore, this project aims to: 
 
1. Investigate the effects of SC specific Ta3 mutations on skeletal muscle 
regeneration after injury.  
 
2. Investigate the effects of SC specific Ta3 mutations on the ability of 
SCs to migrate, proliferate and differentiate. 
 
3. Investigate the effects of SC specific Ta3 mutations on the expression 




A SC specific loss of Ta3 will disrupt normal SC function and the ability of 
skeletal muscle to efficiently regenerate following injury.   
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Chapter 2 Materials and Methods 
2.1 Mouse lines  
All mouse lines used in this study were obtained from collaborators and 
were bred on a C57BL/6 background. Breeding strategies were used to obtain 
mice that had the Ta3 gene removed in adult SCs to study the role of Ta3 in 
muscle regeneration and SC maintenance, differentiation and self-renewal.  
For injury experiments female mice were used aged between 12-18 
weeks. For myofibre isolation experiments both male and female mice were 
used that were at least 12 weeks of age. 
 
2.1.1 Conditional Talpid3 mutant mice  
The conditional Ta3 mutant mice were a gift from Prof. Cheryll Tickle 
(University of Bath). These mice have exons 11 and 12 of the Ta3 gene flanked 
by lox P sites (discussed in section 1.4.5). Homozygous Ta3 floxed (Ta3f/f) mice 
were crossed with a mouse line expressing a Cre recombinase – ERT2 fusion 
protein that had been knocked into the Pax7 locus obtained from The Jackson 
Laboratory (B6;129-Pax7tm2.1(cre/ERT2)Fan/J). The resulting genotypes from the F1 
generation, Ta3f/+//Pax7CreERT2/+ mice were crossed with Ta3f/f mice to produce 
an F2 generation containing both Ta3 heterozygous and homozygous mutants 
that are also Pax7CreERT2/+.  The line was maintained by crossing 
Ta3f/f//Pax7CreERT2/+ mice with Ta3f/f//Pax7+/+ or Ta3f/+//Pax7+/+ to ensure mice 
remained heterozygous for Pax7 expression.  These mice were used in all 
experiments to study the effect of removing Ta3 from SCs. Cre-mediated 
recombination of floxed alleles was induced by intraperitoneal (IP) injection of 
tamoxifen (Sigma, UK; T5648) at a dose of 3mg/40g body weight on 5 
consecutive days followed by one rest day and a final injection. Tamoxifen was 








2.1.2 Reporter mouse lines  
Several reporter mouse lines were crossed with the Ta3f/f//Pax7Cre-ERT2/+ 
mice to assess recombination efficiency and to visualise and track Pax7+ SCs.  
To assess recombination efficiency Ta3f/f//Pax7Cre-ERT2/+ mice were crossed with 
Rosa26-LacZ mice; used for staining with β-galactosidase on muscle sections, 
or with Rosa26-tdTomato mice (Madisen et al., 2010); used for fluorescence 
imaging of SCs on single myofibres. To allow for ex vivo visualisation of WT and 
Ta3 mutant SCs a Pax7ZsGreen mouse line was used (Bosnakovski et al., 2008).  
 
2.1.3 Animal maintenance  
All mice were maintained in accordance with Home Office regulations 
under specific pathogen free conditions in individually ventilated cages. Mice 
were weaned at approximately 3 weeks of age and separated by gender. Soon 
after weaning mice were ear tagged/notched and ear biopsies were taken for 
genotyping.  
Experimental animals were sacrificed by cervical dislocation. Maintenance 
animals that were no longer required were sacrificed by exposure to increasing 
CO2, in line with Home Office, Schedule 1 guidelines.  
 
2.2 Molecular biology techniques 
2.2.1 Genotyping PCR  
Mouse genotypes were determined by PCR on genomic DNA extracted 
from ear biopsies. Biopsy samples were incubated in 50µl lysis buffer (0.1M 
TrisHCl pH8.5, 0.25M NaCl, 0.2% SDS, 5mM EDTA, 0.1mg/ml Proteinase K, 
Sigma H20) overnight at 55°C. Lysate was diluted 1:20 for PCR. 
The product size of each band is detailed in Table 2.1. PCR primers are 






Table 2.1 Expected PCR product size for genotyping PCR 
Allele PCR product size 
(bp) 
Talpid3 floxed  470 
Talpid 3 wild type 351 
Talpid 3 null 273 
Cre/ Cre-ERT2 650 
ROSA26 – LacZ wild type 600 
ROSA26 – LacZ mutant 320 
ROSA26 – tdTomato wild 
type 
297 
ROSA 26 – tdTomato 
mutant 
196 
Pax7 ZsGreen 300 
 
 
Table 2.2 Genotyping primer sequences 
Talpid3 Forward 5’-TGCCATGCAGGGATCATAGC-3’ 
Reverse 5’-GCTAGTACATTGCTGCAAGC-3’ 
Null Reverse 5’-GAGCACACTGGAGGAAAGC-3’ 
Cre Forward 5’-ATCCGAAAAGAAAACGTTGA-3’ 
Reverse 5’-ATCCAGGTTACGGATATAGT-3’ 
Rosa26 Lac Z Mutant 5’-AAGACCGCGAAGAGTTTGTC-3’ 






 5’ -AAGGGAGCTGCAGTGGAGTA- 3’ 
 5’ -CCGAAAATCTGTGGGAAGTC- 3’ 
 5’ -GGCATTAAAGCAGCGTATCC- 3’ 
 5’ -CTGTTCCTGTACGGCATGG- 3’ 
Pax7 ZsGreen Forward 5’ -CTGCATGTACCACGACTCCA- 3’ 
Reverse 5’ -GTCAGGTGCCACTTCTGGTT- 3’ 
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PCR reagents were added to a master mix (Table 2.3) and aliquoted, 3µl 
of lysate was added to each reaction 
 
Table 2.3 Master mix for genotyping PCR 
Reagent Concentration Volume per 
reaction 
Biomix Red (Bioline) N/A 12.5µl 
Forward Primer 10mM 0.5µl 
Reverse Primer 10mM 0.5µl 
Sterile H2O N/A 7-8.5µl 
Final Volume - 25µl 
 
PCR reactions were subject to the following conditions; 
Table 2.4 Conditions for genotyping PCR 
Stage Temperature (°C) Time Cycles 
Denaturation 94 3 minutes  
 
 
      X 30 cycles 
Denaturation 95  40 seconds 
Annealing 58 40 seconds 
Extension 72  30 seconds 
Final extension 72 5 minutes 
 
2.2.2 Agarose gel electrophoresis  
Agarose (Sigma, UK) gels were made at a 1.5% concentration in 1x TAE 
buffer by warming. Ethidium Bromide (Sigma, UK) was added to the gel at a 
concentration of 0.5µg/ml. Electrophoresis was carried out at 90-100V for 30-60 
minutes, depending on gel size. DNA was visualised using a UV trans-




2.3 Cardiotoxin (CTX) injection 
Mice were anesthetised by isoflurane inhalation and muscle injury was 
induced with a 50µl intramuscular injection of cardiotoxin (100µM) into the right 
Tibialis Anterior (TA) muscle. The contralateral un-injured TA muscle was used 
as a control.  
 
2.4 Dissection of mice 
2.4.1 Tibialis anterior (TA) isolation 
Following CTX induced injury and after the required period of 
regeneration (5, 10, 15 or 25 days) mice were sacrificed by cervical dislocation 
and the TA muscle was collected, pinned in a physiologically stretched position 
and frozen in isopentane cooled in liquid nitrogen. Muscles were stored at -
80°C until required. 
 
2.4.2 Single myofibre isolation 
Following administration of Tamoxifen according to the schedules 
detailed in Chapter 3, Extensor Digitorum Longus (EDL) muscles were isolated 
from 8-14 week old mice and incubated in Collagenase I (2mg/ml, Sigma, UK) 
for 60-90 minutes at 37°C. After collagenase treatment muscles were 
transferred to BSA (Sigma, UK) coated dishes with deactivation medium 
(DMEM Glutamax media (Gibco), 1% PenStrep (Gibco)). EDL muscles were 
subjected to repeated trituration through descending diameter glass Pasteur 
pipettes until single myofibres separated from the isolated muscle. Single 
myofibres were selected and cultured in the conditions detailed in Table 2.5 








Table 2.5 Culture conditions of single myofibres 
Use Culture Medium Culture time  
Time-lapse imaging of 
live myofibres  
DMEM, 20% FBS, 1% 
Chick embryo extract 
(CEE), 1% PenStrep 
Up to 110 hrs 
Immunofluorescence 
staining 
DMEM, 10% Horse 
Serum, 0.5% CEE, 1% 
PenStrep 
24-96 hrs 
Outgrowth of Satellite 
Cells 
DMEM, 20% FBS, 10% 
Horse Serum, 1% 






Frozen TA muscles were mounted using a small amount of OCT (Tissue 
Tek – Agar Scientific) and sectioned at a thickness of 10µm. Sections were 
collected on Superfrost Plus slides and stored at -80°C until required. 
 
2.5.2 Immunolabelling on muscle sections  
Frozen sections were equilibrated to room temperature for 10-15 minutes 
before beginning the staining protocol. All washes were carried out at room 
temperature unless otherwise stated. Slides were washed in PBS for 10 
minutes and fixed in 1% PFA for 10 minutes. Brief wash in 0.1% PBST and 
placed in ice cold methanol for 8 minutes followed by a brief wash in PBST. 
Slides were blocked in 5% Normal Goat Serum (NGS, Gibco) for 90 minutes at 
37°C, then rinsed in PBST. Slides were incubated in Nidogen primary antibody 
(Table 2.7) in 2% NGS for 60 minutes at 37°C. Then washed x3 in PBST for 5 
minutes. Slides were incubated in Alexa Fluor 488 secondary antibody (Table 
2.8) in 2% NGS for 60 minutes. Slides were washed x3 in PBST for 5 minutes, 
incubated with DAPI (0.5µg/ml) for 5 minutes and washed x3 in PBST for 5 
minutes. Slides were mounted with hydromount (National Diagnostics).  
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2.5.3 Immunolabelling on single myofibres  
Single myofibres were fixed in 4% PFA for 8 mins at room temperature 
and then washed x3 in 1x PBS for 5 minutes. Fibres were permeabilized in 
0.5% Triton-X Sigma, UK) in PBS for 6 minutes at room temperature, washed in 
1x PBS and incubated in blocking solution (10% NGS in 0.1%TBST) at 37°C for 
90 minutes. Primary antibodies (Table 2.7) in 5% NGS were applied to fibres 
and incubated over night at 4°C. Following 3 washes in TBST for 15 minutes 
each, fibres were incubated in secondary antibodies (Table 2.8) in 5% NGS and 
DAPI (0.5µg/ml) for 1 hour at room temperature. Fibres were washed twice in 
TBST for 15 minutes followed by 1 wash in TBS only. Fibres were then 
mounted using gelvatol (Table 2.6) 
 
Table 2.6 Gelvatol recipe 
Reagent Amount Final 
Concentration 
0.01M KH2PO4 (pH to 
7.2 with Na2HPO4.H2O) 
80ml 0.01M 
NaCl 0.65g 0.14M 
Polyvinylalcohol 
(Gelvatol, Type II, 
Sigma P-1836) 
20g  
Glycerin (Sigma) 40ml  
 
2.5.4 Immunolabelling on satellite cells in culture  
SCs were fixed in 4% PFA for 15 minutes at room temperature and then 
washed x3 in 1x PBS for 5 minutes. SCs were permeabilized in 0.1% Triton-X 
(Sigma, UK) in PBS for 10 minutes at room temperature and incubated in 
blocking solution (10% NGS in PBS) at 37°C for 2 hours. SCs were incubated in 
MF20 primary antibody (Table 2.7) in 5% NGS over night at 4°C. Following 3 
washes in PBS for 5 minutes each, SCs were incubated in secondary 
antibodies (Table 2.8) in 5% NGS and DAPI (0.5µg/ml) for 1 hour at room 
temperature. SCs were washed x3 in 1x PBS for 5 minutes and then stored at 
4°C in PBS. Images were taken within 48 hours of immunostaining.  
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2.5.5 Immunolabelling on C2C12 cells 
C2C12s were fixed in 4% PFA for 15 minutes at room temperature and 
then washed x3 in 1x PBS for 5 minutes. C2C12s were stored in PBS at 4°C or 
processed immediately as follows.  C2C12s were permeabilized in 0.1% Triton-
X (Sigma, UK) in PBS for 10 minutes at room temperature and incubated in 
blocking solution (10% NGS in PBS) at 37°C for 2 hours. C2C12s were 
incubated in Arl13b/ Acetylated alpha tubulin primary antibody (Table 2.7) in 
5% NGS overnight at 4°C. Following 3 washes in PBS for 5 minutes each, 
C2C12s were incubated in secondary antibodies (Table 2.8) in 5% NGS and 
DAPI (0.5µg/ml) for 1 hour at room temperature. C2C12s were washed x3 in 1x 
PBS for 5 minutes and then stored at 4°C in PBS. Images were taken within 48 
hours of immunostaining. 
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1:100 Sigma, UK T7451 
Arl13b Rabbit 
(polyclonal) 





1:200 DSHB AB 2147781 
Myf5 Rabbit 
(polyclonal) 
1:50 Santa Cruz SC-302 
MyoD Mouse 
(monoclonal) 
1:50 Santa Cruz SC-377460 
Myogenin Mouse 
(monoclonal) 
1:100 DSHB AB 2146602 
Nidogen 1 Rabbit 
(polyclonal) 



















Table 2.8 Secondary antibodies used for immunolabelling.  
All secondary antibodies were used at a dilution of 1:500. 
Fluorophore 
name 
Specificity Supplier Catalogue number 
Alexa Fluor 488 Goat anti-
mouse 
Invitrogen A32723 
Alexa Fluor 488 Goat anti-rabbit Invitrogen A-11034 
Alexa Fluor 568 Goat anti-
mouse 
Invitrogen A-11004 
Alexa Fluor 568 Goat anti-rabbit Invitrogen A-11036 
Alexa Fluor 647 Goat anti-
mouse 
Invitrogen A32728 
Alexa Fluor 647 Goat anti-rabbit Invitrogen A32733 
 
2.5.6 Haematoxylin and Eosin (H&E) staining  
Fresh 0.1% Eosin Y (Acros Organics) was prepared with distilled water 
and a few drops of glacial acetic acid. Mayers Hemalum (Merck/EMD millipore) 
was diluted 1:1 in distilled water. All solutions were filtered before use. Frozen 
sections were equilibrated to room temperature for 10-15 minutes before 
staining. All washes were carried out at room temperature. Slides were stained 
with Mayers Hemalum for 1-7 minutes with a brief wash in H20 then ‘blued’ in 
running tap water for 15 minutes. Slides were stained with 0.1 % Eosin-Y for 30 
seconds – 3 minutes, followed by a brief wash in H20. Slides were dehydrated 
through ascending concentrations of ethanol (70, 80, 95, 2x 100%) and placed 
in histoclear (National Diagnositics) for 7 minutes (x2). After staining slides were 
mounted with Depex (Fisher Scientific) mounting medium and left to air dry for 







2.5.7 X-gal staining for the detection of LacZ 
Frozen sections were equilibrated to room temperature for 10-15 minutes 
before staining. Muscle sections were washed in 0.1M Phosphate buffer (Table 
2.9) for 10 minutes, fixed in X-Gal fixation buffer (Table 2.9) and washed twice 
in Wash buffer (Table 2.9) for 5 minutes. Fresh staining solution was prepared 
from Core X-Gal buffer (Table 2.9) and X-Gal stock solution (Table 2.9). 
Staining solution was filtered before use on sections. Muscle sections were 
incubated in staining solution until LacZ staining was visible, approximately 24 
hours. Following staining, muscle sections were washed twice in Wash buffer 
for 5 minutes, allowed to dry and mounted in hydromount (National 
Diagnostics).  
 
Table 2.9 Reagents for X-Gal Staining 




NaH2PO4, Na2HPO4, H2O 
Fixation buffer 5mM EGTA, 2mM MgCl2, 0.2% Glutaraldehyde, 0.1M 
Phosphate Buffer 
Wash Buffer 2mM MgCl2, 0.1M Phosphate Buffer 
Core X-Gal 
Buffer 
2mM MgCl2, 5mM K4Fe (CN) 6-3H2O, 5mM K3Fe (CN) 6-
3H2O, 0.1M Phosphate Buffer 
X-Gal Stock 
Solution 









2.6 Tissue culture 
2.6.1 Culture of single myofibres in Collagen I gels  
Following isolation, single myofibres were plated on ice in a collagen I gel 
(Table 2.10 and Table 2.11) with 2 fibres per well of the inner 24 wells of a 48 
well plate. The plate was then incubated at 37°C for 60 minutes for the gel to 
set. 200µl of medium was added to each well and incubated at 37°C for 60 
minutes. 
 
Table 2.10 Reagents used for 4x Media to make collagen gels 
Reagent Volume 
10X DMEM 4ml 
100x pyruvate 0.4ml 
0.5M NaHCO3 2ml 
H2O 3.6ml 
 
Table 2.11 Reagents used to make collagen gels 
Reagent Final Concentration Volume 
4x Media mix - 1.5ml 
FBS 20% 1.2ml 
H2O - 720µl 
5 mg/ml Collagen I 2mg/ml 2.4ml 
0.1M NaOH 230µl/ml 480µl 
Final Volume  6ml 
 
2.6.2 Outgrowth and culture of satellite cells 
Following isolation, single myofibres were plated on Matrigel-coated 
(Scientific lab supplies) 12 well plates. Matrigel was briefly washed over the 
surface of each well and excess was removed. Matrigel was left to set at 37°C 
for 30 minutes before plating. Approximately 100-150 myofibres were plated per 
well in proliferation medium (Table 2.5). Myofibres were cultured for 72hrs to 
allow SCs to migrate from the myofibres, after which myofibres were removed. 
The remaining proliferation medium was removed, SCs were washed in PBS 
and treated with trypsin for approximately 5 minutes. SCs were re-suspended in 
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proliferation medium and re-plated on Matrigel. SCs were then cultured in 
proliferation medium for 9 days. Fresh medium was given every 3-4 days.  
 
2.6.3 Culture of C2C12 myoblasts 
C2C12 myoblast cells were cultured in growth medium (Table 2.10) in a 
75cm2 flask. Cells were maintained at a confluency no higher than 70% to 
prevent spontaneous differentiation. During maintenance, fresh medium was 
given every other day. 
C2C12 cells were used for differentiation once they reached 80-90% 
confluency. They were then washed x2 with PBS to remove all growth medium 
and then exposed to differentiation medium (Table 2.12). During the 
differentiation process, fresh medium was given every day. Cells used for 
immunostaining were seeded onto poly-l-lysine-coated glass cover slips and 
grown in the conditions stated above. 
 
Table 2.12 Reagents used for C2C12 myoblast media 
Media type  Reagent Final Concentration 
Growth media DMEM (GlutaMAX) - 
Pen/Strep 1% 
FBS 10% 
Differentiation media DMEM (GlutaMAX) - 
Pen/Strep 1% 
Horse Serum  2%  
 
2.6.4 Transfection of C2C12 cells 
E. coli cells containing a pDEST-Arl13b12 plasmid (Addgene) were 
grown on LB medium over night at 37°C. DNA was extracted using a QIAGEN 
Plasmid Mini Kit (Qiagen, UK) according to manufacturer’s instructions. DNA 
quantity and purity was measured using a nanodrop.  
Proliferating C2C12 cells were plated on 6 well tissue culture plates and 
grown until 70% confluency at which point they were transfect with 4µg of 
pDEST-Arl13b12 plasmid per well using lipofectamine (Life Technologies) 
according to manufacturer’s instructions.   
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Following transfection cells were washed twice in PBS and fixed in 4% 
PFA for 15 minutes at room temperature and then washed x3 in 1x PBS for 5 
minutes.  
2.7 Microscopy 
2.7.1 Imaging of muscle sections, single myofibres and C2C12 cells  
Brightfield and fluorescent images of muscle sections were taken using a 
Zeiss AxioPlan 2ie microscope. Images were captured using 20x PlanNeofluar 
objective (0.6NA) and a Zeiss AxioCam HRm CCD camera.  
 
2.7.2 Time lapse imaging  
Brightfield and fluorescent images were captured using a Zeiss Axiovert 
200M inverted microscope. Images were captured using a 10x PlanNeofluar 
objective and a Zeiss AxioCam HRm CCD camera. An image was captured 
every 20 minutes for a duration of 94-96hrs.  
 
2.7.3 Imaging of satellite cells in culture 
Multiple phase 1 and fluorescent images were captured that represented 
areas in the middle and towards the edge of the culture dish using a Zeiss 
AxioVert 2 microscope. Images were captured using a 10x PlanNeofluar 
objective and a Zeiss AxioCam HRm CCD camera.  
 
2.8  Image analysis – Image J 
2.8.1  Muscle fibre diameter  
Images of muscle sections stained with Nidogen antibody to visualise the 
basement membrane and DAPI to visualise the nuclei were used to analyse 
fibre diameter post injury.  
Images were processed in Fiji (ImageJ) to subtract background, then 
converted to a binary image for better visualisation of fibre basement 
membranes. Areas of Nidogen staining that were lost when converting the 
image to binary were filled in using the paint tool. Minimum ferret diameter was 
measured using the Analyse Particles tool (further details in Fig. 3.4) 
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2.8.2 Analysis of time lapse movies 
Migration speed of satellite cells on myofibres was analysed using the 
MTrackJ plugin (Meijering et al., 2012) with Fiji (ImageJ) software. In brief, SCs 
were followed frame by frame as they migrated along the fibre between 
divisions. MTrackJ produces data on distance between two points between 
frames, this was used to calculate the distance individual SCs had migrated 
over time, i.e. speed of migration.  
Proliferation data was gathered by manually counting the number of 
divisions occurring during the time lapse movies.  
 
2.9 Statistics and Graphs 
2.9.1 Statistical analysis 
All statistical analysis was carried out using Graphpad Prism 6 software. 
For all experiments, multiple data points were collected for each mouse which 
were used to generate the population mean. The population mean values were 
used for statistical analysis to compare between control and mutant mice.  
Data was tested for Gaussian distribution using a Shapiro-Wilk test and 
was also analysed visually by histograms.  
For each experiment an n number of 3 mice was used unless otherwise 
stated. Due to the small n number non-parametric statistical analysis is not 
appropriate, therefore a parametric analysis was used. Unpaired, two tailed 
students T-tests carried out pairwise were used to calculate statistical 
significances.  p value interpretations for this thesis are detailed in Table 2.13. 
 
Table 2.13 Interpretation of p value to assess statistical significance 
p value Interpretation 
p ≤ 0.05 Statistically significant 
p > 0.05 - ≤ 0.1  Data trend 





All graphs were produced using Graphpad Prism 6 software. Appropriate 
graphs were selected depending on the data being displayed. Histograms were 
used to visualise data distribution and analyse shifts in distribution. Bar graphs 





Chapter 3 The loss of Talpid3 in muscle satellite 
cells impairs muscle regeneration following injury 
3.1 Introduction 
To investigate the role of primary cilia in SCs and their contribution to 
muscle regeneration we used a tamoxifen inducible, SC specific, Talpid3 KO 
mouse line subjected to a muscle injury and regeneration protocol. Ta3 mutants 
are known to have defects in primary ciliogenesis, which leads to disrupted Shh 
signalling. Both functional primary cilia and Shh signalling have been shown to 
be important for normal satellite cell function, most recently for self-renewal, and 
normal skeletal muscle regeneration (Fu et al., 2014; Jaafar Marican et al., 
2016; Straface et al., 2009). Therefore, this chapter aims to explore the effects 
of Ta3 mutations in SCs on the ability of skeletal muscle to regenerate after 
injury.  
We generated a tamoxifen inducible, SC conditional Ta3 mutant mouse 
line by crossing Ta3f/f and Pax7Cre-ERT2 mice, which allowed for normal 
development and growth of skeletal muscle during embryonic, foetal and post-
natal periods but removed Ta3 function in the adult animal upon the 
administration of tamoxifen.  
To investigate the role of Ta3 function in SCs during muscle regeneration, 
a muscle injury protocol was adopted (detailed in Fig. 3.3A/3.7A/3.9A). 
Tamoxifen was administered to all experimental mice. Ta3f/fPax7+ or 
Ta3f/+Pax7Cre-ERT2/+ were used as WT, whilst Ta3f/fPax7Cre-ERT2/+ were used as 
Ta3 mutants.  
Injury was induced in the Tibialis Anterior (TA) muscle by injection of 
Cardiotoxin (CTX), a potent toxin isolated from Cobra venom, on one or two 
occasions. CTX causes contracture of skeletal muscle by releasing membrane 
Ca2+ inducing injury (Lin Shiau et al., 1976).  Morphology of regenerating 
muscle was assessed by H&E staining of muscle sections. Regeneration 
efficiency was assessed by measuring myofibre diameter after 10, 15 and 25 
days of regeneration or after double injury and compared to contralateral 
uninjured control muscle. We also assessed the effects of a deletion of Ta3 in 
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SCs on homeostasis of muscle structure by inducing recombination of Ta3 and 
allowing mice to live normally for 4 months before injury was induced. 
 
3.2 Generation of Talpid3 conditional knockout in skeletal 
muscle satellite cells 
3.2.1 Breeding strategies to generate tamoxifen inducible conditional 
Talpid3 mutants 
To generate a Cre-recombinase inducible line to remove Ta3 function 
specifically in satellite cells, Ta3f/f females, that have loxP sites flanking exons 
11 and 12, were crossed with Pax7Cre-ERT2/+ males to generate Ta3f/+Pax7Cre-
ERT2/+ F1 generation (Fig. 1A, B). F1 mice were then crossed with a Ta3f/f 
mouse to generate Ta3f/fPax7Cre-ERT2/+, Ta3f/+Pax7Cre-ERT2/+ and Ta3f/fPax7+/+ F2 
generation (hereafter referred to as Pax7-Ta3f/f, Pax7-Ta3f/+ and Ta3f/f 
respectively). The Pax7Cre-ERT2/+ line used was generated as a knock-in mutant 
therefore the Pax7 allele was maintained as heterozygous to ensure Pax7 
remained functional in SCs.  
 
3.2.2 Genotyping of Talpid3 cKO mice  
To confirm the generation of mice with Pax7-Ta3f/f, Pax7-Ta3f/+ and Ta3f/f 
genotypes, genomic PCR was carried out on ear clippings of weaned pups. 
Previously published primers (See Table 2.2) were used that can distinguish 
the Ta3 floxed and Ta3 WT alleles along with the presence of Cre-recombinase 
gene. PCR results confirmed the presence of the Ta3 floxed (470bp), the Ta3 
WT (351bp) and Cre (650bp) in F2 generation pups (Fig. 3.1C), confirming the 
















Figure 3.1 Generation of a tamoxifen inducible, satellite cell specific Taplid3 
KO mouse line. 
(A) Schematic of the wildtype, floxed and null alleles of Talpid3, including primer binding 
sites for genotyping PCR. (B) Breeding strategy to generate Talpid3 mutant mice. (C) 
Example electrophoresis gel following genotyping PCR. Positive Cre-recombinase band at 
650bp, Talpid3 floxed allele at 470bp and Talpid3 wild typed (WT) band at 351bp. M= Base 
pair ladder.  
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3.2.3 Confirming the efficient recombination of the Talpid3 locus  
To assess recombination of the floxed Ta3 allele three approaches were 
used, two indirectly assessed the recombination of reporter genes and one 
directly assessed the presence of a Ta3 null allele.  
Ta3f/fPax7Cre-ERT2/+ (Pax7-Ta3f/f) and Ta3f/fPax7+ (Ta3f/f) mice were 
crossed with Rosa26-LacZ (R26RLacZ) reporter mice, which contain a loxP-
STOP-loxP-LacZ cassette targeted to the ubiquitously expressed R26R gene. 
Presence of the reporter allele was confirmed by genomic PCR (data not 
shown). Pax7 driven expression of a Cre-ERT2 fusion protein, that undergoes a 
conformational change upon tamoxifen induction allowing Cre-recombinase to 
translocate to the nucleus, was used to recombine the loxP-STOP-loxP and 
drive expression of the LacZ gene. Following tamoxifen induction and 
cardiotoxin injury muscle sections were tested for β-galactosidase activity, 
positive fibres were seen in muscle sections from Pax7-Ta3f/f mutant mice but 
not Ta3f/f control mice (Fig. 3.2A) confirming the recombination of the R26R 
locus upon administration of tamoxifen in Pax7-Ta3f/f mutant mice containing 
the Pax7Cre-ERT2 allele, but no recombination of in the Ta3f/f control mice due to 
the absence of Cre-recombinase. It was assumed that successful 
recombination of the R26R allele would coincide with the successful 
recombination of the Ta3 allele. The presence of β-galactosidase positive fibres 
following CTX injury indicated that Pax7-Ta3f/f mutant SCs are still able to fuse 
to myofibres (Fig. 3.2A).  
To quantify the efficiency of recombination by Pax7Cre-ERT2, Pax7-Ta3f/f 
mutant or Pax7-Ta3f/+control mice were crossed with Rosa26-tdTomato 
(R26RtdTom) reporter mice, which contain loxP-STOP-loxP cassette downstream 
of a CAG promotor that drive a fluorescent tdTomato gene. These were also 
crossed with Pax7ZsGreen mice which express green fluorescent protein under 
the control of the Pax7 promotor to allow for the identification of SCs. Presence 
of the reporter alleles was confirmed by genomic PCR (data not shown). Pax7 
driven expression of a Cre-ERT2 fusion protein was used to recombine the 
loxP-STOP-loxP and drive expression of the tdTomato gene. Single myofibres 
were isolated and fixed at T0 from Pax7-Ta3f/f mutant or Pax7-Ta3f/+control mice 
following 3 consecutive tamoxifen injections. SCs were identified by the 
presence of ZsGreen fluorescence and recombination was confirmed by the 
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presence of tdTomato fluorescence (Fig. 3.2B). Recombination efficiency was 
calculated as the percentage of ZsGreen positive SCs that were also tdTomato 
positive, 92% in Pax7-Ta3f/+controls (calculated from 37 SCs on 19 myfibres 
from 2 mice) and 94% in Pax7-Ta3f/f mutants (calculated from 81 SCs on 22 
myofibres from 2 mice) (Fig. 3.2C). Again, it was assumed that recombination 
of the R26R locus would coincide with recombination of the Ta3 allele.  
Finally, the presence of the Ta3 null allele was directly assessed through 
PCR. Whole muscle samples from uninjured TA muscles of Pax7-Ta3f/f, Ta3f/+ 
and Ta3f/f mice that were used for injury experiments were subjected to 
genomic PCR with primers that can identify WT, floxed and null alleles of the 
Ta3 gene. The null allele was present only in Pax7-Ta3f/f samples, floxed allele 
remains present in all samples due to the presence of myonuclei which do not 
undergo Pax7 specific Cre recombination (Fig. 3.2D).  
 Taken together these data show that Pax7Cre-ERT2 recombines LoxP sites 
with approximately 93% efficiency after 3 consecutive tamoxifen injections, and 
this recombination generates a null allele in Ta3 floxed SCs. All experimental 
mice were subject to 6 tamoxifen injections prior to being exposed to 
experimental conditions, it was therefore assumed that recombination of the 
floxed Ta3 locus would be more than 93% by start of any experiment.  
 We were able to demonstrate that our mutation causes a loss of Talpid3 
function on a genomic level, which according to previously published research 
results in the production of a non-functional protein (Yin et al., 2009). However, 
by removing Ta3 within adult SCs there will be a period in which functional 
protein will still be present after recombination has occurred. The half-life of TA3 
remains unknown, we therefore wanted to confirm the presence/ absence of 
TA3 protein following recombination by tamoxifen. We attempted to used a 
commercially available Talpid3 antibody for immunolabelling in C2C12 cells. 
Unfortunately, we were not able to detect TA3 using this method. Ideally, we 
would have used the antibody for western blott detection of the TA3 protein 
from isolated SCs from Ta3f/f controls and Pax7-Ta3f/f mutants, however we 
were not able to culture enough SCs for protein extraction. Therefore, we were 
unable to confirm the amount of time functional TA3 protein is present after 




Figure 3.2 The Talpid3 locus is efficiently recombined in satellite cells upon 
induction with tamoxifen in Ta3f/fPax7Cre-ERT2 mice.  
(A) Tamoxifen induced recombination of the Talpid3 locus was measured indirectly by LacZ 
staining in Ta3f/f//Pax7Cre-ERT2//Rosa-LacZ injured muscle sections. (B) Zs-Green and Tomato 
positive SCs in Ta3f/f//Pax7Cre-ERT2//Rosa-tdTomato myofibres indicate successful tamoxifen 
induced recombination of the Rosa-26 locus and an indirect measurement of Talpid3 
recombination. (C) Quantification of efficiency of recombination by the administration of 
tamoxifen. Pax7-Ta3f/+controls = 37 SCs on 19 myfibres from 2 mice, Pax7-Ta3f/f mutants = 
81 SCs on 22 myofibres from 2 mice. (D) Direct confirmation of recombination of the floxed 
Ta3 allele by PCR. M= base pair ladder. Floxed allele = 470bp, WT allele = 351bp, null allele = 
273bp. 
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3.2.4 The effect of a Talpid3 mutation on the presence of primary cilia in 
satellite cells 
In all cell types studied to date, mutations within Ta3 cause the loss of 
primary cilia (Bangs et al., 2011; Yin et al., 2009).  When this project started the 
presence of primary cilia on SCs had yet to be confirmed. We therefore set out 
to detect primary cilia on SCs by immunolabelling isolated myofibres.  
Primary antibodies against Arl13b and Acetylated ⍺-tubulin were 
successful in immunolabelling primary cilia on undifferentiated C2C12 cells (Fig 
3.3A). However, we were not successful when using the same combination of 
antibodies for immunolabelling primary cilia on SCs.  
Transfection of a GFP tagged Arl13b plasmid (pDEST47-Arl13b12, 
Addgene) was also successful in labelling primary cilia in C2C12 cells (Fig 
3.3B). This technique however was not used in SCs. Over expression of Arl13b 
by this plasmid has been shown to increase ciliary length in cultured MEFs 
(Larkins et al., 2011), we were therefore concerned that transfection could lead 
to artificial false positives.   
The presence of primary cilia on SCs was later confirmed by Jaafar 
Marican et al. (2016), we therefore changed our focus for this project away from 
the detection of primary cilia. However, this still leaves the question of when is 
the primary cilium removed from SCs in our model? Due to the quiescent, non-
cycling state of SCs at the time of recombination of the Ta3 locus it is possible 
that the primary cilium remains intact until the SC is activated and begins to 
progress through the cell cycle. There is no evidence to date that Ta3 is 
required for the maintenance of the primary cilium, only that it is required for its 
assembly. It is therefore essential that future experiments in this project are 
conducted to analyse the presence of primary cilia on SCs from Pax7-Ta3f/f 
mutants immediately after isolation and then again after SCs have been 
activated and are cycling. This could be achieved by immunolabelling with 
Arl13b or by culturing SCs and performing western blott analysis for the 














Figure 3.3 Primary cilia on C2C12 cells 
(A) Positive immunostaining for primary cilia on C2C12 cells at T0 +6hrs in differentiation 
media (white arrows). Arl13b (green) and Acetylated ⍺-Tubulin (red) co-localise to the 
primary cilium. (B) Positive labelling of primary on C2C12 cells (white arrows) by transfection 
with Arl13b-GFP plasmid. Scale bar = 10µm.  
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3.3 Analysis of muscle regeneration following short-term 
removal of Talpid3 in skeletal muscle satellite cells  
Short term removal of Talpid3 refers to tamoxifen induced recombination 
being carried out directly before injury with CTX and was used for all 
experiments in this section.  
 
3.3.1 Tamoxifen induction and injury experiment protocol  
To investigate the role of Ta3 in skeletal muscle regeneration Pax7-Ta3f/f 
mutants and Ta3f/f controls were subject to the protocol detailed in Fig. 3.4A. 
This included a seven-day period of SC DNA recombination through the IP 
administration of tamoxifen (with one rest day on day 6). On day 8 injury to the 
right TA muscle was carried out by intramuscular injection of CTX, the 
contralateral limb was left as an uninjured control. Mice were allowed to recover 
and sacrificed 5, 10, 15 or 25 days post injury. During the recovery and 
regeneration period tamoxifen was administered every other day to minimise 
contribution from SCs that may have escaped recombination during the initial 
period of tamoxifen induction. The number of mice used from each genotype 
and time point are detailed in Table 3.1 
 
Table 3.1 Mice used for short term regeneration experiments 
Experimental Time Point Genotype Number of mice 
5 days Ta3f/f 3 
Pax7-Ta3f/f 3 
10 days Ta3f/f 3 
Pax7-Ta3f/f 3 
15 days Ta3f/f 3 
Pax7-Ta3f/f 3 





3.3.2  Histological analysis of regenerating skeletal muscle following CTX 
injury 
Following the specified period of regeneration TA muscle was isolated, 
frozen and cryosectioned. 12 sections from each TA muscle from each mouse 
were selected that sampled multiple locations throughout the length of the 
muscle and subjected to H&E staining. In both Pax7-Ta3f/f mutant and Ta3f/f 
control mice centrally located nuclei were present at all time points, indicating 
the muscle had been injured and was undergoing regeneration. Five days after 
injury the presence of numerous regenerating myofibres was seen in Ta3f/f 
controls (Fig. 3.4B) whereas there were far fewer present in Pax7-Ta3f/f 
mutants (Fig. 3.4C), those that were present were visibly smaller. After 10, 15 
and 25 days of regeneration the number of regenerating myofibres in Pax7-
Ta3f/f muscle had increased compared to 5 days (Fig. 3.4D-I) however, 
myofibres in Pax7-Ta3f/f mutant muscle still appeared visably smaller than Ta3f/f 
controls (Fig. 3.4D-I).  
Non-injected control muscles from Pax7-Ta3f/f mutants and Ta3f/f controls 
showed no signs of centrally located nuclei, confirming the muscle had not been 
injured. There was no difference in myofibre size, number and organisation in 
non-injured muscle (Fig. 3.4J, K). 
Due to the visual differences in myofibre size between Pax7-Ta3f/f 
mutants and Ta3f/f controls observed in H&E stained sections of CTX injected 






Figure 3.4 Satellite cell specific deletion of Ta3 impairs muscle regeneration 
after CTX injury.  
(A) Schematic of tamoxifen and CTX treatment. (B-K) TA muscle sections from Pax-Ta3f/f 
mutant and Ta3f/f control mice were analysed by H&E staining on days 5, 10, 15 and 25 after 
injury. Representative images from 12 TA sections from each mouse at each time point.  
n=≥3 mice for each time point. (Scale bars = 50µm). 
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3.3.3 Quantitative analysis of regenerating skeletal muscle following CTX 
injury 
To more accurately understand the differences in progression of muscle 
regeneration in Pax7-Ta3f/f mutants and Ta3f/f controls a quantitative approach 
was used to measure the size of regenerating myofibres. The basement 
membrane (BM) surrounding individual myofibres was visualised by 
immunostaining against Nidogen, a BM protein that connects collagens and 
laminins, on muscle sections taken from injured and non-injured TA muscles. 
Up to 5 images were taken from different areas of each muscle section (Fig 
3.5A) to ensure that representation of the whole injured area was sampled. 
Myofibre size was measured using ImageJ software to calculate the minimum 
feret diameter (Detailed in Fig. 3.5B). A measurement of minimum feret 
diameter was taken to reduce the error associated with a non-transverse 
section through myofibres. Minimum feret diameter is calculated by measuring 
the diameter between every possible pair of parallel tangents and taking the 
smallest distance, which should always be the same irrespective of the plane of 
sectioning, assuming myofibres are cylindrical (Fig. 3.5C).  
Quantitative analysis was carried out on muscle sections after 10, 15 and 
25 days of regeneration but not after 5 days of regeneration. At this early time 
point the integrity of the BM is very weak making Nidogen staining of distinct 
basement membrane and measurement using ImageJ very difficult and 
inaccurate.  
Quantitative data was collected from an average of 1706 myofibres from 
16 areas across 6 muscle sections for each TA muscle analysed. The exact 
number of myofibres, areas and sections analysed for each mouse is detailed in 










Figure 3.5 Method of quantitative analysis of minimum feret diameter using 
ImageJ software.  
(A) Schematic representation of imaged areas within TA muscle sections. (B) Work flow of 
ImageJ software. Raw images of Nidogen immunostaining were opened with ImageJ. 
Background subtraction was applied and the threshold of the image adjusted to create a 
binary image. Missing pixels (indicated by red circles) were filled in using the paintbrush tool. 
Analyse particles function was used to measure minimum feret diameter of each myofibre, 
producing an outline overview of each fibre and a related data point in a spreadsheet. DAPI 
stained image was overlayed with the outline image and non-regenerating fibres were 
discarded. (C) Schematic representation of minimum feret diameter.  
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Nidogen immunostaining revealed similar phenotypic results to the H&E 
staining. Five days after injury the presence of numerous regenerating 
myofibres was seen in Ta3f/f controls (Fig. 3.6A’) whereas there were far fewer 
regenerating myofibres present in Pax7-Ta3f/f mutants (Fig. 3.6A’’), those that 
were present were visibly smaller with a less well defined surrounding 
membrane. After 10, 15 and 25 days of regeneration there was a normal 
distribution of fibre diameter in both Pax7-Ta3f/f mutants and Ta3f/f controls, 
however, there was a shift in the distribution towards a smaller feret diameter in 
Pax7-Ta3f/f mutants (Fig. 3.6G-J). At all time points quantified, the mean 
minimum feret diameter was significantly smaller in Pax7-Ta3f/f mutants 
compared to Ta3f/f controls (p<0.005, n≥3) (Fig. 3.6F), suggesting regeneration 
is impaired in Pax7-Ta3f/f mutant mice. There was no difference in fibre size in 
non-injured myofibres (Fig. 3.6E’, E’’, F, J)  
In Ta3f/f controls at 10 and 15 days of regeneration average myofibre size 
was significantly smaller than non-injured muscle (10 days p=0.0007, 15 days 
p=0.0028, n=3) (Fig. 3.6F). By 25 days of regeneration myofibres in Ta3f/f 
controls had increased in size and were not significantly different to non-injured 
myofibres (p=0.1523, n≥3) (Fig. 3.6F) indicating full recovery from injury. This 
gradual increase in myofibre size is to be expected during muscle regeneration. 
However, in Pax7-Ta3f/f mutants myofibre size was significantly smaller 
compared to non-injured muscle at all time points including 25 days (p<0.0001, 
n≥3) (Fig. 3.6F) suggesting that a mutation in Ta3 in SCs leads to impaired 





Figure 3.6 Myofibre size is significantly smaller after injury with CTX in satellite 
cell specific Ta3 mutants.  
(A’-E’’) Representative images of TA Muscle sections from CTX injured and non-injured Pax7-
Ta3f/f mutant and Ta3f/f control mice were analysed by Nidogen (green) immunostaining and 
DAPI (red) at 5, 10, 15 and 25 days after injury. (F) Mean minimum feret diameter of myofibres, 
calculated from population mean of each mouse from Pax7-Ta3f/f mutant and Ta3f/f control mice 
at 10, 15 and 25 days after injury and non-injured muscle. ** indicates p≤0.005, *** indicates 
p≤0.0005, ns indicates p>0.05, calculated by unpaired, two tailed t-test. n≥3 mice for each time 
point. Error bars = SEM. (G-J) Minimum feret diameter distribution of myofibres from Pax7-Ta3f/f 
mutant and Ta3f/f control mice at 10 (G), 15 (H), 25 (I) days after regeneration and from non-
injured muscle (J). 
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3.3.4 ⍺-Smooth Muscle Actin expression is prolonged in Pax7-Ta3f/f 
mutants 
Pax7-Ta3f/f mutant mice showed impaired muscle regeneration after injury 
with CTX. Myofibres remained significantly smaller than both time matched 
controls and non-injured muscle. To assess whether these fibres were stuck at 
an early stage of regeneration or were just simply smaller in size we utilised the 
dynamic expression of ⍺–smooth muscle actin (⍺-SMA) throughout 
regeneration in adult skeletal muscle.  
⍺-SMA was expressed in myofibres during early stages of regeneration, 
until approximately 8 days after injury, but expression was down-regulated in 
later stages (Fig. 3.7A). In myofibres from Ta3f/f control TA muscles there was 
no expression of ⍺-SMA after 10 or 15 days of regeneration (Fig 3.7 B, D) 
however in Pax7-Ta3f/f mutant TA muscles many myofibres were positive for ⍺-
SMA after 10 days of regeneration (Fig. 3.7C). This was true of all sections 
analysed, 12 sections from 3 mutants and 12 sections from 2 control mice. This 
suggests myofibres at 10 days after injury are at an earlier stage of 
regeneration in mutants compared to the controls. Myofibres from Pax7-Ta3f/f 
mutant TA muscles appeared to progress past this early stage of regeneration 
as 15 days after injury the majority of myofibres were ⍺-SMA negative (Fig 
3.7E). This suggests that Pax7-Ta3f/f mutants do have some capacity for 
muscle regeneration but the process is delayed.  
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Figure 3.7 Satellite cell specific KO of Ta3 leads to prolonged expression of ⍺-
SMA. 
(A) Representative images of time course of ⍺-SMA expression during muscle regeneration 
in WT mice from 2-12 days after injury (n=2 mice for each time point). ⍺-SMA positive 
myofibres (white arrows) are present 4-8 days after injury. (B-D) Representative images of ⍺-
SMA expression in myofibres from Pax7-Ta3f/f mutants and Ta3f/f controls 10 and 15 days 
after injury (n≥2 mice for each time point). ⍺-SMA positive fibres are present in Pax7-Ta3f/f 
mutants (100% of images analysed showed 10+ ⍺-SMA positive fibres) (C) at 10 days of 
regeneration but not in Ta3f/f controls (100% of images analysed showed less than 10 ⍺-SMA 
positive fibres) (B). All images are immunostaining on TA muscle sections for Nidogen 
(green), ⍺-SMA (red) and DAPI (blue). Arrow heads indicate positive staining of blood 
vessels. Scale bars = 50µm. 
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3.4 Analysis of muscle regeneration following long-term 
removal of Talpid3 in skeletal muscle satellite cells  
Short term injury experiments showed Pax7-Ta3f/f mutants have impaired 
muscle regeneration due to Ta3 being knocked out in SCs. It has been reported 
that SCs not only activate following injury but also play a role in general 
homeostasis and turnover of skeletal muscle (Pawlikowski et al., 2015). We 
therefore designed another set of experiments (referred to as long term (LT)) in 
which Ta3 was knocked out of SCs and mice were left to live normally for 
almost 4 months, before injury with CTX. We hypothesised that if SCs are 
contributing highly to the homeostasis of skeletal muscle we would observe 
defects in myofibres in non-injured muscle from Pax7-Ta3f/f mutants and 
possibly a more severe phenotype after injury due to evidence that the loss of 
primary cilia impairs SCs ability to self-renew (Jaafar Marican et al., 2016). 
 
3.4.1 Tamoxifen induction and injury experiment protocol  
To investigate the role of Ta3 in SCs during muscle homeostasis and 
general wear and tear Pax7-Ta3f/f mutants and Ta3f/f controls were subject to 
the protocol detailed in Fig. 3.8A. Similar to the ST protocol recombination of 
Ta3 was induced by 5 consecutive days of tamoxifen IP injections, followed by 
another 10 days of tamoxifen administered every second day. Following this, 
mice were left to live normally for 17 weeks. Ctx injury was induced in the right 
TA muscle, contralateral limbs were left as non-injured controls. TA muscles 
were harvested after 10 days of regeneration as this was the time point during 
the ST experiment in which we saw the biggest discrepancy between stage of 
regeneration between Pax7-Ta3f/f mutants and Ta3f/f controls. 4 Pax7-Ta3f/f 






3.4.2 Histological analysis of regenerating skeletal muscle following CTX 
injury 
Following 10 days of regeneration at the end of the protocol, TA muscle 
was isolated, frozen and cryosectioned. 12 sections from each TA muscle from 
each mouse were selected that sampled multiple locations throughout the 
length of the muscle and subjected to H&E staining. 
In non-injured muscle of both Ta3f/f controls and Pax7-Ta3f/f mutants 
myofibres looked healthy with no centrally located nuclei. Myofibres appeared to 
be of similar size and organisation (Fig. 3.8F, G).  
Ten days after injury with CTX the presence of many regenerating fibres 
was seen in Ta3f/f control (Fig 3.8D) and Pax7-Ta3f/f mutant (Fig. 3.8E) 
muscles, however similar to what was seen in the ST experiment, myofibres 
from Pax7-Ta3f/f mutants were observed to be visibly smaller than in controls 
(Fig 3.8B-E).  
Due to the visual differences in myofibre size between Pax7-Ta3f/f 
mutants and Ta3f/f controls observed in H&E stained sections of CTX injected 





























Figure 3.8 Satellite Cell specific deletion of Ta3 for an extended period impairs 
muscle regeneration following injury with CTX but does not affect muscle 
homeostasis. 
(A) Schematic of tamoxifen and CTX treatment. (B-G) TA muscle sections from Pax-Ta3f/f 
Mutant and Ta3f/f Control mice were analysed by H&E staining 10 days after injury and in non-
injured muscle. Representative images from 12 sections from each TA muscle, n=4 mice. ST= 
short term, tamoxifen induced recombination immediately prior to CTX injury. LT= long term, 
tamoxifen induced recombination 4 months prior to CTX injury. (Scale bars = 50µm) 
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3.4.3 Quantitative analysis of regenerating skeletal muscle following CTX 
injury 
As with the short-term experiments, myofibre size was quantified using 
ImageJ software (explained in section 3.3.3 and Fig. 3.5). Quantitative data 
was collected from an average of 4291 myofibres from 34 areas across 7 
muscle sections for each TA muscle analysed. The exact number of myofibres, 
areas and sections analysed for each mouse can be found in Appendix 1.2 
Nidogen immunostaining revealed similar phenotypic results to the H&E 
staining. Ten days after injury the presence of numerous regenerating 
myofibres was seen in Ta3f/f controls (Fig. 3.9A’) and Pax7-Ta3f/f mutants (Fig. 
3.9A’’). Similar to the ST experiments, after 10 days of regeneration in LT 
experiments there was a normal distribution of fibre diameter in both Pax7-Ta3f/f 
mutants and Ta3f/f controls, however there was a shift in the distribution towards 
a smaller feret diameter in Pax7-Ta3f/f mutants (Fig. 3.9C). In LT experiments, 
10 days after injury mean minimum feret diameter was significantly smaller in 
Pax7-Ta3f/f mutants compared to Ta3f/f controls (p<0.05, n≥3) (Fig. 3.9E) 
suggesting regeneration is impaired in Pax7-Ta3f/f mutant mice. There was no 
difference in fibre size in non-injured myofibres (Fig. 3.9B’, B’’, D, E). 
To understand the contribution of SCs to homeostasis of the muscle and 
to see if this is impaired with the long-term removal of Ta3, the mean minimum 
feret diameter of myofibres from Pax7-Ta3f/f mutants and Ta3f/f controls in the 
ST experiments was compared to those in the LT experiments. There was no 
significant difference in fibre size depending on whether Ta3 was removed 
immediately prior or 4 months prior to injury in controls (p= 0.6898, n=3) or 
mutants (p= 0.4715, n=3) (Fig 3.9F) suggesting there is not more of a 









Figure 3.9 Muscle regeneration is not further impaired by the removal of Ta3 
for an extended period before injury. 
(A’-B’’) Representative images from TA muscle sections from CTX injured and non-injured 
Pax7-Ta3f/f mutant and Ta3f/f control mice were analysed by Nidogen (green) immunostaining 
and DAPI (red) at 10 days after injury. (C, D) Minimum feret diameter distribution of 
myofibres from Pax7-Ta3f/f mutant and Ta3f/f control mice at 10 days (C) after injury and in 
non-injured muscle (D). (E) Mean minimum feret diameter of myofibres, calculated from 
population mean of each mouse from Pax7-Ta3f/f mutant and Ta3f/f control mice at 10 days 
after injury and non-injured muscle. (F) Mean minimum feret diameter of myofibres, 
calculated from population mean of each mouse from Pax7-Ta3f/f mutant and Ta3f/f control 
mice at 10 days after injury in short term (ST) and long term (LT) experiments.  * indicates 
p≤0.05, ns indicates p>0.05, calculated by unpaired, two-tailed t-test. n≥3 mice. 
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3.5 Analysis of Talpid3 mutant satellite cells ability to self-
renew. 
We have already shown that a SC specific loss of Ta3 impairs muscle 
regeneration as hypothesised based on evidence that primary cilia and Shh 
signalling are required for the normal proliferation and differentiation of muscle 
progenitors. However, SCs being stem cells must also be able to self-renew to 
maintain the stem cell pool and allow for multiple rounds of muscle repair and 
regeneration following injury. Recent evidence indicated that primary cilia play a 
vital role in this process. Jaafar Marican et al. (2016) showed that removing the 
primary cilium from SCs, using treatment with nocodazol or taxol which 
destabilise microtubules, or with forchlorfenuron which inhibits a family of 
proteins that regulate cilium length, reduced the number of cells that re-express 
Pax7 following 72hrs in ex vivo culture, suggesting a reduced number were re-
entering quiescence. We therefore hypothesised that Pax7-Ta3f/f mutants, 
which we assume to not possess a primary cilium on SCs, would have impaired 
self-renewal and should therefore have more severe impairment of muscle 
regeneration following double injuries.  
 
3.5.1 Tamoxifen induction and injury experiment protocol  
To investigate the role of Ta3 in the self-renewal of SCs after injury 
Pax7-Ta3f/f mutants and Ta3f/f controls were subject to the protocol detailed in 
Fig. 3.11A. This included a seven-day period of SC DNA recombination through 
the IP administration of tamoxifen (with one rest day on day 6). On day 8 injury 
to the right TA muscle was carried out by intramuscular injection of CTX, the 
contralateral limb was left as an uninjured control. After 25 days of regeneration 
a second injury to the TA muscle was carried out by CTX injection. Mice were 
allowed to recover and sacrificed 10 days post 2nd injury. During the recovery 
and regeneration period tamoxifen was administered every other day to 
minimise contribution from SCs that may have escaped recombination during 
the initial period of tamoxifen induction.  
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3.5.2 Analysis of myofibres after double CTX injury 
Following 10 days of regeneration at the end of the protocol, TA muscle 
was isolated, frozen and cryosectioned. 12 sections from each TA muscle from 
each mouse were selected that sampled multiple locations throughout the 
length of the muscle and subjected to H&E staining. Visual analysis of the full 
muscle section revealed variability in the size of the area injured in each TA 
muscle (Fig 3.10). In all Ta3f/f control mice more than approximately 50% of the 
muscle has been injured whereas in 3/4 Pax7-Ta3f/f mutants only approximately 
25-30% of the muscle is injured. Closer analysis of these regenerating areas 
must therefore be done with the caveat that the area of injury was different in 
control compared to mutant mice.  
 
 
Figure 3.10 Whole muscle sections following double cardiotoxin injury. 
(A-D) Whole TA muscle sections from Ta3f/f control mice following double injury with CTX. (E-
H) Whole TA muscle sections from Pax7-Ta3f/f mutant mice following double injury with CTX. 
Representative images from 12 muscle sections from each mouse. Dotted line indicates 
border of injury site. * indicates injured region. Images not to scale.  
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H&E staining showed the presence of regenerating fibres in all Ta3f/f 
control mice samples. The morphology and size of regenerating fibres in Ta3f/f 
controls appeared to be as expected 10 days post CTX injury (Fig. 3.11B-E). 
Quantification of myofibre size in Ta3f/f controls by measuring minimum ferret 
diameter showed a normal distribution of myofibre sizes. There was no 
significant difference in myofibre size in Ta3f/f controls 10 days after a single 
injury or 10 days after a second injury (p=0.5129, n=3) (data not shown). These 
data show that in control mice SCs were still able to efficiently regenerate the 
muscle after a second injury, suggesting the SC pool had been maintained, 
following the first injury, through self-renewal.  
The results from Pax7-Ta3f/f mutants were somewhat inconclusive. H&E 
staining revealed areas within the injured TA muscle that showed no sign of 
regeneration, the presence of myofibres with centrally located nuclei was very 
low in these areas in 3 TA muscles (Fig. 3.11G-I), only one muscle had many 
regenerating fibres (Fig 3.11F). Quantification of myofibre size was not possible 
in Pax7-Ta3f/f mutants due to the severity of the injury site and disruption to the 
BM. 
These data suggest there could be a defect in self-renewal of SCs from 
Pax7-Ta3f/f mutants, which led to the SC pool being depleted after the first injury 
leaving too few SCs to be able to regenerate the muscle after a second injury. 
However, there were limitations to this technique (discussed in section 3.6), 





















Figure 3.11 Satellite cell specific loss of Ta3 results in limited SC self-renewal 
and loss of muscle regeneration after repeated CTX injuries.  
(A) Schematic of tamoxifen and CTX treatment. (B-I) Representative images of 12 TA 
muscle sections from each Pax-Ta3f/f Mutant and Ta3f/f Control mouse were analysed by 
H&E staining on days 10 days after 2nd injury. (Scale bars = 50µm) 
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3.6 Discussion  
The aim of this chapter was to investigate the requirement of Ta3 in SCs 
for muscle regeneration after injury. Published research has shown that 
mutations in Ta3 lead to the loss of primary cilia and disruption in Shh 
signalling, both of which have been shown to play vital roles in normal SC 
function during muscle regeneration (Fu et al., 2014; Jaafar Marican et al., 
2016; Koleva et al., 2005). 
The experiments in this chapter utilised the generation of a tamoxifen 
inducible, SC specific Ta3 mutant mouse line. We successfully generated 
Ta3f/fPax7Cre-ERT2 mice that also expressed one or more reporters (R26RLacZ, 
R26Rtd-Tomato, Pax7ZsGreen). Cre-recombinase mediated recombination in these 
mice was at least 93% efficient after 3 consecutive tamoxifen injections, in line 
with previously published data on the Pax7Cre-ERT2 mouse (Lepper et al., 2009). 
Caution has to be applied when using the Cre-loxP system in SCs however, 
due to the ability of very few SCs to repopulate the whole muscle after injury if 
they have escaped recombination (von Maltzahn et al., 2013). Therefore, we 
administered tamoxifen by IP injection every second day throughout the 
regeneration period.  
SC specific KO of Ta3 caused a deficiency in muscle regeneration after 
CTX injury as indicated by significantly smaller myofibres at all time points 
studied (5, 10, 15 and 25 days). It was evident that muscle regeneration was 
delayed in Pax7-Ta3f/f mutants due to the prolonged expression of ⍺-SMA 10 
days after injury. However, this expression was downregulated again by 15 
days. This, along with the fact that there were regenerating fibres present in 
Pax7-Ta3f/f mutants suggested a deficiency in regeneration but not a complete 
loss or inability of SCs lacking cilia to contribute to the process. In Ta3f/f control 
mice, by 25 days of regeneration, myofibres had regenerated to a point where 
their size was not significantly different to the non-injured myofibres. This is 
consistent with published observations that regeneration restores muscle to 
homeostasis by 28 days post injury (Hardy et al., 2016). However, in the Pax7-
Ta3f/f mutants myofibres were still significantly smaller than the non-injured 
muscle. It is possible that this is as far as the myofibres are able to recover, 
however it would be interesting to assess the muscle at an additional later time 
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point, maybe 30-35 days post injury, to determine if the myofibres are able to 
make a full recovery or not.  
The delayed/ deficient phenotype but not complete loss of regenerative 
ability fits well with a cilium mutation. As previously discussed, Shh signalling in 
Ta3 mutants is not simply a KO of Shh signalling. Ta3 mutants show many 
pleotropic phenotypes due to the mis-regulation of GLIA:GLIR ratio. It is 
therefore possible that the low level of regeneration that is occurring is due to a 
low level of Shh signalling still taking place in Pax7-Ta3f/f SCs, however the 
highest levels of Shh signalling are perturbed which are required for normal and 
effective SC function after injury. It would therefore be interesting to determine 
the Shh signalling status in Ta3 mutant SCs, for example by sorting cells and 
examining expression of GLI isoforms.  
From these injury experiments it is not possible to deduce at what stage in 
the regeneration process SCs from Pax7-Ta3f/f mice are defective. It could be a 
problem with SC activation, proliferation, differentiation or apoptosis that cause 
a regeneration phenotype. This will be addressed in Chapters 4 and 5.  
After confirming a phenotype for Pax7-Ta3f/f mutant SCs during muscle 
regeneration we were interested to investigate their role during muscle 
homeostasis and everyday wear and tear. There is still much discussion in the 
field as to the contribution of SCs to the turn-over of adult skeletal muscle. It is 
largely accepted that SCs contribute greatly to post-natal and juvenile muscle 
growth (Mesires and Doumit, 2002; Oustanina et al., 2004). However, there is 
conflicting evidence regarding the contribution of SCs to myonuclear turnover in 
uninjured muscles. Some studies show that up to 20% of myofibres in adult 
mice hind limbs are tdTomato+ 2 weeks after SC labelling (Pawlikowski et al., 
2015). Whilst others have found that skeletal muscle is still able to undergo 
hypertrophy in the absence of SC in the short term (McCarthy et al., 2011). 
However, a follow up study revealed that growth does plateau in the absence of 
SCs (Fry et al., 2014b). We hypothesised that if SCs are contributing to 
myonuclear turnover and cilium deficient SCs have reduced self-renewal, that 
there would be a depletion in the SC number in Pax7-Ta3f/f mutant mice that 
had been treated with tamoxifen and then allowed to live normally. Due to a 
potential reduction in SC number we anticipated a more severe muscle 
regeneration phenotype following CTX injury in Pax7-Ta3f/f mutant mice that 
 90 
had been treated with tamoxifen 4 months prior to injury (LT experiment) 
compared to those treated with tamoxifen 1 week prior to injury (ST 
experiment). However, there was no significant difference in myofibre size 10 
days after injury in Pax7-Ta3f/f mutant mice in the ST experiment compared to 
the LT experiment. Suggesting the pool of SCs was similar in both 
circumstances. This is likely due to a low turnover of SCs leaving enough to 
partially recover the muscle after injury. To exacerbate any potential phenotype, 
it would be interesting to repeat these experiments incorporating an exercise 
regime. Causing stress and small injuries to the muscles would require the 
contribution of some SCs for low level repair. It would be interesting to see how 
Pax7-Ta3f/f mutants would then respond to a severe injury with CTX.  
To understand further if Pax7-Ta3f/f mice have a defect in self-renewal, as 
would be expected from evidence from cilia depleted SCs (Jaafar Marican et al., 
2016), we carried out double injury experiments. Initial results appear to 
suggest that muscle regeneration is severely compromised in Pax7-Ta3f/f 
mutant mice after a second CTX induced injury. In 3/4 Pax7-Ta3f/f mutants there 
were areas of injured muscle that appeared to be completely devoid of 
regenerating fibres, this was not seen in any of the Ta3f/f control mice. However, 
there are some limitations to these experiments.  One of the Pax7-Ta3f/f mice 
showed levels of regeneration that were similar to the regeneration seen in 
other Pax7-Ta3f/f mutants after a single injury. It is possible that either the first 
or second CTX injection in this mouse missed the TA muscle and therefore the 
muscle was only subjected to a single injury. Unfortunately, with the technique 
used it is not possible to determine that the same part of the muscle has been 
injured twice.  
Another limitation of the CTX injury technique is possible differences in 
diffusion of the toxin throughout the muscle with each injection. Every care was 
taken to try to direct the injection to the same place each time however on some 
occasions the CTX may only hit a small area on the edge of the muscle, which 
sometimes leads to less diffusion of CTX throughout the muscle. This could 
lead to a large volume of CTX concentrating in a small area of the muscle, 
causing a far more severe injury in this localised area. This would then result in 
more necrosis than if the CTX had diffused throughout the whole muscle, 
potentially requiring full de novo regeneration of muscle fibres rather than just 
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repair. Unfortunately, analysis of images of the full area of the TA muscle from 
the double injury experiments indicates that the area of damage in some of the 
Pax7-Ta3f/f mutants was quite small (Fig 3.10F, H). This seemed to coincide 
with a severe regeneration phenotype, compared to Ta3f/f controls, in which the 
area of injury was quite extensive (Fig 3.10A-D). It is therefore possible that the 
lack of regeneration was due, at least in part, to the very localised injury. This 
was observed in a couple of mice after single injury with small areas of muscle 
damage (data not shown). To draw more definitive conclusions, this double 
injury experiment should be repeated to increase the probability that both CTX 
injections cover the same, widespread area of the TA muscle.  
To summarise, in this chapter we have shown that SC specific mutations in Ta3 
cause a delay in regeneration following injury with CTX and that there is 
potentially a defect in SC self-renewal with preliminary evidence suggesting that 
double injury with CTX may cause a very severe regeneration defect. The 
molecular mechanism through which this occurs is still not clear but will be 




Chapter 4 The loss of Talpid3 in muscle satellite 
cells on their ability to migrate, proliferate and 
differentiate  
4.1 Introduction 
The results obtained in Chapter 3 suggest that the loss of Ta3 from SCs 
impairs their ability to efficiently repair and regenerate skeletal muscle following 
injury. This chapter will explore in more detail the phenotypic differences 
between WT and Ta3 mutant satellite cells to try to understand the reason for 
the deficiency in regeneration.  
The proliferation and migration of satellite cells after activation is vital to 
their ability to efficiently regenerate injured skeletal muscle. Following activation, 
SCs must migrate along their associated myofibre or between myofibres to the 
site of injury. They must be able to proliferate to produce a pool of myoblasts 
that will differentiate to repair and repopulate damaged myofibres.  
To investigate if the loss of Ta3 from SCs affects their ability to migrate or 
proliferate we used time-lapse microscopy to visualise the behaviour of WT and 
Ta3 mutant satellite cells whilst still associated with their resident myofibre. 
Previously published research using this technique has shown that SCs move 
from beneath the basal lamina of their myofibre to the exterior within 12-24hrs 
of activation (Siegel et al., 2009). Proliferation of SCs has been shown to be 
asynchronous, with the first division happening anytime from 24-48hrs after 
activation, subsequent division happens anytime from 5-17hrs after the first 
division with an average of 10hrs (Siegel et al., 2011).   
As previously discussed, Ta3 mutations leads to a loss of primary cilia 
formation which subsequently causes a disruption of Shh signalling. Primary 
cilia are present on quiescent SCs and are disassembled within the first 24hrs 
of activation, we therefore wanted to capture this period during our time-lapse 
recording and imaging was started 4-5hrs after myofibre isolation. The primary 
cilium begins to appear in SCs again between 72-96hrs in those cells destined 
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to re-enter the stem cell niche, we therefore continued our imaging for 90hrs 
after isolation.  
Myogenic progenitor cells that are generated following SC proliferation 
must differentiate and fuse to each other or the damaged myofibre in order to 
repair damaged muscle. Myogenic progenitors generated from SCs in culture 
will begin to spontaneously differentiate when the level of serum in the culture 
media is low. To investigate the effects of a Ta3 mutation on differentiation we 
cultured SCs isolated from Ta3f/f controls and Pax7-Ta3f/f mutants, following 
tamoxifen induction, on matrigel and observed morphological changes that are 
associated with myogenic differentiation. Once the presence of mature 
myotubes was evident in Ta3f/f control cultures, cells were fixed and 
immunostained to detect Myosin Heavy Chain (MHC) protein.  
 
4.2 Analysis of migration of Talpid3 mutant satellite cells  
To assess any changes in migration due to the loss of Ta3 myofibres from 
the EDL, composed predominately of type II fast twitch myofibres, were used. 
At starting number of 81 SCs on 48 myofibres from 4 Ta3f/f control mice and 97 
SCs on 55 myofibres from 4 Pax7-Ta3f/f mutant mice were analysed using the 
MTrackJ plugin for ImageJ. Each SC was manually tracked in each frame and 
migration distance was recorded until the SC divided or to the end of the video, 
one daughter cell was then picked at random and analysed in a new track 
unless they separated and migrated in different directions, in which case both 
were analysed (Fig. 4.1A’, A’’). Including F1 and F2 daughter cells in total 
migration of 228 SCs from Ta3f/f controls and 266 SCs Pax7-Ta3f/f mutants were 
tracked.  
 
4.2.1 Migration speed  
Migration speed was calculated from the distance recorded for each 
track and the number of frames over which the cell was tracked (converted to 
time in hours). The average migration speed of all SCs tracked from Ta3f/f 
controls and Pax7-Ta3f/f mutants was 8.7µm/hr for both (Fig. 4.1B). Within the 
first 24hrs following isolation SCs are activated and begin to move through the 
basal lamina to the surface of the myofibre, migration during this period is 
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usually slower than after the SC has reached the exterior. Therefore, the 
migration speeds were re-calculated within the first 24hrs and 24+hrs to 
represent these different migration phases. Ta3f/f controls showed an average 
migration speed of 8.6 and 12.1µm/hr between 0-24hrs and 24+hrs respectively 
whilst in Pax7-Ta3f/f mutants migration speeds were 7.1 and 9.4µm/hr (Fig. 
4.1C). For both time periods, there was no significant difference between Ta3f/f 
controls and Pax7-Ta3f/f mutants. The appearance that Ta3f/f controls migrate 
slightly faster than Pax7-Ta3f/f mutants both between 0-24hrs and 24+hrs but 
not when the average migration speed is taken over all (Fig. 4.1C vs Fig. 4.1B) 
is due to only F0 cells being analysed in the split time periods, whilst the total 
average was determined from all SC generations. This difference led to the 
analysis of migration speed of each generation of cells, again there was no 
significant difference between Ta3f/f controls and Pax7-Ta3f/f mutants (Fig. 
4.1D). 
It appears that the loss of Ta3 does not affect the ability of SCs or their 
daughter cells to migrate along their host myofibre. One thing of note is the 
migration speed of all cells analysed was much slower than previously 
published data (maximum average of 12µm/hr compared to 30-40µm/hr). The 
timelapse interval of 20 minutes assumes linearity of migration however SCs do 
not always migrate in a linear fashion, therefore using smaller intervals may 











Figure 4.1 Satellite cell specific loss of Ta3 does not affect satellite cell 
migration speed. 
(A’, A’’) Example tracks from migration analysis using MTrackJ plugin for ImageJ. Scale bars 
= 50µm. (B) Average migration speed of all SCs analysed calculated as average of 
population mean from each mouse. (C) Average migration speed of F0 SCs within the first 
24hrs of time-lapse recording and 24+hrs until first division calculated as average of 
population mean from each mouse. (D) Average migration speed of SCs and their daughter 
cells, F0 = SCs, F1= daughters from first division, F2 = daughters from second division 
calculated as average of population mean from each mouse. ns indicates p>0.05 calculated 
by unpaired, two-tailed t-test. Error bars = SEM. 
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4.3 Analysis of proliferation of Talpid3 mutant satellite cells  
To assess the effects of the loss of Ta3 on SC proliferation we analysed 
both the number of divisions that occurred and the time taken for the first and 
subsequent divisions to occur. Divisions were manually observed during the 
time-lapse video and the frame number of the division was noted, this was then 
converted to give the time of division.  
 
4.3.1 Timing of proliferation 
Published data suggests that once activated, SCs will undergo their first 
division within 24-48hrs. In this study time to first division ranged from 27-70hrs 
and 24-71hrs from the beginning of recording in Ta3f/f controls and Pax7-Ta3f/f 
mutants respectively, with an average time of 43 and 45hrs, which is not 
significantly different (p=0.8, n=4) (Fig. 4.2). Average time to first division was 
calculated by averaging the population mean of each mouse. In total 74 SCs 
from Ta3f/f controls and 82 SCs Pax7-Ta3f/f mutants were used in this analysis. 
The large range in time to first division is in line with the observation that SC 
divisions occur at irregular intervals. This continued with subsequent division 
happening anywhere from 2-50hrs and 9-30hrs after the first division in Ta3f/f 
controls and Pax7-Ta3f/f mutants respectively. The average cycling time to the 
next division in Ta3f/f controls was 17hrs and in Pax7-Ta3f/f mutants was 15hrs, 
again not significantly different (p=0.5, n=4) (Fig. 4.2). Average time between 
first division and second divisions was calculated by averaging the population 
mean of each mouse. In total 73 SCs from Ta3f/f controls and 51 SCs Pax7-
Ta3f/f mutants were used in this analysis. 
The exact timing of any further divisions was not calculated due to the 
formation of cell clusters in the majority of videos analysed which made it very 














4.3.2 Number of divisions 
There appeared to be no difference in the timing of divisions between 
Ta3f/f controls and Pax7-Ta3f/f mutants. Next, we analysed SC proliferation to 
see if there was any difference in the number of divisions SCs went through 
between controls and mutants.  
In 3 out of the 4 Ta3f/f control mice all SCs divided at least once compared 
to Pax7-Ta3f/f mutant mice in which each mouse had at least one SC that did 
not divide. The average percentage of cells that did not divide was 7% and 13% 
in Ta3f/f controls and Pax7-Ta3f/f mutants respectively (Fig. 4.3). This is not 
statistically significant (p=0.5, n=4). This is likely due to the large SEM 
associated with the Ta3f/f control data due to the one mouse in which 5/19 
(26%) SCs did not divide at all whilst all other control SCs did divide.  
Figure 4.2 Satellite cells specific loss of Ta3 does not affect the time taken for 
SCs to divide after activation. 
Graph showing the average time taken for SCs to undergo their 1st division and time 
between their 1st to 2nd division, calculated by averaging the population means from each 
mouse. Error bars = SEM. p>0.05, n=4 calculated by unpaired, two-tailed t-test.  
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There was no significant difference in the percentage of SCs that went 
through 1, 2 or 3+ divisions in Pax7-Ta3f/f mutants compared to Ta3f/f controls 
(Fig. 4.3) (p=0.5, 0.07, 0.1 respectively, n=4). There is a possible trend in fewer 
Pax7-Ta3f/f mutant SCs going through 2 divisions compared to Ta3f/f controls 
(p= 0.07). Again, this is likely due to the large differences between individual 
animals. A higher number of experimental animals is needed to increase the 








Figure 4.3 Satellite specific loss of Ta3 does not affect the number of 
divisions activated SCs go through.  
Graph showing the average percentage of SCs that divide 0, 1, 2 or 3+ times during the 
time-lapse movie (90-92hrs after isolation) from Ta3f/f controls (n=4) and Pax7-Ta3f/f 
mutants (n=4), calculated by averaging population mean from each mouse. Error bars = 
SEM. ns indicates p>0.05, calculated by unpaired, two-tailed t-test.   
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4.4 Analysis of differentiation of Talpid3 mutant satellite cells  
We found that SCs with mutated Ta3 appeared to have no defect in 
migration compared to WT SCs. It remains unclear as to whether proliferation is 
affected. We also wanted to investigate how a SC specific loss of Ta3 affects 
isolated SCs ability to differentiate. To isolate SCs, myofibres were dissected 
and plated on matrigel coated 12 well plates. Unfortunately, isolation of SCs 
was not efficient enough to obtain a high enough cell number to accurately 
count using a haemocytometer. To try to ensure a similar number of cells were 
seeded, at the time of plating myofibres were counted and between 100-120 
were plated in each well. After 3 days of incubation SCs had migrated onto the 
matrigel plate and myofibres were removed. Cells were re-plated on fresh 
matrigel, at this stage all cells from one well were transferred together to a new 
well, cells were not diluted or split. SCs were incubated for up to 14 days post 
isolation. Images of the cells were taken every other day to assess 
differentiation and finally cells were fixed and stained with MF20 to visualise 
mature myotubes.  
At 6 days post isolation (dpi), which is 2 days after re-plating, there were a 
similar number of cells present in both Ta3f/f control and Pax7-Ta3f/f mutant 
cultures upon visual assessment (Fig. 4.4A’, A’’). Unfortunately, reporter mice 
were not available for these experiments so it was not possible to determine the 
proportion of SCs compared to other types of cells that may be present in the 
culture. Due to the limited number of culture wells it was not possible to identify 
myogenic cells by immunolabelling with Pax7 or MyoD as this would have 
required fixing cultures at early time points before terminal differentiation had 
occurred. 
At 8dpi many elongated myoblasts were present that had started to 
orientate themselves parallel to each other in Ta3f/f controls (Fig. 4.4B’) 
whereas only a few cells from Pax7-Ta3f/f mutants had an elongated shape and 
cells were orientated more randomly (Fig. 4.4B’’). By 12dpi long multinucleated 
myotubes had formed in Ta3f/f control cultures and by 14dpi filled the majority of 
the field of view (Fig. 4.4C’, D’). This was in stark contrast to Pax7-Ta3f/f mutant 
cultures in which only a few short myotubes had begun to form. Even by 14dpi, 
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these were only bi-nucleated suggesting fusion was limited to only 2 myoblast 
(Fig. 4.4C’’, D’’).  
Immunostaining with an MF20 antibody that recognises Myosin Heavy 
Chain (MHC) protein, a component of mature myofibres, revealed all cells in 
Ta3f/f control cultures were MHC positive and myofibres were multinucleated 
(Fig. 4.4E’) whereas very few cells were MHC positive in Pax7-Ta3f/f mutant 
cultures (Fig. 4.4E’’). Staining with DAPI revealed that there were many cells 
present in Pax7-Ta3f/f mutant cultures, but they were not MHC positive and had 
not fused to form mature myotubes. This suggests that the loss of Ta3 in SCs 
impairs their normal differentiation and fusion to form mature myotubes.  
The intention with this experiment was to first determine optimal culture 
conditions for SC culture and differentiation and then repeat the experiment with 
a more accurate count of the number of SCs plated with the intention of 
quantifying the number of SCs per field of view every second day throughout 
the culture period or assessing proliferation through analysis of BrdU or Edu 
incorporation. Unfortunately, we were not able to obtain sufficient SCs to carry 
out this quantification. Therefore, it was not possible to assess whether SCs 
from Pax7-Ta3f/f mutants were proliferating at a similar rate to SCs from Ta3f/f 
controls. This means it is possible that the differences in the number of mulit-




Figure 4.4 Satellite specific loss of Ta3 disrupts differentiation ability of SCs in 
culture. 
(A-D) Representative phase 1 images of SCs cells in culture isolated from myofibres from  
Ta3f/f control (A’-E’) and Pax7-Ta3f/f mutant (A’’-E’’) mice and allowed to spontaneously 
differentiate (n=2). (E’, E’’) Immunostaining against MF20 (green) and DAPI staining (red) of 
differentiated SCs. Scale bars = 50µm.  
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4.5 Discussion  
The aim of this chapter was to investigate the effects that the loss of Ta3 
has on SCs ability to migrate along their host myofibre, proliferate and 
differentiate. These steps are all vital for normal muscle regeneration following 
injury, which was found to be impaired in mice with Ta3 deficient SCs.  
Migration defects have been reported in fibroblasts isolated from Ta3-/- 
mouse limb. In a scratch assay Ta3-/-  cells migrated more slowly and with less 
directionality compared to WT cells and therefore took longer to close the 
scratch (Bangs et al., 2011). We did not observe this defect in the SCs from 
Pax7-Ta3f/f mutants, which migrated at the same speed as SCs from Ta3f/f 
controls. The speed of migration of SCs in these experiments was much slower 
than previously published. Three studies of note have measured SCs migration 
speed using time lapse imaging of SCs on their associated myofibre. These 
showed an average migration speed of 30-40µm/hr in WT SCs (Collins-Hooper 
et al., 2012; Otto et al., 2011; Siegel et al., 2009). The technique used to isolate 
the myofibres was the same in all experiments and was identical to the method 
used here. The culture media used to culture the myofibres was also the same. 
Siegel et al. (2009) cultured myofibres in suspension for 24hrs prior to 
transferring into collagen matrix for time lapse imaging, it is not clear when or if 
myofibres in the other experiments were transferred into collagen.  
The major discrepancy of these published studies with our research was 
the frequency of images taken, every 10-15 minutes compared to every 20 
minutes. SCs do not migrate in a linear fashion and often move back and forth, 
it is therefore possible that some movements of the SCs were missed due to 
fewer images. However, it seems unlikely that this would account for migration 
speeds being around a quarter the speed of those previously published 
(8.7µm/hr compared to 30-40µm/hr). 
Otto et al. (2011) detailed the dynamic nature of migration speed following 
isolation, showing that migration is much slower whilst the SC is still under the 
basal lamina (27µm/hr), then once it has emerged migration speed increases 
(50µm/hr). Our observations followed a similar trend with migration speed in the 
first 24hrs being slower, however speed only increased marginally and did not 
double as in Otto’s study.  
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Another key property of SCs is their ability to proliferate upon activation to 
generate a large enough population of MPCs to repair and regenerate damaged 
muscle. Shh has been implicated as a mediator of cell proliferation in a number 
of cell types including SCs. Koleva et al. (2005) reported an increase in BrdU 
incorporation in SCs cultured in the presence of Shh, but this increase was 
halved with the addition of cyclopamine, providing evidence that the increase in 
proliferation was dependent on the Shh pathway. Shh has also been proposed 
as a possible therapy for muscular dystrophies following the discovery that Shh 
can increase the proliferative capacity of SCs isolated from mdx mice (Piccioni 
et al., 2014b). It is therefore possible that Pax7-Ta3f/f mutant SCs may show 
proliferation defects due to disruptions in Shh signal transduction. Although we 
did not observe any statistically significant differences in the number of divisions 
Pax7-Ta3f/f mutant SCs went through compared to Ta3f/f controls, there was an 
observable trend that fewer mutant SCs made it to each round of proliferation 
and an increased proportion did not divide at all during the 85+hrs of recording. 
This would be in line with findings from Bashford (2015) that mutations in Ta3 
lead to reduced proliferation in granule neuron progenitor (GNP) cells. Loss of 
another protein, Cep120, also produces a reduced proliferation phenotype in 
GNP cells. Cep120 mutants also fail to form primary cilia. It has been shown 
that Ta3 and Cep120 directly interact, with Cep120 being dependant on Ta3 for 
its correct localisation and distribution between mother and daughter centrioles 
(Wu et al., 2014). Therefore, it is reasonable to propose that mutations in Ta3 
may lead to reduced proliferation due to effects on Cep120 distribution. Bringing 
these findings together it appears that Ta3, primary cilia and Shh signalling are 
all required for normal proliferation. It is therefore important that proliferation in 
Pax7-Ta3f/f mutant SCs is re-assessed with a greater number of biological 
replicates to conclude if proliferation is affected in our model. 
 
The data collected from the analysis of time-lapse imaging of Ta3f/f control 
and Pax7-Ta3f/f mutant SCs appears to show that a Ta3 mutation does not 
affect SCs ability to migrate compared to controls or their ability to proliferate. 
However, there were multiple technical problems that occurred during the 
collection of the data, in order to draw unambiguous conclusions, the 
experiments need to be repeated. Here, this experiment was conducted on 8 
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separate occasions in which myofibres from 7 Ta3f/f control mice and 8 Pax7-
Ta3f/f mutant mice were isolated and set up for time-lapse imaging.  On 2 
occasions the experiment ran as planned, while on other occasions some wells 
had bacterial infections or myofibres died before the end of the experiment. 
Much of this data was disregarded, however some myofibres used for the 
analysis were in the same plate as others that had become infected.  Despite 
these difficulties there are still trends within the data which will be useful for 
informing future experiments. 
 
We have shown that Pax7-Ta3f/f mutant SCs are not able to regenerate 
myofibres as efficiently as those from Ta3f/f controls. In an in vivo setting of 
skeletal muscle injury there are however other cell types that might be 
contributing in part to the repair of damaged muscle, therefore we isolated SCs 
to try to reveal any direct phenotypic traits that are present in the mutant SCs 
themselves. The involvement of Shh signalling in myogenic differentiation has 
been well studied. Shh signalling has been shown to be vital in the control of 
MRFs that allow MPCs to progress through differentiation (Borycki et al., 1999). 
Evidence is also present for the role of Shh in the reactivation of the myogenic 
pathway in adult skeletal muscle following injury through the control of Myf5 and 
MyoD (Straface et al., 2009). These previous studies are consistent with the 
striking defect observed in the differentiation ability of Pax7-Ta3f/f mutant SCs, 
with reduced number of MHC positive myofibres compared to Ta3f/f controls 
cultured for the same amount of time. This could be due to inability of mutant 
SCs to sufficiently upregulate Myf5 or MyoD and therefore a reduced ability to 
enter the myogenic programme. Unfortunately, due to time constraints it was 
not possible to directly analyse the expression of the MRFs during the 
differentiation time course. It would be very interesting to compare the 
expression of Myf5 and MyoD in the first couple of days of differentiation and 
then later the expression of Mgn and MRF4 by immunostaining of mutant and 
control SCs in culture.  
 
There were also some technical difficulties encountered during these 
experiments. In our hands, the isolation technique did not harbour enough SCs 
to accurately count them. Therefore, an indirect approach was used to ensure 
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that a similar number of Ta3f/f control and Pax7-Ta3f/f mutant cells were plated. 
However, this allows for the possibility that there were more SCs present in 
control cultures compared to mutant cultures and could have limited the 
possibility for mutant SCs to fuse and differentiate. Efforts were made to plate 
the same number of myofibres in each culture and visual assessment showed a 
similar coverage of cells in each culture. It was also observed that in the control 
cultures, even in areas where cell coverage was sparse formation of myotubes 
still occurred. This was not the case in the mutant cultures, where few myotubes 
were seen even in areas of dense cell coverage. It is possible that 
differentiation was impaired due to presence of non-SC cell types. The purity of 
the cell population plated could not be accurately assessed, as reporter mice 
were not available for these experiments. It is therefore possible that even 
though the cell density of control and mutant cultures appeared the same, there 
may have been much higher proportion of SCs in control cultures, allowing for 
the generation of more myotubes. It would be ideal to repeat these experiments 
using R26RtdTom reporter mice crossed with Pax7-Ta3f/f mutant and Pax7-Ta3f/+ 
control mice to enable visualisation of tdTomato positive SCs and calculate the 
purity of SC cultures. It would also be possible to use a marker of other cell 
types that could possibly be in the culture, for example fibroblast or adiopocytes 
to negatively assess purity. 
To summarise, in this chapter we have shown that the loss of Ta3 from 
SCs does not appear to affect their ability to migrate but may reduce their ability 
to proliferate. It is also likely that SC specific mutations of Ta3 leads to a 
reduction in myogenic differentiation and the formation of myotubes. This could 
explain the reduced capacity of Ta3 mutant SCs to support muscle regeneration 
following injury that was observed in chapter 3. It is possible the reduction of 
differentiation is due to a reduced upregulation of MRF members following SC 






Chapter 5 The effect of Talpid3 loss in satellite cells 
on their expression of myogenic regulatory genes 
 
5.1 Introduction 
In chapters 3 and 4 we have shown that a SC specific loss of Ta3 impairs 
their ability to efficiently repair and regenerate skeletal muscle following 
localised injury and that this impairment appears to be due to a decreased 
ability of the satellite cells to differentiate and possibly a decreased ability to 
proliferate. In chapter 4 we showed that Pax7-Ta3f/f SCs were not able to form 
mature myotubes in vitro. This chapter will investigate if this is due to an inability 
to correctly re-activate the myogenic differentiation pathway by analysing the 
expression of MRFs (Myf5, MyoD and Mgn) in Pax7-Ta3f/f mutant SCs 
compared to Ta3f/f controls at 0, 24, 48 and 72hrs after myofibre isolation 
(hereafter referred to as T0, T24, T48 and T72). The number of SCs and 
myofibres analysed at each time point is summarised in Table 5.1. We thought 
measuring fibres from 3 mice of each genotype would be sufficient for 
determining the differences between controls and mutants, but from the data it 
is clear a greater n number is required. Therefore, this chapter serves as a pilot 
study that needs to be repeated to strengthen the results. 
 




Number of SCs 
Number of 
Myofibres 
Number of Mice 
Ta3f/f Pax7-Ta3f/f Ta3f/f Pax7-Ta3f/f Ta3f/f Pax7-Ta3f/f 
T0 90 96 22 20 4 4 
T24 80 109 14 21 3 4 
T48 149 168 17 22 3 4 
T72 322 295 32 31 3 4 
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The timing and expression of Pax7, Myf5, MyoD and Mgn in SCs following 
activation has been well studied (summarised in Fig. 5.1) and their roles have 
been well defined.  
Quiescent SCs robustly express Pax7 and therefore 100% of SCs are 
Pax7+ immediately after myofibre isolation. Of these Pax7+ SCs approximately 
90% are also Myf5+ whilst approximately 12% are also MyoD+ (Beauchamp et 
al., 2000). At this stage Mgn is not expressed in SCs. Within 24hrs MyoD+ SCs 
become much more common with approximately 65% of SCs expressing either 
Myf5, MyoD or both together (Cornelison and Wold, 1997). By 48hrs 
approximately 85% of SCs are Pax7+/MyoD+ with the expression of Mgn 
starting between 48 and 72hrs. By 72hrs approximately 40% of SCs are 
Pax7+/MyoD+. At this stage SCs appear to make a fate decision, those that 
begin to express Mgn are destined for terminal differentiation whilst those that 








Figure 5.1 Expression of MRFs during SC activation and differentiation 
Quiescent SCs express Pax7, a large proportion also express Myf5. Following activation 
by isolation almost all begin to express either Myf5/MyoD or both. By 48hrs post isolation 
all SCs will be expressing either Myf5 or MyoD and many will have down regulated Pax7. 
72hrs post isolation a proportion of SCs will express Mgn, these are destined for terminal 
differentiation whilst a smaller population will re-express Pax7, destined to re-enter the 
stem cell niche. 
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To investigate if there are any changes in Pax7 or MRF expression in SCs 
with a mutation in Ta3 EDL myofibres were isolated from Ta3f/f control and 
Pax7-Ta3f/f mutant mice that had been exposed to the tamoxifen scheme 
detailed in Fig 5.2. All mice used also contained Pax7ZsGreen reporter to visualise 
Pax7 positive SCs. Following isolation, a proportion of myofibres were fixed 
immediately to be used for T0 quiescent SC analysis, whilst the rest were 
cultured in suspension in the presence of serum to activate SCs. Myofibres 
were then fixed at 24, 48 and 72hrs following isolation (Fig 5.2). T0 and T24 
myofibres were immunostained with antibodies against Myf5 or MyoD. T48 
myofibres were immunostained with antibodies against Pax7 and MyoD and 
T72 fibres were stained with Pax7 and MyoD or MyoD and Mgn antibodies 




Figure 5.2 Tamoxifen and isolation protocol. 
Schematic of tamoxifen protocol and timing of myofibre fixation post isolation.  
 109 
5.2 Analysis of SC number  
Immediately after isolation at T0 the number of SCs on each myofibre was 
the same in Ta3f/f controls and Pax7-Ta3f/f mutants, an average of 4.15 ± 0.26 
and 4.65 ± 0.88 SCs per myofibre respectively (mean ± SEM). At T24 and T48 
the number of SCs per myofibre was not different in Pax7-Ta3f/f mutants 
compared to Ta3f/f controls (T24; p=0.28, T48; p=0.52) (Fig. 5.3). At T72    
although not significant there was a trend towards Pax7-Ta3f/f mutants having 
fewer SCs per myofibre compared to controls (T72; p=0.06) (Fig. 5.3).  
The average number of SCs per myofibre increased in Ta3f/f controls at 
each time point, as would be expected due to SC activation and proliferation. In 
Ta3f/f controls at T72 the average number of SCs per myofibre had increased 
significantly from T0, to 10.06 ± 0.09 SCs (p<0.0001, n=3). In Pax7-Ta3f/f 
mutants the number of SCs per fibre had not increased (p=0.27, n=3) (Fig. 5.3), 
This may suggest that Pax7-Ta3f/f mutant SCs show delayed proliferation 
compared to Ta3f/f controls.  
 
 
Figure 5.3 The average number of SCs per myofibre increases less over 
time in mice with SC specific loss of Ta3. 
Graph to show the average number of SCs per myofibre at T0, 24, 48 and 72 hours 
after myofibre isolation. **** indicates p≤0.0001, ns indicates p>0.05 calculated using 
unpaired, two-tailed t-test. n=3/4 Error bars = SEM.  
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5.3 The expression of Pax7 and Myf5 at SC isolation  
The expression of Pax7, through the ZsGreen reporter, Myf5 and MyoD, 
by immunostaining, was detected in SCs by fluorescence microscopy (Fig 5.4A, 
B). The expression of Pax7 in SCs fixed at T0 was the same in both Ta3f/f 
controls and Pax7-Ta3f/f mutants with 100% of SCs being ZsGreen positive 
(data not shown). A possible trend was observed for Myf5 expression, the 
proportion of Myf5 positive SCs was smaller in Pax7-Ta3f/f mutants (19%) 
compared to Ta3f/f controls (33%) although this difference was not statistically 
significant (p=0.09, n=4) (Fig. 5.4C). This may in part be due to the high degree 
of variation between the percentage of Myf5 positive SCs in each Pax7-Ta3f/f 
mutant mouse (3-36%), whereas the proportion was much more consistent in 
the Ta3f/f controls (24-32%). The expression of MyoD was significantly lower in 
Pax7-Ta3f/f mutants (0.6%) compared to controls (7%) (p=0.04, n=4) (Fig. 
5.4C). 
The majority of SCs in both Ta3f/f controls and Pax7-Ta3f/f mutants were 
Pax7 positive only, the proportion in mutants (81%) was not significantly 
different to controls (64.5%) (Fig. 5.4D) however there was a trend towards a 
higher proportion of Pax7 positive only SCs in Pax7-Ta3f/f mutants (p=0.09, 
n=4). All SCs were negative for Mgn (data not shown).  
The trend in these data suggests that the loss of Ta3 in SCs may disrupt 































Figure 5.4 The SC specific loss of Ta3 leads to a reduction in MyoD expression 
at T0. 
(A, B) Example images of Ta3f/f control and Pax7-Ta3f/f mutant SCs associated with their 
myofibre. Pax7 expression detected via ZsGreen fluorescence, Myf5 (magenta) and MyoD 
(red) detected via immunostaining, nuclei (blue) detected via DAPI staining. Scale bars = 
50µm. (A) Pax7 and Myf5 positive, MyoD negative SC. (B) Pax7 positive, Myf5 and MyoD 
negative SC. (C) Average percentage of SCs expressing Myf5 and MyoD. * indicates p≤0.05, 
ns indicates p>0.05 calculated by unpaired, two-tailed t-test. n=3/4. Error bars = SEM. (D) 
Percentage of SCs expressing each combination of Pax7/Myf5/MyoD.  
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5.4 The expression of Pax7, Myf5 and MyoD at T24 
The expression of Pax7, through the ZsGreen reporter, Myf5 and MyoD, 
by immunostaining, was detected in SCs by fluorescence microscopy (Fig 5.5A, 
B). The expression of Pax7 in SCs fixed at T24 was the same in both Ta3f/f 
controls and Pax7-Ta3f/f mutants with 90% and 91% of SCs being ZsGreen 
positive, respectively (Fig. 5.5C). There was no difference in the proportion of 
SCs expressing Myf5 and MyoD in Pax7-Ta3f/f mutants (76% and 64%, 
respectively) compared to Ta3f/f controls (85.5% and 83%, respectively) (Myf5; 
p=0.53, MyoD; p=0.30, n=3/4) (Fig. 5.5C).  
By T24 the majority of SCs in both Ta3f/f controls and Pax7-Ta3f/f mutants 
were now Pax7, Myf5 and MyoD triple positive, 69% and 54% respectively (Fig. 
5.5D), with no difference in proportion between controls and mutants (p=0.4, 
n=3/4). The percentage of SCs expressing Pax7 alone or Pax7 and Myf5 was 
not different between Pax7-Ta3f/f mutants compared to Ta3f/f controls (Pax7 
p=0.4, Pax7 and Myf5 p=0.35 n=3/4) (Fig. 5.5D).  
Similar to the data at T0, in mutants there was quite a large variability in 
the proportion of SCs, which were Pax7 positive (4.5-52%), whereas the 
controls were again much more consistent (0-19%). All SCs were negative for 
Mgn (data not shown).  
At T24 there is no difference in the expression levels of Pax7, Myf5 or 






























Figure 5.5 A SC specific loss of Ta3 does not significantly affect the 
expression of Myf5 or MyoD at T24. 
(A, B) Example images of Ta3f/f control and Pax7-Ta3f/f mutant SCs associated with their 
myofibre. Pax7 expression detected via ZsGreen fluorescence, Myf5 (magenta) and MyoD 
(red) detected via immunostaining, nuclei (blue) detected via DAPI staining. Scale bars = 
50µm. (A) Pax7 and Myf5 positive, MyoD negative SC. (B) Pax7 and Myf5 positive, MyoD 
negative SC. (C) Average percentage of SCs expressing Myf5 and MyoD. ns indicates 
p>0.05, calculated by unpaired, two-tailed t-test. n=3/4. Error bars = SEM. (D) Percentage of 
SCs expressing each combination of Pax7/Myf5/MyoD.  
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5.5 The expression of Pax7 and MyoD at T48 
The expression of Pax7 and MyoD, by immunostaining, was detected in 
SCs by fluorescence microscopy (Fig 5.6A, B). At later time points (T48 and 
T72) antibodies against Pax7 were used rather than ZsGreen. This was to 
ensure that active Pax7 protein was detected rather than ZsGreen protein that 
was still present from earlier Pax7 expression.  
There was no difference in the proportion of SCs expressing Pax7 at T48 
in Ta3f/f controls (83%) compared to Pax7-Ta3f/f mutants (69%) (p=0.50, n=3/4) 
(Fig. 5.6C). There was no difference in the proportion of SCs expressing MyoD 
in Pax7-Ta3f/f mutants compared to Ta3f/f controls (both 93%) (Fig. 5.6C).  
By T48 the majority of SCs in both Ta3f/f controls and Pax7-Ta3f/f mutants 
were now Pax7, MyoD double positive (75.5% and 62% respectively), there was 
no difference in the proportion in controls compared to mutants (p=0.32, n=3/4) 
(Fig. 5.6D). The percentage of SCs expressing Pax7 alone was the same (both 
7%), there was also no difference in the proportion of SCs expressing MyoD 
alone in Pax7-Ta3f/f mutants (31%) compared to controls (17%) (p=0.4, n=3/4) 
(Fig. 5.6D). At this time point there was large variability in the proportion of SCs 
expressing MyoD alone in Ta3f/f controls (0-37%) and Pax7-Ta3f/f mutants (12-







Figure 5.6 A SC specific loss of Ta3 does not significantly affect the 
expression of Pax7 or MyoD at T48. 
(A, B) Example images of Ta3f/f control and Pax7-Ta3f/f mutant SCs associated with their 
myofibre. Pax7 (green) and MyoD (Red) detected via immunostaining, nuclei (blue) 
detected via DAPI staining. Scale bars = 50µm. (A) 2 Pax7, MyoD positive SCs and 1 
MyoD positive, Pax7 negative SC. (B) 1 Pax7, MyoD positive SC and 1 MyoD positive, 
Pax7 negative SC. (C) Average percentage of SCs expressing Pax7 and MyoD. ns 
indicates p>0.05, calculated by unpaired, two-tailed t-test. n=3/4. Error bars = SEM (D) 
Percentage of SCs expressing each combination of Pax7/MyoD. 
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5.6 The expression of Pax7, MyoD and Mgn at T72 
The expression of Pax7, MyoD and Mgn by immunostaining, was detected 
in SCs by fluorescence microscopy (Fig 5.7A, B and 5.7A, B). To analyse 
terminal differentiation of SCs, myofibres were immunostained with antibodies 
against MyoD and Mgn. To analyse SC self-renewal myofibres were 
immunostained with antibodies against Pax7 and MyoD. Unfortunately, the only 
antibodies available to us against Pax7 and Mgn were both raised in mouse, we 
were therefore unable to analyse Pax7 and Mgn together. 
 
5.6.1 Terminal differentiation 
There was no difference in the proportion of SCs expressing Mgn at T72 
in Pax7-Ta3f/f mutants (80%) compared to Ta3f/f controls (69%) (p=0.21, n=3) 
(Fig. 5.7C). There was also difference in the proportion of SCs expressing 
MyoD in Pax7-Ta3f/f mutants compared to Ta3f/f controls (98% and 99.5%) 
(p=0.35, n=3) (Fig. 5.7C).  
By T72 the majority of SCs in both Ta3f/f controls and Pax7-Ta3f/f mutants 
were now MyoD, Mgn double positive, there was no difference in the proportion 
in mutants (78%) compared to controls (68%) (p=0.22, n=3) (Fig. 5.7D).  
These data suggest that there is no difference in the timing of Myogenin 






Figure 5.7 A SC specific loss of Ta3 does not affect the expression of Mgn at 
T72. 
(A, B) Example images of Ta3f/f control and Pax7-Ta3f/f mutant SCs associated with their 
myofibre. MyoD (green) and Mgn (Red) detected via immunostaining, nuclei (blue) detected 
via DAPI staining. Scale bars = 50µm. (A) 1 MyoD, Mgn double positive SC and 1 MyoD 
positive, Mgn negative SC. (B) 2 MyoD, Mgn double positive SCs (C) Average percentage of 
SCs expressing MyoD and Mgn. ns indicates p>0.05, calculated by unpaired, two-tailed t-
test. n=3/4. Error bars = SEM (D) Percentage of SCs expressing each combination of 
MyoD/Mgn. 
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5.6.2 Satellite cell self-renewal 
The proportion of SCs expressing Pax7 at T72 was higher in Ta3f/f 
controls (21%) compared to Pax7-Ta3f/f mutants (9%), unfortunately only fibres 
from 2 control mice were available so statistical analysis was not performed 
(Fig. 5.8C). There was very little difference in the proportion of SCs expressing 
MyoD in Pax7-Ta3f/f mutants compared to Ta3f/f controls (98% and 99.5%) (Fig. 
5.8C).  
By T72 the majority of SCs in this experiment in both Ta3f/f controls and 
Pax7-Ta3f/f mutants were MyoD positive alone, the proportion was slightly 
higher in mutants (91%) compared to controls (79%) however this could not be 
statistically determined (Fig. 5.8D). The percentage of SCs expressing both 
Pax7 and MyoD was higher in controls (9.5%) compared to mutants (3.5%) but 
again couldn’t be statistically determined (Fig. 5.8D). 
These data suggest that SCs from Pax7-Ta3f/f mutants may not self-renew 
as efficiently as evidenced by a smaller proportion of cells retaining or 
reactivating Pax7 expression, however this would need to be repeated to 
increase the n number so statistical analysis can be performed before firm 


















Figure 5.8 The effect of a SC specific loss of Ta3 on Pax7 expression at T72. 
(A, B) Example images of Ta3f/f control and Pax7-Ta3f/f mutant SCs associated with their 
myofibre. Pax7 (green) and MyoD (Red) detected via immunostaining, nuclei (blue) 
detected via DAPI staining. Scale bars = 50µm. (A) 2 Pax7, MyoD double positive SCs and 
1 MyoD positive, Pax7 negative SC. (B) 4 MyoD positive, Pax7 negative SCs (C) Average 
percentage of SCs expressing Pax7 and MyoD. n=2 (D) Percentage of SCs expressing 
each combination of Pax7/MyoD. Error bars = SEM. 
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5.7 Expression of Pax7 and MRFs over time during SC 
activation and differentiation 
The proportion of SCs expressing Pax7 decreased over time following myofibre 
isolation as would be expected when SCs initiate the myogenic programme this 
decrease coincided with an increase in the proportion of cells expressing Myf5 
and MyoD (Fig. 5.9). This pattern of expression was observed in both Ta3f/f 
control and Pax7-Ta3f/f mutant mice. The only difference observed between 
Ta3f/f control and Pax7-Ta3f/f mutant mice was a reduction in MyoD expression 




























Figure 5.9 Trend in expression of Pax7 and MRFs over 72hrs following SC 
activation and in vitro culture. 
Graph showing the average percentage of SCs expressing Pax7 (full line), Myf5 (dashed 
line) and MyoD (dotted line) at T0, 24, 48 and 72. n=3/4.   
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5.8 Discussion 
The aim of this chapter was to investigate some of the molecular 
differences in Ta3f/f mutant SCs that could be playing a role in the regeneration 
defect revealed in chapter 3. However, unfortunately due to high variability 
between biological replicates using an n of 3/4 mice did not allow for enough 
statistical power to draw definitive statistical conclusion therefore this chapter 
will act as a pilot study to inform future experiments.  
Published data has determined the temporal expression of Pax7 and the 
MRFs during SC activation, proliferation and differentiation illustrating the 
importance of correct expression for myogenic progression and SC self-
renewal.  
SC specific KO of Ta3 did not affect the number of SCs present on each 
myofibre immediately after isolation with both Ta3f/f controls and Pax7-Ta3f/f 
mutants having an average of 4 SCs per myofibre (Fig 5.3). This is slightly less 
than previously published data which reported an average of 7-8 SCs per 
myofibre in EDL muscles (Zammit et al., 2002). The discrepancy between the 
number of SCs could be due to the number of myofibres analysed. Zammit and 
colleagues (2002) analysed 178 myofibres, whereas here we analysed 20 
myofibres from Ta3f/f controls and 22 myofibres from Pax7-Ta3f/f controls. 
However, the variability in the majority of our data is quite low, therefore 
counting more fibres may not increase the average to published levels. There is 
also the possibility of technical issues during cell counting. In particular, the 
MyoD antibody producing quite a high level of back ground which can make 
counting positive cells more difficult. It is therefore possible that we were too 
conservative in our counting to avoid false positives, however, this may have 
resulted in some positive SCs being missed. It is therefore important that these 
experiments are repeated and counted by more than one person.  
At T72 even though there was not a statistically significant difference 
between the number of SCs per fibre in Ta3f/f controls and Pax7-Ta3f/f mutants 
(Fig 5.3), the number of SCs per fibre had increased significantly in Ta3f/f 
controls from T0 to T72 and a significant increase in the number of SCs per 
fibre in Pax7-Ta3f/f mutants was not observed. Paired with the results from 
chapter 4 that showed a lower proportion of Pax7-Ta3f/f mutant SCs went 
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through 2 divisions compared to Ta3f/f control SCs, it suggests that a SC 
specific loss of Ta3 may lead to decreased proliferation in the mutant 
population. However, to confirm this more SCs and myofibres will need to be 
analysed to increase statistical power.  
We showed in chapter 4 that SCs with a Ta3 mutation do not differentiate 
as efficiently as control SCs in in vitro culture. The importance of the expression 
of Myf5, MyoD and Mgn for this process has been well documented (reviewed 
in Section 1.1.4.3). The general trend in Pax7 and MRF expression was the 
same in both Ta3f/f control and Pax7-Ta3f/f mutant SCs (Fig 5.9) and followed 
that of previously published data (Table 5.2).  
Pax7 expression was highest in quiescent satellite cells, gradually 
decreased over the 48hrs post isolation and eventually decreased dramatically 
by 72hrs in line with many SCs down regulating Pax7 in order to differentiate, 
with a small population retaining or re-expressing Pax7 to re-enter the stem cell 
niche. At T0 and T24 Pax7 expression in control and mutant SCs was similar to 
published values however at T48 and T72 the number of SCs expressing Pax7 
in controls was slightly lower than published, whilst in mutants was quite a lot 
lower. Together with previous evidence that the loss of primary cilia from SCs 
impairs their ability to self-renew and leads to a decrease in the number of SCs 
expressing Pax7 (Jaafar Marican et al., 2016) and our observations of severe 
defects in muscle regeneration after repeate injuries it is possible that Pax7-
Ta3f/f SCs may not be retaining Pax7 expression leading to a decreased ability 













Table 5.2 Comparison of Pax7 and MRF expression in Ta3 mutant and control 
SCs to published data. 
Number of SCs are expressed as average percentages. Data from (Beauchamp et al., 2000; 
Jaafar Marican et al., 2016; Zammit et al., 2004; Zammit et al., 2002; Zammit et al., 2006) 
 
The onset of expression of MRFs in SCs following activation happens 
within a few hours of isolation. Zammit et al. (2002) showed an increase from 
11% to 86% of SCs expressing MyoD within 6hrs of isolation. In our 
investigations, SCs were fixed within 2hrs of isolation (T0) and then again at 
24hrs. In doing this we observed a stark increase in the expression of Myf5 and 
MyoD in both Ta3f/f control and Pax7-Ta3f/f mutant SCs. With previous 
publications showing the expression of MyoD changing so dramatically within a 
short period of time, and given that primary cilia appear to be active during the 
first 24hrs of SC activation, it would be interesting to determine the profile of 
Myf5 and MyoD expression in more detail during the first 24hrs. Straface et al. 
(2009) have previously reported that blocking Shh signalling can prevent 
upregulation of Myf5 and MyoD expression that normally occurs following 
muscle injury. In our experiments, we observe that a smaller proportion of Pax7-
Ta3f/f mutant SCs express MyoD at T0, which could be due to the mis-
regulation of Shh signalling that occurs in Ta3 mutants.  
Time 
point 




Pax7 100 100 100 
Myf5 90 33 19 
MyoD 12 7 0.6 
T24 
Pax7 98 90 91 
Myf5 98 85.5 76 
MyoD 98 83 64 
T48 
Pax7 98 83 69 
MyoD 99 93 93 
T72 
Pax7 40 21 9 
MyoD 99 99.5 98 
Mgn 60 60 80 
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All of the differences observed in the expression profiles of Pax7-Ta3f/f 
mutants and Ta3f/f controls none of them were statistically significant (except 
MyoD expression at T0). Although the general timing of expression of the MRFs 
has been established, this will differ slightly between and within SC populations. 
This is also evident in the data for this chapter with the proportion of SCs 
expressing different genes at specific time points varying greatly. By 
immunostaining it is only possible to capture the expression profile of a SC at 
the time of fixation. It is therefore necessary to analyse a large number of SCs 
and myofibres to ensure that effects of variation in timings of expression are 
reduced. To support more definitive conclusions from this data, it is therefore 
necessary to repeat this time course again to increase the sample size. 
However, the data that has been obtained so far, indicate that a loss of Ta3 
from SCs may lead to a slower upregulation of Myf5 and MyoD within the first 
24hrs of activation and prevents SCs from re-entering the stem cell niche. Both 

















Chapter 6 Discussion 
This project focused on the roles of Ta3 in skeletal muscle satellite cells 
by investigating the molecular and phenotypic differences of SCs with a Ta3 
mutation and the implications this has on their ability to repair and regenerate 
skeletal muscle after injury. Ta3 null mutants are embryonic lethal (Cole, 1942) 
therefore to enable the study of adult SCs, mice were generated that had a 
tamoxifen inducible, SC specific mutation within the Ta3 gene. Mutant mice 
showed less efficient muscle regeneration following injury with Ctx. This 
phenotype became more severe and resulted in a loss of muscle regeneration 
when the muscle was subject to a repeat injury in 3/4 mice. This defect is 
potentially due to a reduced ability of Ta3 mutant SCs to proliferate and 
sufficiently upregulate the important MRFs, Myf5 and MyoD, leading to a 
reduced ability to differentiate. It also appears SC specific loss of Ta3 reduces 
the number of SCs that re-enter quiescence as a reduced proportion maintain/ 
re-express Pax7 following activation and proliferation, attaining to the more 
severe regeneration defect observed with repeat injuries.  
To date, little has been published on the effects Ta3 mutations have on 
skeletal muscle development. It has been briefly reported that epithelial cells 
within the dermomyotome express MyoD, which is usually restricted to the 
myotome (Davey et al., 2006). This expansion suggests a gain of Shh function 
within the developing somite. In terms of adult skeletal muscle regeneration 
there has been nothing published to date on the role of Ta3. Here we provide 
the first evidence that Ta3 is essential for normal muscle regeneration after 
injury. Using an in vivo model we provide quantitative analysis that showed 
muscle fibres in mutant mice were unable to reach the same size as control 
mice following injury. We also begin to explore how mutations in Ta3 effect the 
normal progression of SCs through the myogenic programme through analysis 
of proliferation, differentiation and the expression of key MRFs.  
 
 The impairment we observed in muscle regeneration in Pax7-Ta3f/f 
mutant mice could be due to defects in a number of steps of the regeneration 
pathway: proliferation, differentiation and SC self-renewal, which will be 
discussed in this chapter. 
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6.1 Satellite cell proliferation 
 Following injury SCs are activated and go through a few rounds of 
proliferation to produce an adequate amount of muscle progenitor cells for 
regeneration. There is contradictory evidence within the literature as to the role 
of Shh signalling and primary cilia for this process. In vitro studies using mouse 
SCs (Koleva et al., 2005) and myoblasts isolated from 3 day post hatch chicks 
(Elia et al., 2007) have shown that proliferation is increased when N-Shh protein 
is introduced to cultures. This increase in proliferation can be antagonised by 
adding cyclopamine together with N-Shh, suggesting the observed proliferation 
increase results from the Shh pathway. From this observation, it is inferred that 
Shh is therefore required for SC proliferation. Contradictory to this, the loss of 
primary cilia in C2C12 myoblast cells, which is accompanied by a reduction in 
the expression of Ptc1 and Gli1, also results in an increase in proliferation (Fu 
et al., 2014), correlating a reduction in Shh signalling with increased 
proliferation. The contradictory evidence within these pieces of research are 
likely due to the methods used to modulate Shh signalling. In the studies by 
Kolvea et al. and Elia et al. proliferation was not assessed when Shh signalling 
is disrupted without first artificially increasing it via N-Shh, leaving the possibility 
that the increase in proliferation is an artefact of the artificially high levels of 
Shh. Whereas, Fu et al. disrupted Shh signalling by disrupting primary cilia 
formation. This therefore is potentially more biologically relevant, however, this 
does not exclude the possibility that other pathways may also be affected. 
It is of course possible that both findings are relevant and the effects of 
Shh signalling and the presence of primary cilia act at different levels. The 
presence of a primary cilium is required for correct transduction of the Shh 
pathway, as revealed by the plethora of Shh phenotypes seen in cilia mutants 
(Cortellino et al., 2009; Huangfu et al., 2003; Sasai and Briscoe, 2012), 
therefore increasing the amount of Shh ligand in the presence of a primary 
cilium will lead to an increase in Shh signal transduction, which may signal to 
the SCs to proliferate. However, before an individual cell can divide the primary 
cilium must be disassembled to allow the centrosome to function as a spindle 
organiser (Izawa et al., 2015). Therefore, the response to a Shh signal and the 
proliferation of the cell must be a two step process. By removing the primary 
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cilium, the cells’ ability to respond to Shh is perturbed but its ability to proliferate 
is not due to the availability of the centrosome. 
In our observations, there is a small amount of evidence that proliferation 
may be reduced in SCs with Ta3 mutations. This would contradict the evidence 
provided in C2C12 cells when the primary cilium is disrupted (Fu et al., 2014). 
However, there are some differences in the methodologies used that could 
possibly affect the results. Firstly, Fu and colleagues disrupted primary cilia by 
suppression of Cep290, IFT80 and IFT88 with miRNAs resulting in a reduction 
in the number of ciliated cells by approximately 50%. The location and function 
of IFT proteins and Ta3 within the cilium differ and although disruptions in both 
seem to affect Shh signalling at the level of Gli proteins (Davey et al., 2006; 
Wang et al., 2013) it is possible that cilia disruption by these proteins have 
differing effects on proliferation. Using miRNA to disrupt cilia proteins may also 
show different effects to genetic disruption as was used in our research, 
approximately 15-20% of C2C12 cells still presented a cilium when treated with 
miRNA (Fu et al., 2014), however, Ta3 genetic mutations have been shown to 
result in the complete loss of primary cilia in chick and mouse (Bangs et al., 
2011; Yin et al., 2009).  
Another possibility for a reduction in proliferation in Ta3 mutant cells could 
be due to the positioning of the centrosome in Ta3 mutants. Although it has 
been robustly shown that Ta3 mutants fail to form primary cilia this is due to a 
failure of the centrosome to dock into the plasma membrane (Yin et al., 2009), 
therefore unlike in other cilia mutants, it is possible that the centrosome in Ta3 
mutants is not available for cell division as it remains located at the cell 
periphery.  
 
Although the findings by Fu et al. (2014) and (Koleva et al., 2005) appear 
to contradict each other, the function of the primary cilia in the response to Shh 
signal may be separate to its function in proliferation. Which of these processes 
is disrupted in Pax7-Ta3f/f mutant SCs though remains unclear and more in-
depth analysis of proliferation is required by a combination of repeating time 
lapse imaging experiments and also possibly labelling isolated SCs for markers 
of proliferation such as EdU.  
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6.2 Satellite cell differentiation 
The activation of SCs after skeletal muscle injury culminates in the 
differentiation of myoblasts and the formation of multinucleated myofibres. It 
appears this process is under the control of Shh signalling (Elia et al., 2007; Fu 
et al., 2014; Koleva et al., 2005), however reports are again somewhat 
contradictory.  
 We have observed a striking reduction in MHC positive myotube 
formation in Pax7-Ta3f/f mutant SCs grown in culture and a possible delay in the 
expression of Myf5 and MyoD in SCs following isolation of myofibres. This is 
similar to observations from C2C12s with disrupted ciliogenesis in which levels 
of Myf5, MyoD and Mgn are all reduced along with the formation of MHC 
positive myotubes (Fu et al., 2014). Similar results were also observed in 
primary chick myoblast cells in which the addition of N-Shh lead to an increase 
in MHC protein (Elia et al., 2007), contradictory to this addition of N-Shh to 
mouse SC cultures appeared to block the expression of myogenin and the 
formation of myotubes. This was rescued by the addition of cyclopamine 
(Koleva et al., 2005). However, unlike the study by Elia et al. in which they 
added N-Shh after ensuring primary chick cultures were quiescent, this was not 
specified by Koleva et al. It is therefore possible that the different response to 
the addition of N-Shh is due to the timing of exposure, which may lead to 
different effects in this dynamic system. Again, both of these only assess the 
consequences of artificial activation of Shh signalling via N-Shh and not what 
happens when endogenous Shh signalling is perturbed. There is in vivo 
research that provides evidence indicating Shh signalling is necessary for SC 
differentiation. By blocking endogenous Shh signalling with cyclopamine 
Straface et al. (2009) showed that the upregulation of Myf5 and MyoD is 
impaired in injured muscle. This provides a more biologically relevant 
comparison to our investigations.  
 Although we have shown a trend suggesting a delay in upregulation of 
MyoD in cultured Pax7-Ta3f/f mutant SCs, which could be due to a mis-
regulation of the Shh signalling pathway, statistical differences in Myf5 
expression were not observed and variability within our data was high. Our data 
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therefore remains inconclusive and further analysis of MRF expression in 
mutant SCs is required.   
6.3 Satellite cell self-renewal 
To ensure skeletal muscle is able to withstand multiple injuries throughout 
a life time, a proportion of activated SCs re-enter the stem cell niche by self-
renewal to maintain the stem cell pool. In our Pax7-Ta3f/f mutants the almost 
absence of regeneration in muscles that have undergone consecutive injuries, 
suggests that Ta3 is playing a vital role in the ability of SCs to self-renew. This 
would support research by Jaafar Marican et al. (2016) who reported for the first 
time the involvement of primary cilia in SC self-renewal, observing the 
reappearance of primary cilia on a proportion of SCs after 72hrs in culture, 
these cilia were preferentially distributed to Pax7 expressing cells. When 
primary cilia were disrupted they observed a reduction in the number of SCs 
expressing Pax7. These data suggest the need for a primary cilium for self-
renewal, however it does not address which signalling pathways may be 
affected that is leading to the reduction in self-renewal. It is speculated in the 
paper that Shh would be involved due to its reliance on primary cilia for its 
transduction. Our observations in Ta3 mutant SCs provide some evidence that 
this is likely the case, because of the close link between Ta3 and the Shh 
pathway. However, the stability of the primary cilium in the absence of 
functional TA3 protein still remains to be understood. Therefore, the exact 
timing that the primary cilium is lost or leads to disruption of the Shh pathway in 
our model needs to be determined before conclusive links between the 
phenotypes we observe and disruptions of the Shh pathway can be made. 
 
6.4 Ta3 mutations and primary cilia  
The presence of primary cilia on quiescent SCs was recently confirmed by 
immunostaining with antibodies against Arl13b, a protein that localises to the 
primary cilium membrane (Jaafar Marican et al., 2016). A hallmark phenotype of 
the Ta3 mutants is their lack of primary cilia in all cell types (Yin et al., 2009), 
therefore it is assumed that SC specific mutations in Ta3 will lead to the loss of 
primary cilia in SCs. Unfortunately, during this project we were unable to 
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successfully immunolabel primary cilia on SCs and therefore were not able to 
confirm their loss in Ta3 mutants. Successful identification of primary cilia was 
achieved in C2C12 cells by immunostaining using antibodies against acetylated 
⍺-tubulin and Arl13b, however when the same antibodies were applied to 
myofibre preparations we were not able to detect primary cilia on SCs.  
It is well documented that primary cilia are highly dynamic, disassembling 
and re-assembling in cells that are actively progressing through the cell cycle. 
Jaafar Marican et al. (2016) documented that primary cilia are mainly present 
on quiescent SCs and 24hrs after isolation of myofibres very few SCs possess 
a primary cilium. Although we aimed to fix SC whilst they were still quiescent 
following myofibre isolation it is possible that the cilium had already begun to 
disassemble.  
With the loss of primary cilia being reported in all other cell types analysed 
in Ta3 mutants the results presented in this research have been interpreted with 
the assumptions that unperturbed, quiescent SCs in their niche have a primary 
cilium and that Ta3 mutant SCs will lose their primary cilium. However, as 
previously mentioned it is currently not clear as to when the primary cilium is 
lost in Ta3 mutant SCs. Due to the presence of functional TA3 during embryonic 
and post-natal development QSCs will posses a primary cilium. It is not yet 
known if TA3 is required for the maintenance of the primary cilium. If it is not 
required the primary cilium will remain on QSCs even after recombination of the 
Ta3 locus my tamoxifen until SCs re-enter the cell cycle, during which time the 
primary cilium is disassembled. It is critical for the correct interpretation of this 
data that the presence or absence of primary cilia on SCs are determined in our 
model. 
 
6.5 Ta3 mutations and Shh signalling  
The effects of mutations in the Ta3 gene have been well studied in 
embryonic development in mouse, chick and zebrafish. All Ta3-/- models show 
pleiotropic Shh phenotypes (Bangs et al., 2011; Ben et al., 2011; Ede and Kelly, 
1964a, b) caused by a misregulation of the pathway at the level of Gli protein 
processing (Davey et al., 2006). It has been recently demonstrated that both 
Gli2 and Gli3 require intact cilia for their correct processing. Gli2 activator 
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function is disrupted if not localised to the cilium (Liu et al., 2015), whilst Gli3 is 
dependent on the cilium for processing into the repressor form (Huangfu and 
Anderson, 2005). A further complexity to the pathway is the differential 
degradation of Gli3A and Gli3R, with the repressor form (R) being more stable 
than the activator (A). The loss or disruption of primary cilia therefore results in a 
decrease in Gli2A but also a decrease in Gli3R and an increase in Gli3A. 
Although Gli3R is more stable the loss of the cilium results in less Gli3R being 
produced. This loss of Gli3R can still allow for a low level of transcription of 
some Shh response genes. It is this loss of repression that is likely the reason 
cilia mutants show less severe phenotypes than Shh-/- mutants. There is no 
comparable data to directly assess the difference between Shh-/- mutants and 
cilia mutants. However, Shh-/- mutants display complete loss of Myf5 and MyoD 
expression in the epaxial somite (Borycki et al., 1999) whereas this does not 
appear to be the case in Ta3 mutants, they actually display an expansion of 
MyoD expression in the somite (Davey et al., 2006). This is a possible 
explanation for the fact that we observe only a delay in muscle regeneration 
and not a complete loss after a single injury in Pax7-Ta3f/f mutant mice. 
 Whether a particular system shows a gain or loss of function of Shh 
phenotype in Ta3 mutants is dependent on the endogenous Gli2/3A:Gli2/3R ratio 
required for normal function. At this point it is not known what the normal 
expression of Gli2 and Gli3 and therefore the GliA:GliR ratio within SCs at 
different stages of differentiation is.  
Unfortunately, within the timeframe of this project we were not able to 
explore the effect a SC specific mutation in Ta3 has on the Shh signalling 
pathway, which could potentially provide molecular evidence for some of the 
regeneration phenotypes we observed. For example, the trend in reduced 
differentiation of Pax7-Ta3f/f mutant SCs we observed may suggest a loss of 
function of Shh phenotype. However, without examining changes in the Shh 
pathway it is not possible to conclude whether Ta3 mutations lead to a gain or 
loss of function phenotype in SCs. To begin to answer this question in more 
detail the ratio of GliA:GliR in quiescent, activated and differentiating SCs would 
need to be established and compared to that of SCs with Ta3 mutations. 
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6.6 Other signalling pathways  
A number of other pathways, aside from Hedgehog signalling, have been 
shown to depend on primary cilia for their regulation. These include the 
canonical and non-canonical Wnt pathways (Otto et al., 2008; Wallingford and 
Mitchell, 2011) and Notch signalling (Ezratty et al., 2011), which have not been 
studied in this project but are noteworthy due to both also being implicated in 
the function SCs.  
 The Wnt/β-catenin pathway has been shown to promote SC proliferation 
in the presence of Wnt1, Wnt3a and Wnt5a ligands during muscle regeneration 
whilst Wnt4 and Wnt6 inhibit proliferation by secluding β-catenin to the cell 
membrane. This is supported by the presence of Wnt1, Wnt3a and Wnt5a in 
proliferating myoblasts but the absence of Wnt4 and Wnt6 which are expressed 
in quiescent SCs (Otto et al., 2008). The Wnt/PCP pathway has been linked to 
SC self-renewal. Wnt7a has been shown to act through the Frizzled7 receptor 
to activate the Wnt/PCP pathway (Le Grand et al., 2009). Increasing the 
expression of Wnt7a stimulates symmetrical cell division and expansion of the 
stem cell pool, therefore linking the non-canonical Wnt pathway with SC self-
renewal.  
 Notch has been implicated at multiple steps within the muscle 
regeneration pathway, most notably in the activation and proliferation of SCs. 
Inhibition of the Notch pathway inhibits SC activation and causes muscle 
regeneration impairment; however, the inhibition of Notch is required for the 
onset of myogenic differentiation (Conboy and Rando, 2002). Although the 
evidence published for the involvement of primary cilia in Notch signalling is 
limited, it has been reported that Ift74 mutants show decreased activation of 
Notch reporter activity at an embryonic level (Ezratty et al., 2011).  
Evidence linking the Wnt and Notch pathways with primary cilia remains 
limited and, in the case of Wnt signalling, is conflicting. This is likely due to Wnt 
and Notch specific phenotypes in cilia mutants being subtle (Wallingford and 
Mitchell, 2011) and often masked by the obvious Shh phenotypes. This is 
perhaps why, to date, there has been little investigation into the effect of Ta3 
mutations on Wnt and Notch signalling. However, due to their importance in SC 
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activity it would be interesting to investigate changes that may be occurring in 
these pathways in the Pax7-Ta3f/f mutant. 
 
6.7 Impact of research  
Mutations in the human orthologue of Ta3 have been implicated in the 
development of some human ciliopathies. Primarily patients with mutations in 
TA3 present with Joubert Syndrome, a severe but rare ciliopathy characterised 
by a mid-hindbrain malformation (Roosing et al., 2015; Stephen et al., 2015), 
however a couple of patients have been identified that present with both 
Joubert and Jeune Syndromes (Malicdan et al., 2015). The majority of 
symptoms of Joubert Syndrome develop due to neurological defects including 
the presentation of hypotonia and ataxia (Maria et al., 1999). Although these 
symptoms are neurologically induced it is possible that they are masking an 
additional skeletal muscle defect arising from poor regenerative ability due to a 
defect in SCs. Therefore, providing insights into the role of Ta3 in satellite cells 
and skeletal muscle regeneration may aid in further understanding these 
syndromes.  
There is growing evidence that modulating the Shh pathway may be a 
viable treatment for age and disease related defects in muscle regeneration 
(Piccioni et al., 2014a; Piccioni et al., 2014b). Administration of Shh by injection 
of plasmid expressing human Shh improved muscle regeneration after injury in 
aged mice, increasing the number of Myf5 positive cells, the number of 
regenerating fibres and decreasing the amount of fibrosis. Similar 
improvements have also been observed with the introduction of human Shh 
expressing plasmids in mdx mice. Our research using the Pax7-Ta3f/f mutant 
provides further evidence for the role of Shh signalling and primary cilia in SC 
mediated muscle regeneration. The generation of a SC specific Ta3 mutant 
model and our preliminary results provide a platform for further research, which 
will aid in a deeper understanding of the function of Ta3 and the complex 
process of muscle regeneration.  
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6.8 Future research  
We have demonstrated in this research a clear requirement for Ta3 in 
skeletal muscle regeneration, however the exact mechanism and signalling 
pathways which are disrupted in Pax7-Ta3f/f mutant SCs remain unclear. 
Although the Shh signalling pathway is one of the strongest candidates, it is 
vital to confirm this, potentially through q-PCR analysis of Ptc1 and Gli1 to 
assess the activity of the Shh pathway in Ta3 mutant SCs. The normal ratio of 
GliA:GliR in SCs and how this differs from Ta3 mutant SCs will be critical to the 
determination of whether Ta3 mutations specific to SCs produce a gain or loss 
of function of Shh signalling phenotype.  
 The precise phenotypic traits of Ta3 mutant SCs also requires further 
investigation. SC migration needs to be re-assessed using time-lapse 
microscopy. At the same time the rate and dynamics of SC proliferation can be 
re-analysed. With the evidence that primary cilia are required for SC self-
renewal it would be interesting to assess the orientation of SC division whilst 
associated with their myofibre. Previous studies have shown that apical-basal 
divisions are more often asymmetric, with the daughter cell that remains in 
contact with the basal lamina giving rise to a cell that will re-enter quiescence 
(Kuang et al., 2007). This evidence suggests the niche plays a role in the 
maintenance of stem cell identity. It would therefore be interesting to analyse if 
Ta3 mutant SCs are still able to respond to signals from the niche without a 
primary cilium. This could be assessed by quantifying the number of apical-
basal and planar division during time lapse microscopy. The symmetry of 
division could be assessed on fixed fibres by immunolabelling pairs of SCs and 
noting the expression of Pax7 and Myf5 in relation to the plane of divison.  
More detailed investigations into the proliferative activity of Ta3 mutant 
SCs is also important. In this research, we examined proliferation by analysing 
the number of cell divisions during time lapse imaging. However, it is not always 
possible to count every division, especially when cell clusters begin to form.  It 
is also possible that some actively cycling cells are missed if they do not divide 
within the time frame of the imaging, or the cells move out of the field of view. 
Therefore, measuring the incorporation of EdU in isolated SC cultures will allow 
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for a more accurate and quantitative representation of the proportion of SCs 
actively proliferating.  
 Although we show what appears to be a clear defect in differentiation 
and myotube formation in Pax7-Ta3f/f mutant SC cultures there were limitations 
to these experiments, for example we were not able to accurately count the 
number of SCs plated and were not able to determine the purity of the culture. 
These experiments therefore need to be repeated using quantitative seeding of 
a pure SC population. 
Taking advantage of the fact we have generated Pax7-Ta3f/f mutant mice 
that also express the Pax7ZsGreen reporter, SCs could be sorted by fluorescence 
activated cell sorting (FACS) providing a pure and quantifiable culture that can 
then be used to assess proliferation by EdU incorporation and differentiation by 
myotube formation and MHC staining. FACS sorted SCs could also be used as 
a source of mRNA and protein to investigate the expression levels of 
components of the Shh pathway including Ptc1 and Gli1 whilst also assessing 
the ratio of GliA:GliR and address the question as to whether Ta3 mutations 




Appendix 1  
Appendix 1.1 Number of myofibres analysed for quantification for short term 
injury experiments. 
Table detailing the number of myofibres, images and sections analysed for each mouse at 
















4318 2584 25 5 
4319 1715 20 5 




4349 2173 15 4 
4344 2219 14 7 




4316 953 13 6 
4317 1507 20 4 




4336 1892 15 4 
4330 740 13 4 




4649 632 10 8 
4650 719 10 7 
4651 592 10 7 




4686 1327 10 7 
4744 1295 10 7 
4745 1849 10 8 
4691 1456 10 8 
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Appendix 1.2 Number of myofibres analysed for quantification for long term 
injury experiments. 
Table detailing the number of myofibres, images and sections analysed for each mouse. 








4320 3100 29 6 
4558 3844 39 8 
4576 5180 37 8 




4350 5767 30 6 
4351 4257 25 5 
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